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The Maine Department of Environmental Protection (DEP) currently monitors 
river dioxin levels through the sampling and destructive analysis of fish. Recent state law 
mandates that by December 3 1,2002, the dioxin concentrations in fish downstream of a 
bleached Kraft pulp and paper mill are not to exceed the concentrations in fish upstream 
of the mill (38 M.RS.A. $420-A). The objective of this thesis project was to develop an 
alternate method for determining Kraft mill compliance to this Dioxin law. This new 
method that uses semipermeable membrane devices (SPMDs) circumvents many of the 
concerns generated by the upstream-downstream fish test. An important advantage is 
that the SPMDs sample current dioxin concentrations at fixed sites. 
Over the course of two field seasons, we assessed the feasibility of using SPMDs 
to monitor dioxin concentrations in Maine rivers. The 1999 field season focused on 
developing viable field and laboratory SPMD methods. Field methods included design of 
the vertical deployment apparatus for the SPMDs and determination of which 
environmental conditions to monitor. In the laboratory, the final SPMD extraction and 
cleanup methods included extraction by dialysis of the entire SPMD into hexane followed 
by two cleanup methods: acidified silica gel slurry to remove residual lipids and gel 
permeation chromatography to remove interference through size exclusion. The final 
laboratory analysis involved EPA Method 16 13B and high resolution gas 
chromatography 1 high resolution mass spectrometry (HRGC/HRMS). 
For the 2000 field season we applied the developed methods to assess the effects 
of varying environmental conditions on SPMD sampling and to test two pairs of 
upstream-downstream sites: one on the Androscoggin River and one on the Kennebec 
River. A preliminary investigation of the effect of varying environmental conditions on 
SPMD dioxin concentrations was conducted. The positive temperature correlation and 
negative water velocity correlation with SPMD dioxin concentrations are significant and 
require further research. Investigations indicated that there was no statistical difference 
between upstream and downstream dioxin concentrations at both pairs of sites. 
The effects of environmental conditions on SPMD dioxin concentrations need to 
be further studied with experimental designs that allow for additional statistical tests; 
otherwise, a permeability reference compound for dioxin should be identified to correct 
SPMD concentrations for varying environmental conditions at the sites during a 
deployment. Repeating the 2000 field season experimental design provides for 
comparisons to be made between years and all current hypotheses may be re-evaluated. 
This thesis identifies a potentially significant alternative to compare with the rest of the 
dioxin monitoring data gathered during the 2000 field season, the various sample types 
and species of fish as well as caged freshwater mussels. The Department of 
Environmental Protection's evaluation of all available data will bring the state of Maine 
closer to determining the most appropriate upstream-downstream test. 
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1. INTRODUCTION 
Maine's Dioxin Monitoring Program through the Department of Environmental 
Protection (DEP) is faced with the challenge of determining an appropriate upstream- 
downstream dioxin monitoring test as a result of the 1997 Dioxin Law. This law 
mandates that by December 3 1,2002, the dioxin concentrations in fish downstream of a 
bleached Kraft pulp and paper mill are not to exceed dioxin concentrations in fish 
upstream of the mill (38 M.R.S.A. $420-A). This project investigates the feasibility of 
using semipermeable membrane devices (SPMDs) to perform this upstream-downstream 
test. 
This introductory chapter begins with an examination of the problem tackled in 
this project. However, before dioxin-monitoring methods can be investigated, 
background information on dioxin must be compiled in order to understand what this 
pollutant is and why dioxin must be monitored. Therefore, a dioxin question and answer 
section in this chapter substantiates the significance of dioxin monitoring in the State of 
Maine. 
This preliminary dioxin information provides a foundation for understanding the 
subsequent related research section, which discusses Maine's Dioxin Monitoring Program 
and the multiple approaches taken to develop an upstream-downstream test. With the 
alternatives presented, we probe the possibilities presented with the SPMDs by gaining an 
understanding of both their capabilities and their limitations. A comprehensive summary 
of previous SPMD experiments and how the devices compare to alternate pollutant 
monitoring methods completes the related research section of the introduction. Finally, 
with the major project parameters discussed in the first three sections, we provide the 
research objectives and hypotheses in the fourth section and present the scientific and 
societal importance of this project in the final section. 
1.1 The Problem 
Polychlorinated dibenzo-p-dioxins (PCDDs) and polychlorinated dibenzofurans 
(PCDFs), collectively termed as dioxin, are two classes of chemically similar and toxic 
compounds. Dioxin, specifically 2,3,7,8-tetrachlorodibenzo-p-dioxin, has been positively 
identified as both a human carcinogen and an endocrine disrupter (EPA 2000). A wide 
variety of both anthropogenic and natural processes lead to the inadvertent production of 
dioxin as a byproduct. These processes include incinerating of solid waste, chlorine 
bleaching of wood pulp, and burning of forest fires. In Maine, the various bleached Kraft 
pulp and paper mills are currently working with the Department of Environmental 
Protection to comply with the Dioxin law by December 3 1,2002. This law states that the 
dioxin concentrations in fish downstrean1 of a bleached Kraft pulp and paper mill are not 
to exceed the concentrations in fish upstream of the mill (38 M.R.S.A. $420-A). 
Therefore, a method is needed which can measure the compliance of mills with this 
mandate. The search for a sensitive, cost-effective, and accurate method of routinely 
monitoring dioxin levels in natural waters has begun in order to find the best test. 
1.1.1. Current dioxin monitoring method 
Water samples obtained from surface waters are difficult to use for determining 
dioxin concentrations because these compounds are typically present at concentrations 
below the established method detection limits. However, despite these low 
concentrations, dioxin may bioaccumulate in fish to levels where its toxicity becomes 
hazardous to consumers. Because of this process of bioaccumulation in the food chain, 
fish are currently used for analysis since dioxin accumulates in their lipids through 
respiration, dermal contact, and mostly ingestion of dioxin-containing food sources 
(Huckins et al. 1996). Although fish can be used to monitor many contaminants, there 
are concerns with this current method: 
1. Fish are mobile and their populations are generally non-uniformly distributed. 
2. Dioxin levels in fish vary with fish age. Older fish have higher levels of 
dioxin than younger fish. 
3. Different species of fish bioaccumulate dioxin at different rates. 
4. Due to bioaccumulation, fish provide historical dioxin concentrations rather 
than current dioxin concentrations. 
5. Different species of fish metabolize and eliminate dioxin at different rates, 
thus introducing more potential for bias. 
6. It can be difficult to produce a homogenous sample for extraction and 
analysis. 
7. Inherent error is present. There is a need for the sampling of many fish in 
order to prove a statistical difference between upstream and downstream 
concentrations. 
Therefore, in assessing the upstream-downstream legislation ramifications, it is essential 
to develop a method which: 
J Is reliable in its sampling of a particular location. 
J Involves exposure of the samples for both fixed deployment times and 
sampling rates that are uniform for both upstream and downstream testing 
sites. 
J Has the sensitivity to detect small minimum significant differences in 
dioxin concentrations between sites. 
1.1.2. Proposed upstream-downstream dioxin monitoring method 
Semipermeable membrane devices (SPMDs) are exclusively manufactured in the 
United States by Environmental Sampling Technologies of St. Joseph, Missouri. SPMDs 
consist of a thin film of triolein, which is a large molecular weight, chemically neutral 
lipid, encased by a low-density polyethylene membrane. This configuration allows the 
devices to sequester trace organic contaminants from natural waters (Huckins et al. 
1990). However, while SPMDs subvert many concerns associated with the sampling of 
fish, the devices are not perfect. Biofouling (which is exterior debris and periphyton that 
collect on the device over the sampling period), temperature, water velocity, and 
dissolved organic carbon (DOC) may effect SPMD uptake rates, thus presenting the need 
to assess these factors at each deployment site. 
1.2 Dioxin: Questions and Answers 
1.2.1. What is dioxin? 
Dioxin is the collective term used for 75 polychlorinated dibenzo-para-dioxins 
and 135 polychlorinated dibenzofurans (PCDDIFs) which are two classes of chemically 
similar compounds (Figure 1.1). The basic carbon backbone consists of two benzene 
rings joined by either two oxygen atoms ( PCDDs) or one oxygen atom (PCDFs). The 
oxygen atoms in PCDD are arranged directly across from one another, adopting apara  
configuration. The numbers adjacent to each carbon in the benzene rings signify a 
potential site for chlorination. When one of the sites is chlorinated, a carbon-chlorine 
bond replaces a carbon-hydrogen bond. 
PCDDs and PCDFs are two large classes of compounds; a congener is the general 
term used for each member of the PCDD and PCDF classes. Therefore, a congener has 
the same structural backbone (i.e. belongs to the same class such as PCDD or PCDF) but 
has a different number andlor positioning of chlorine atoms on the carbon backbone. 
There are a total of 75 PCDD and 135 PCDF congeners (EPA 2000). While the term 
congener generally dominates as the descriptor of dioxin, the tenn isomer is used when 
discussing groups of congeners. All isomers are congeners but not all congeners are 
isomers of one another. Structural isomers have the same molecular formula (same 
number of carbon, chlorine, and hydrogen atoms) yet vary in the positioning of the 
chlorine atoms (Carey 1996). There are eight sets each of PCDD and PCDF isomers 
since it is feasible to have one through eight chlorine atoms on the carbon backbones 
(mono- through octa- substituted dioxin). A homologue is the term used to represent a 
class of congeners, which consists of all of the isomers possible at one level of 
FIGURE 1.1. Seventeen Toxic Dioxin Congeners: Structures and Nomenclature 
Polychlorinated Dibenzo-p-Dioxin (PCDD) 
- 
Toxic Congeners Studied Abbreviation Molecular CAS 
Formula Registry 
1,2,3,4,6,7,8-Heptachlorodibenzo-p-dioxin 1,2,3,4,6,7,8-HpCDD CL2H02C17 35822-46-9 
Octachlorodibenzo-p-dioxin OCDD C1202ch 3268-87-9 
Polychlorinated Dibenzofuran (PCDF) 
Toxic Congeners Studied Abbreviation Molecular CAS 
Formula Registry 
1,2,3,4,6,7,8-Heptachlorodibenzofuran 1,2,3,4,6,7,8-HpCDF C12HOC17 67562-39-4 
1,2,3,4,7,8,9-Heptachlorodibenzofuran 1,2,3,4,7,8,9-HpCDF CI2HOCl7 55673-89-7 
Octachlorodi benzofuran OCDF c120Ch 3900 1-02-0 
chlorination (Eitzer 1993). Therefore, all of the congeners that belong to the same 
homologue group are isomers of one another. 
There are a total of seven toxic PCDD congeners and ten toxic PCDF congeners 
(EPA 1994; 2000; Van den Berg et al. 1998). All seventeen toxic congeners have 
chlorine atoms in the 2,3,7, and 8 positions (Fries 1995; EPA 2000), and are persistent in 
the environment. 
1.2.2. What are the sources and fates of dioxin? 
Widely publicized outbreaks of dioxin contamination and the resulting adverse 
health effects in places like Seveso, Italy in 1976 (Bertazzi et al. 1993), Love Canal, NY 
in 1979, and Times Beach, MO in 1983, have fieled the need to investigate the sources of 
dioxin so that emissions can be controlled and exposure reduced through government 
regulation (EPA 1994; 2000). The most current EPA Dioxin Reassessment draft lists five 
major sources of dioxin: 1. Combustion and incineration sources (both anthropogenic and 
natural combustion sources), 2. Metal smelting, refining, and processing, 3. Chemical 
manufacturing / processing (this would include the chlorine bleaching of pulp), 4. 
Reservoir sources including sediment, soil, and organic matter, and 5. Biological and 
photochemical processes (EPA 2000). This source listing illustrates the combination of 
anthropogenic and natural processes that lead to the unintentional existence of these toxic 
compounds in the environment. Human activity is believed to be the major source of 
dioxin (Thomas and Spiro 1996). Data from EPA's Quantitative Inventory of 
Environmental Releases of Dioxin in the United States was used to illustrate the 
distribution of dioxin releases among various media (EPA 2000). 
FIGURE 1.2. % Dioxin Release Inventory for the United States, 1995. The bulk of 
dioxin is emitted to the air through incineration processes. 
Most dioxin investigations have focused on combustion processes, with 
incineration being the primary source of PCDD/Fs (Czuczwa and Hites 1984, 1986; Fries 
1995; Thomas and Spiro 1996; Baker and Hites 2000a,b). These processes provide ideal 
conditions for dioxin formation: ample organic material for forming the carbon backbone, 
chlorine-containing materials, and heat. Scientists have identified these sources through 
their investigation of what has proven to be the ultimate environmental sink of dioxin: 
sediments. 
In the mid-1980's, Czuczwa and Hites (1 984, 1986) conducted studies of Great 
Lake sediments and urban air particulates to examine the transport and fate of dioxin. 
Octachlorinated dibenzo-p-dioxin, OCDD, dominated the congener profiles in both 
sediments and urban air particulates. Furthermore, correlating the dating of sediment 
cores with trends in dioxin levels showed a major increase in dioxin levels in the 1940's 
and a decrease in c%xin levels since the 1970's. What do these landmark dates signify? 
The increase in the 1940's correlates with the production of chlorinated organic 
compounds such as chlorobenzenes and chlorophenols (Czuczwa and Hites 1984). The 
decrease in the 1970's correlates with the restrictions placed on particulate emissions 
from combustion processes due to the Clean Air Act Regulations of 1970 (Czuczwa and 
Hites 1986). 
The congener profiles found in sediments varied from the flat congener profile of 
combustion samples in that sediments had less of the lower chlorinated congeners. 
Czuczwa and Hites (1986) attributed this finding to environmental degradation of the 
lower chlorinated congeners. These congeners have more carbon-hydrogen bonds than 
the higher chlorinated congeners thus rendering them more susceptible to atmospheric 
photolysis. While there are other environmental degradation pathways besides 
atmospheric photolysis, such as microbial degradation, Czuczwa and Hites (1 986) 
suggested the atmospheric photolysis hypothesis because the same congener profiles were 
found in both sediment and urban air particulate samples. This finding minimized the 
likelihood that degradation was occurring in the water or sediments. 
As the dioxin assessment has evolved in the United States and emissions have 
been reduced, scientists have been trying to balance the dioxin budget in order to identify 
missing sources. Most investigations have found dioxin deposition to be greater than 
emissions (Baker and Hites 2000a; Baker and Hites 2000b; Wagrowski and Hites 2000). 
Combustion sources of OCDD and heptachlorinated dibenzo-p-dioxin (HpCDD) are not 
declining like the other congeners (Baker and Hites 2000a). Therefore, as dioxin mass 
balance investigations continue, insights into possible missing dioxin sources have been 
provided. For instance, laboratory tests have confirmed the creation of OCDD and 
HpCDD from pentachlorophenol (PCP), a wood preservative, by a photochemical 
reaction in condensed air (Baker and Hites 2000a). There are also natural sources of 
dioxin. For example, forest fires have been proposed as one of the major natural 
combustion sources of dioxin (Thomas and Spiro 1996). Furthermore, a study by 
Ferrario, Byme, and Cleverly (2000) unearthed evidence of naturally occurring dioxin in 
mined clay products. Ball clay mined from prehistoric deposits in northwestern 
Mississippi was mixed in poultry feed as an anti-caking agent. The PCDD/Fs contained 
in the clay were ingested by the poultry. As a result, dioxin was detected in the poultry 
itself. The congener profile generated from the ball clay was different from all of the 
profiles of known dioxin sources; therefore, no anthropogenic source could be attributed 
to the presence of the PCDDIFs, thus rendering the clay the probable natural dioxin 
source (Ferrario et al. 2000). 
Transport of dioxin with air particulates and the deposition onto the oceans and 
lakes of the world remains the prevalent fate of dioxin produced from various sources. 
The low water solubility of dioxin directs its eventual burial in sediments. However, 
aerial transport leads to deposition of dioxin not only on water but also on land. Dioxin 
deposition on land occurs under the following scenarios: 1. Dioxin is deposited on plants 
which are then consumed by animals thus entering dioxin into the food chain, 2. Dioxin is 
deposited on the soil where it is taken up by plants that are then eaten by animals, or 3. 
Dioxin is deposited on the soil and the dioxin-contaminated soil is eaten directly by the 
animals, transported by erosion, or removed through photodegradation, volatilization or 
biodegradation processes (Fries 1995). 
This current investigation of dioxin in Maine has been generated by a widely 
investigated fate of dioxin: its introduction into the food chain. The persistence of these 
compounds due to their lipophilic nature allows them to be transferred from organism-to- 
organism up the trophic levels (Larsson et al. 2000). The eventual increase in dioxin 
concentrations, as dioxin is biomagnified in the food chain, results in fish consumption 
advisories issued by the Maine Bureau of Health and consequently violates Maine's water 
quality standards, specifically, the designated use of fishing. 
1.2.3. Why is there a concern about dioxin levels in surface waters? 
The concern about dioxin levels in surface waters stems from the various physical, 
biological, and chemical properties of dioxin that make it a threat to ecosystem health. 
The persistence, bioaccumulation, and low water solubility of dioxin make it difficult for 
organisms to metabolize these compounds. The persistence of dioxin is reflected in its 
estimated half-life of ten years to twelve years in both the environment and humans 
(Birnbaum and DeVito 1995). Moreover, due to dioxin's bioaccumulation 
characteristics, it affects the entire food because the predator inherits the dioxin present in 
the lipids of its prey. Thus 95% of human exposure to dioxin is through the consumption 
of animal products including meat, dairy products, and fish (Fries 1995; EPA 2000). 
Exposure to dioxin is believed to cause adverse health effects for a variety of 
organisms. Chloracne, a visible skin condition, develops after exposure to high levels of 
dioxin and disappears when exposure ends (EPA 1994; 2000). However, not all of the 
adverse health effects are as visible as chloracne. 2,3,7,8-TCDD has been identified as a 
human carcinogen and sixteen other toxic congeners are considered likely human 
carcinogens (EPA 2000). In addition, dioxin in laboratory animals has been found to 
produce carcinogenic, immunotoxic and reproductive effects (Fries 1995; Van den Berg 
et al. 1998; Maczka et al. 2000). 
Recently 2,3,7,8-TCDD was positively identified as an endocrine disrupter, or a 
hormonally active agent (Maczka et al. 2000). This identification raises concern because 
endocrine disruption carries with it many adverse health effects. First, endocrine 
disrupters are maternally transferred to fetuses in the womb and through breast feeding 
(Colborn et al. 1993). Hormonally active agents not only may generate reproductive and 
developmental effects but also may foster immune suppression and increased risk of 
hormone-related cancers (Maczka et al. 2000). Genetic dysfunction stems from the 
dioxin structure resembling that of a hormone (Van den Berg et al. 1998). 
In its dioxin reassessment, the EPA describes the cascade of biochemical events 
triggered by dioxin, which is depicted in Figure 1.3. Dioxin diffuses into the cell and 
binds to the Ah (aryl hydrocarbon) receptor, a cytosolic protein. The complex is then 
translocated into the cell nucleus where it is joined by the nuclear protein ARNT (Ah 
receptor nuclear translocator). This complex acts as a transcriptional activator thus 
binding to DNA and signaling the beginning of messenger RNA synthesis. The mRNA is 
then translocated back to the cytosol where it is translated by the ribosomes to make 
proteins. Depending on the genes activated, these proteins can be players in a variety of 
cellular events such as cell proliferation (EPA 1994; 2000). 
FIGURE 1.3. Schematic of the Mechanism of Dioxin Action (UC-Davis) 
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1.2.4. How is risk to dioxin exposure assessed? 
2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is the most toxic of the dioxin 
congeners and is used as the reference compound for potency comparisons (Birnbaum 
and DeVito 1995). Using this reference toxicity, the EPA has established a conventional 
hierarchy of toxicity with each dioxin congener, as well as other toxic species such as 
polychlorinated biphenyls, being assigned a toxic equivalency factor (TEF). The TEF 
represents "an order of magnitude estimate of the toxicity of a compound relative to 
TCDD" (Van den Berg et al. 1998, p.776). With each of the seventeen toxic dioxin 
congeners being assigned a TEF by the World Health Organization (WHO) (Table 1. I), 
the risk assessment of a given environmental sample is provided by summing all of the 
congener concentrations multiplied by their respective TEF values. This summation of 
products is termed the toxic equivalency (TEQ) of the mixture. The TEQ value obtained 
for complex environmental sample mixtures is used to estimate environmental risk 
assessment (Birnbaum and DeVito 1995). It is important to note that the TEF values and 
the TEQ system are based on the observed Ah receptor-mediated responses (Van den 
Berg et al. 1998). 
TABLE 1.1. WHO TEF Mammal Values for the Seventeen Toxic Dioxin Congeners 
PCDD Congener WHO TEF 
2.3.7.8-TCDD 1 .O 
1 OCDF 0.0001 
PCDF Congener WHO TEF 
2.3.7.8-TCDF 0.1 
1,2,3,4,6,7,8-HpCDD 0.01 
OCDD 0.0001 
1.2.5. How is dioxin analyzed? 
1.2.5.1. Laboratory cleanup methods 
Due to the low levels of dioxin in environmental samples, dioxin analysis starts 
with extraction and cleanup procedures outlined in EPA Method 16 13B: Tetra-Through- 
2,3,4,6,7,8-HxCDF 0.1 
1 ,2,3,7,8,9-HxCDF 0.1 
1,2,3,4,6,7,8-HpCDF 0.01 
Octa-chlorinated Dioxins and Furans by Isotope Dilution HRGCMRMS (Telliard 1994). 
To ensure that sample contamination does not occur, dioxin extraction and cleanup 
procedures are carried out in a regulation M3.5, Class 100, clean room environment with 
Tyvek frocks, safety glasses, and gloves required (nitrile and viton) as personal protective 
equipment. Since the procedures used in this project will be discussed in further detail in 
chapter two, only a brief overview will be presented. 
The first step when working with an environmental sample is the addition of 
surrogates in order to monitor recovery. Dioxin extraction and cleanup procedures 
involve many analytical transfers so it is necessary to determine the amount of sample 
lost throughout the entire procedure. By adding a known amount of I3ci2 -labeled 
analogs of the seventeen toxic dioxin congeners under investigation, one can correct the 
quantified amounts of native, unlabeled dioxin for possible losses during the extraction 
and cleanup processes. This cocktail of surrogates is purchased commercially from 
Cambridge Isotope Laboratories (CIL) of Andover, Massachussetts. After the appropriate 
surrogates are added, the dioxin is extracted from the sample matrix. Extraction is 
achieved through dialysis for the SPMDs and through hot solvent extraction for other 
sample matrices. 
Extraction procedures remove more than just dioxin from the sample matrices; 
therefore cleanup steps must be followed to remove potential interferences prior to 
analysis. A cleanup standard of an alternate dioxin congener is added at this stage to 
enable quantification of the amount of sample lost during the cleanup procedures. The 
congener chosen as a cleanup standard for the method is 3 7 ~ 1 4 - 2 , 3 , 7 , 8 - ~ ~ ~ ~  (all four 
chlorine atoms are 3 7 ~ ~  substituted) and this standard is also purchased from CIL. 
Reactive steps such as acidified silica gel slurry are helpful in hydrolyzing and removing 
the lipids present in many of the samples. Finally, size exclusion procedures, like gel 
permeation chromatography, help remove non-reactive, interfering constituents of the 
samples. 
1.2.5.2. Final analysis by HRGC / HRMS 
As dioxin analysis has evolved, detection limits have been lowered using high- 
resolution gas chromatography / high-resolution mass spectrometry (HRGCIHRMS). 
These lower detection limits are vital due to the decreasing environmental levels of 
dioxin over the past decades linked to regulatory measures and awareness. The standard 
operating procedures for the HRGCJHRMS used in dioxin analyses are provided in EPA 
Method 16 1 3B (Telliard 1994). 
The fundamental principle behind a mass spectrometer is the creation of parent 
and fragment ions from sample analytes and the subsequent identification of these 
compounds through positive classification of the parent and fragment ions. The 
fragments are identified through their signature mass-to-charge ratios. 
What is the mass-to-charge ratio? In mass spectrometry, the basic mass unit used 
in describing the various isotopes is called the atomic mass unit (mu) ,  also termed the 
dalton. With high-resolution mass spectrometers, we look to the exact mass of the 
elemental isotopes, m (Skoog and Leary 1992). Identification involves looking at the 
mass-to-charge ratio of the ion fragments which "is obtained by dividing the molecular 
mass of an ion m (in m u )  by the number of charges z that the ion bears" (Skoog and 
Leary 1992, p. 422). It is important to note that most of the ions observed have a charge 
of one so that mass is the determining variable. 
With mass vocabulary established, what defines high-resolution? Resolution, R, 
refers to the mass spectrometer's ability to differentiate between the ions (Skoog and 
Leary 1992): 
R =  m l  lml-mzl (1.1) 
where : 
R = resolution 
- 
m = mean mass of two adjacent peaks 
I ml - m2 I = mass difference between the two peaks 
The mass-resolution power of the MS for this project is approximately 10,000. 
Therefore, the instrument can resolve peaks at m/z values of 300.00 and 300.03 (Skoog 
and Leary 1992 ). Since the ions for not only the dioxin congeners but also interfering 
analytes are all over 300 mh, a high-resolution MS is needed to distinguish between m/z 
values of various ions to the hundredths place. 
How does the instrument work? The gas chromatograph (GC) component of 
HRGCMRMS has the task of separating the mixture in the environmental sample into 
individual components. The GC is composed of a DB-5, fused silica, open-tubular 
capillary column. Compounds migrate through the sixty-meter column at different rates 
depending on size and structure. Thus for dioxin, the congeners elute from smallest 
(tetra-substituted) to largest (octa-substituted). This separation is vital before mass 
spectrometry because the MS is incapable of dealing with complex mixtures present in an 
environmental sample (Bierbaum et al. 1995). 
One end of the GC capillary column is introduced into the ion source of the mass 
spectrometer. In our current study, we use a Micromass Autospec-UltimaE Mass 
Spectrometer, Manchester, U.K.. This instrument uses electron impact ionization in the 
source and has double-focusing electric and magnetic sector analyzers (Figure 1.4). The 
system is under ultra-high vacuum (analyzer pressure approximately 6 x 10E-6 mbar). 
FIGURE 1.4. Autospec Geometry (Micromass). Schematic of the major MS 
components. 
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Once the compounds elute from the GC capillary column into the MS, they are 
introduced directly into the source. In the source, a potential between a heated tungsten 
filament and an electrode is maintained and a constant electron beam of approximately 29 
eV is emitted. The GC column terminates at the center of the source. This configuration 
leads to collision of the compounds with the electron beam. The collision triggers 
ionization and since the electron beam removes electrons from compounds by 
electrostatic repulsion, positive molecular ion fragments (M.+) are produced (Skoog and 
Leary 1992). A potential difference within the source forces positively charged ions out 
through the source slit and into the instrument flight tube where the ions are sorted by 
both electric and magnetic fields according to the mass-to-charge ratios of the ions 
(Bierbaum et al. 1995). 
The Autospec is configured with two electrostatic analyzers (ESAs) and a 
magnetic sector analyzer. Differential voltages are applied to each ESA and the resulting 
potential defines a range of kinetic energies for ions of the same d z  value that can be 
filtered and focused onto the magnetic sector analyzer, in the case of ESA 1, and onto the 
collector slit, in the case of ESA 2 (Skoog and Leary 1992). The analyst, who sets these 
potential differences when specifying m/z ratios for single ion monitoring, controls this 
filtering process. The reference compound perfluorokerosene (PFK) is used in EPA's 
dioxin method; PFK is fragmented into ion fragments that cover the full range of ion 
fragment sizes of the dioxin congeners. Therefore, the analyzer always identifies the PFK 
fragments as lock masses and can use the location of these fragments to "find" the dioxin 
ions targeted and direct these desired ions to the collector (Telliard 1994; T. Anderson. 
personal communication). 
With the magnetic field established by the ions selected for monitoring (PFK lock 
masses as well as targeted dioxin ions), the magnetic sector analyzer bends the path of the 
charged particles into different radii. The length of the bending radius is related to the 
d z  value of the ion. Only those ions with the desired d z  values will be directed by the 
magnetic sector to the second ESA (Bierbaum et al. 1995). This electrostatic analyzer 
focuses the beam of selected ions onto the collector slit where the signals are 
continuously collected and detected to generate a mass spectrum. Therefore, one can 
detect a range of m/z values through manipulating magnetic field strength and changing 
the course of the ion trajectories (Bierbaum et al. 1995). The fate of the ions that do not 
have the desired d z  ratios is collision into the flight tube. Therefore, periodic baking of 
the flight tube is needed to purge instrument of these ions (T. Anderson, personal 
communication). 
The general specifications of the HRGC 1 HRMS used in this project are given in 
Tables 1.2 and 1.3. 
TABLE 1.2. HRMS Specifications 
Mass Spectrometry Conditions Commercial Source of Product 
TY pe Autospec UltimaE sector Micromass Manchester, 
instrument with EBE U.K. 
geometry 
Resolution 10.000 
Mode Selective ion monitoring 
(SIM) 
Source type Electron ionization under 
~osi t ive conditions 
Ion source 260°C 
temperature 
Electron impact 29 eV 
ionization energy 
Filament trap 400 pA 
current 
Ion acceleration 8000 eV 
voltage 
Source vacuum 6 X 1 o - ~  mbar 
Analyzer vacuum 1 X lo-' mbar 
pressure 
Detector 350 
Tuning Perfluorokerosene = PFK 
compound 
TABLE 1.3. HRGC Specifications 
Gas Chromatography Conditions Commercial Source of Product 
TY pe CarloErba 8000 Micromass Manchester, 
U .K. 
Autosampler CTC 200s Micromass Manchester, 
U.K. 
Injection Volume 2 pL of lop1 sample + 0.5 
pL of air 
Injection mode Splitless with injector 
purge valve activated 2 
minutes after sample 
iniection 
Injector port 290°C 
temperature 
Column type DB-5 fused silica open J&W Scientific Folsom, CA 
tubular capillary column 
Column 60-m long with 0.32 mm 
Specifications inner diameter and 0.25 
pm film thickness of 
bonded-phase fused-silica 
Carrier gas UHP He at constant 30 
PSI head Dressure 
Direct GCMS Micromass Manchester, 
interface 290°C U.K. 
temperature 
- - 
GC Temperature Temperature Time 
Program 
150°C Initial, 1 minute 
after injection 
2°C / minute increase 
ramp to 200°C 
200°C 25 minutes 
- - - 
6°C / minute increase 
ramp to 300°C 
300°C 4 minutes 
1.3 Related Research 
1.3.1. The Maine Dioxin Monitoring Program 
1.3.1.1. History of the program 
The inception of the chlorine bleaching of pulp in the 1960's led to the release of 
PCDD/Fs into surface waters through pulp and paper mill effluent (MacDonald et al. 
1992). This inadvertent dioxin production contributes about 5% of the total dioxin 
emissions in the United States (Thomas and Spiro 1996). Even though the concentration 
of dioxin in water is in the part-per-trillion to part-per-quadrillion range downstream from 
these effluent outlets, fish bioaccumulate these compounds to levels that exceed 
recommended consumption limits. 
The Dioxin Monitoring Program (DMP) was established in 1988 by the Maine 
Legislature to determine the levels of dioxin contamination in waters and fisheries of the 
state. Fish are sampled annually below no more than twelve selected point sources of 
dioxin as part of the DMP in order to determine dioxin concentrations in the fish (Mower 
2000). 
The main point source monitored by the DEP consists of Kraft pulp and paper 
mills. While levels in Maine rivers have decreased over the past decade, detectable levels 
are still present. Therefore, the Maine DEP is working to find a less variable method than 
fish sampling for routinely monitoring dioxin concentrations both upstream and 
downstream of the mills in order to measure mill compliance to the law. An ideal 
monitoring method would: 
1. Be reliable in its sampling of a particular location, i.e. upstream or 
downstream 
2. Involve uniform exposure time and sampling rates for both upstream and 
downstream testing sites 
3. Have the sensitivity to detect relatively small differences between sites. 
The fish test is a possible candidate for the upstream-downstream test. In this project we 
are assessing the feasibility of using SPMDs as an alternate upstream-downstream dioxin 
test. 
1.3.1.2. Maine's multiple approaches to upstream-downstream testing 
In addition to the SPMDs, the Dioxin Monitoring Program (DMP) incorporated 
other approaches in the quest for the appropriate upstream-downstream test. Normally, 
the DMP collects benthic white suckers and pelagic small mouth bass. The whole 
suckers are ground and portions are analyzed while the small mouth bass fillets are 
ground and analyzed. However, the 1999 DMP field season marked the beginning of 
investigating sucker fillets as well as fish livers. Smaller bass, in addition to the larger 
size range, were also added for analysis (Mower 2000). 
Besides fish, caged freshwater mussels were deployed at a pair of upstream- 
downstream sites along the Kennebec River. The mussels circumvent the problems 
presented with the mobility of fish; however, they are still biotic indicators, which make 
them susceptible to other pitfalls such as purging of the contaminants and dying during 
the sampling period as a response to environmental stressors (Rantalainen et al. 2000). 
With these approaches presented, SPMDs remain the only abiotic indicators tested in the 
program. The DMP yearly report is available on the DEP website and provides the entire 
data set of dioxin concentrations (http://janus.state.me.us/dep/home.htm). 
This project was designed to provide the Maine DEP with SPMD data from sites 
where other dioxin monitoring data were collected. It will be the task of the Maine 
Dioxin Monitoring Program staff to compare the results from the various methods and 
determine an appropriate upstream-downstream test. 
1.3.2. Semipermeable membrane devices 
1.3.2.1. What is a semipermeable membrane device? 
FIGURE 1.5. Photos of a Semipermeable Membrane Device 
(a) from the manufacturer (b) on deployment rack being loaded into 
(Huckins et al. 1999a) deployment canister (up to five per canister) 
A standard semipermeable membrane device consists of two components: the 
neutral lipid triolein, which is found in many aquatic organisms and serves as the 
sequestering phase, and a semipermeable polyethylene membrane, which encases the 
triolein. The membrane is approximately 2.5 cm wide and 91.4 cm long with a 75 pm to 
95 pm wall thickness and a 450 cm2 surface area. The thin film of triolein inside the 
membrane, 1,2,3-tri[(cis)-9-octadecenoyl] glycerol (95% purity), consists of one milliliter 
of the lipid, or 0.9 15 grams (Huckins et al. 1999a). 
1.3.2.2. How does the device work? 
The composition of the SPMD pennits small (< 600 m u ) ,  dissolved organic 
pollutants to diffuse through the transport cavities of the polyethylene membrane to the 
triolein. Dioxin congeners are small lipophilic pollutants (306 amu to 460 amu), thus 
allowing them to be physisorbed and concentrated by these devices in natural waters. The 
semipermeable nature of the membrane stems from its exclusion of the entrance of more 
polar, hydrophilic ionic species and its inclusion of lipophilic compounds. The dual 
composition of the device permits uptake of contaminants in an aqueous environment and 
recovery of the compounds in the laboratory through organic solvent dialysis (Huckins et 
al. 1999a). 
1.3.2.3. Who is working with SPMDs? 
The devices have been developed by a group of scientists led by James N. 
Huckins at the USGS Columbia Environmental Research Center in Columbia, MO, USA. 
These scientists obtained two U.S Government-owned patents for this technology, 
#5,098,573 and #5,395,426, and sold an exclusive license for commercial sale of both the 
devices and the dialytic recovery methods to Environmental Sampling Technologies of 
St. Joseph, MO, USA (Huckins et al. 1999a). There have been many studies comparing 
results of the devices with both biotic and abiotic indicators of environmental 
contaminants such as caged fish and mussels, sediments, and ultrafiltered water samples, 
all of which will be discussed in later sections. However, these devices have yet to be 
used in a regulatory situation such as the upstream-downstream test in Maine. 
In addition to the USGS scientists, Kees Booij of the Netherlands and colleagues 
(1 998) have been focusing on the uptake kinetics of the devices, realizing the important 
effects of flow conditions on uptake kinetics and the need for laboratory calibrations. 
Adding permeability reference compounds (PRCs) to the membranes before deployment 
allows comparisons to be made between SPMDs at different sites. Since there is a 
correlation between diffusion of the substance into the membrane and release of the PRC 
from the membrane, the differences in sampling rates among sites due to environmental 
differences can be determined by quantifying the remaining PRC levels in the triolein 
(Huckins et al. 1999a). With permeability reference compounds, the technology is 
evolving to where the environmental factors of biofouling, temperature, and flow can be 
eliminated from affecting the ability of the SPMDs to be used in estimating water 
concentrations of the pollutants investigated. 
1.3.3. How does one connect SPMD pollutant concentrations to water 
concentrations? 
1.3.3.1. Factors affecting SPMD sampling 
The amount of dioxin sampled by an SPMD for a given deployment period 
depends on many factors: 
SPMD sampling rate for the dioxin congener 
octanol-water partition coefficient for the compound 
concentration of dioxin in the river 
temperature in the river 
flow of the river 
extent of SPMD biofouling 
length of deployment (Huckins et al. 1999a). 
The importance of site selection is evident. In choosing sites, we sought to have 
comparable temperature and flow conditions. Water velocity measurements at the 
deployment locations were used as indicators of flow. Water samples were collected to 
quantify total and dissolved organic carbon levels (TOC and DOC). The TOC and DOC 
levels affect the amount of dissolved, bioavailable dioxin in the river. For example, if all 
conditions were the same between two sites except that one site had a higher TOC than 
the other, the SPMDs would collect less dioxin at the higher TOC site because dioxin's 
low water solubility fosters its affinity to attach to particulates rather than to exist in the 
dissolved phase (J.N. Huckins, personal communication). 
1.3.3.2. Mechanism of SPMD pollutant sequestration 
In developing equations for converting SPMD-sampled concentrations to water 
concentrations, the seven factors listed above were considered. The mechanism of SPMD 
pollutant sequestration was also taken into account. Robert Gale (1998) investigated the 
possibility that there is more to SPMD kinetics than a one-compartment model that 
involves diffusion of the dissolved hydrophobic compounds through the aqueous and 
polymer films with partitioning only in the encased lipid. Gale developed a three- 
compartment model of the SPMD sampling mechanism. The three compartments include 
the aqueous film layer, the polyethylene membrane, and the triolein. This design implies 
that dissolved hydrophobic pollutants are sequestered not only by the triolein, but also by 
the membrane itself (Gale 1998). Studies have shown that as much as 50% of the 
compounds recovered from whole SPMD dialysis resided in the membrane (Huckins et 
al. 1990; 1993; 1996; Gale 1998). 
In light of these previous studies, Gale developed the three-compartment model to 
include significant sequestering capability of the membrane. Two major mass transfer 
terms are involved, which include the aqueous film and the polymer film that can either 
separately or collectively control the SPMD accumulation process. The process begins 
with a minor mass transfer step where a dissolved hydrophobic organic compound 
establishes contact with the aqueous film surrounding the polyethylene membrane 
because of turbulence in the water. The contact brings the possibility of the first major 
mass transfer step involving diffusion through the aqueous film layer to the polyethylene 
where the compound partitions onto the SPMD surface. The second major mass transfer 
through the polyethylene membrane then occurs if the compound is the right size, leading 
to sequestration in the triolein (Gale 1998). 
Although biofouling is not taken into account in this three-compartment model, 
biofouling increases the thickness of the aqueous film and thus slows the diffusion of 
compounds through this layer (Gale 1998). SPMD transport kinetics are controlled by the 
aqueous layer around the polyethylene membrane (Gale 1998; Booij et al. 1998; Huckins 
et al. 1999b; Rantalainen et al. 2000). 
1.3.3.3. Modeling the SPMD capacity for chemical uptake 
Formulating equations for SPMD uptake involves not only the mechanism but 
also the capacity of the SPMD for the chemical under investigation. One must determine 
whether the uptake is linear during a deployment period or equilibrium has been reached. 
When does saturation of the SPMD occur and thus no more of the chemical can be 
sequestered? The answer to this question was used to calculate applicable deployment 
lengths for SPMD research. The linear uptake duration ends at one half-time (tlt2) and 
equilibrium concentrations are reached to greater than 95% after four tlt2 (Huckins et al. 
1999a). 
where: 
KsPMD = the compound-SPMD partition coefficient = 0.3*Kow = 7.9 x 10' for 
2,3,7,8-TCDD (Huckins et al. 1999a) 
Kow = octanol-water partition coefficient for the compound 
VsPMD = the volume of entire SPMD in liters = 5.2 x 10 -3 L 
Rs = SPMD sampling rate for the compound, which is the volume of water 
sampled by the SPMD each day = 3.2 Llday for 2,3,7,8-TCDD at 19OC 
Applying this equation to 2,3,7,8-TCDD, we obtain a half-time of about 889 days. Thus 
the standard SPMD 28-day deployments are well within the linear uptake phase. 
1.3.3.4. Equation for calculating water concentrations from SPMD 
concentrations in the linear uptake region 
Huckins et al. (1999a) model the linear region of SPMD pollutant uptake in 
equation 1.3: 
Cw = (CSPMD*~SPMD) (Rs*~) (1.3) 
where: 
Cw = the concentration of the pollutant in the water 
CsPm = the concentration of the pollutant in the SPMD 
VsPm and Rs same as equation 1.2 
t = the deployment duration in days 
The need for the SPMD sampling rate for the compound of interest in equation 1.3 
reinforces the importance of determining Rs values for different environmental pollutants. 
In subsequent sections, calibration experiments focusing on SPMD sampling rates will be 
discussed. Calibration studies were done using the standard SPMD specifications that 
include a fractional lipid content of 20%, a 75 pm to 90 pm membrane thickness, and 
low-density polyethylene layflat tubing manufactured without additives (Huckins et al. 
1999a). Keeping the SPMDs standardized permits direct applicability of laboratory 
calibration results to field results. 
The SPMD sampling rate is influenced by biofouling, temperature, and water 
velocity-turbulence. The sampling rate is independent of the environmental concentration 
of the contaminant. No matter how much of the pollutant is present, the amount of water 
sampled by the SPMD each day does not change. The laboratory calibration studies can 
provide Rs at different temperatures and flows, but do not account for biofouling. 
Therefore, scientists have proposed the use of permeability reference compounds, PRCs, 
to provide the sampling rate correction factors for field studies (Huckins et al. 1999a). 
PRCs are added to the encased triolein in the SPMD just prior to deployment 
(Huckins et al. 1999a). The principle is that the SPMD sampling rate is proportional to 
the loss rate of the PRC regardless of environmental conditions (Booij et al. 1998; 
Huckins et al. 1999a). 
1.3.4. Advantages in applying SPMDs to dioxin monitoring 
Using SPMDs for upstream-downstream test offers several potential advantages 
(Huckins et al. 1999a): 
SPMDs are deployed at a fixed location. 
SPMDs can provide estimates of dioxin concentrations in the water during a 
fixed sampling period. 
SPMDs withstand heavy pollution and can be deployed in toxic environments 
that could stress and kill biotic samplers (Rohr et al. 1996; Rantalainen et al. 
2000). 
Accumulated pollutants are sequestered in the SPMD (Rantalainen et al. 
2000) while fish simultaneously sequester and metabolize pollutants. 
SPMDs provide reproducible homogeneous substrates. 
They are commercially available. 
The usefulness of the SPMD monitoring method has been substantiated by previous 
scientific investigations (Prest et al. 1992; Ellis et al. 1995; Herve et al. 1995; Lebo et al. 
1995; Prest et al. 1995a; Gale et al. 1997; Hofelt and Shea 1997; Meadows et al. 1998; 
Rantalainen et al. 1998; McCarthy and Gale 1999; Echols et al. 2000; and Granrno et al. 
2000). Not only have SPMDs been used to monitor dioxin but also other pollutants, such 
as polychlorinated biphenyls, polyaromatic hydrocarbons, and pesticides. A 
comprehensive summary of the laboratory and field SPMD studies for various 
environmental contaminants will be discussed in the following sections. Most helpful in 
this investigation is the examination of SPMD performance in previous comparative 
studies that included caged mussels, fish, clams, ultrafilter water permeates, and 
sediments. 
1.3.5. SPMD experiments focusing on environmental contaminants other than 
dioxin 
1.3.5.1. Laboratory investigations 
SPMD calibration studies began with Huckins et al. (1993) when they developed 
the mathematical models for linking SPMD concentrations to water concentrations. 
Flow-through exposures and dissipation experiments were done for 2,2',5,5'- 
tetrachlorobiphenyl (TCB) and phenanthrene, a polyaromatic hydrocarbon (PAH). The 
focus of the investigation was to test the model for measuring the water concentrations of 
the studied pollutants from SPMD concentrations. They found that the model estimates 
of average contaminant concentrations differed by less than two-fold from the actual 
average measured water concentrations (Huckins et al. 1993). 
Further studies with TCB calculated the half-life of the chemical to be 82.5 days 
in the SPMD. Comparing that with fish half-lives of the compound at 14.4 and 48.1 days 
for different species, the utility of the SPMDs in contaminant monitoring was 
substantiated (Huckins et al. 1996). The longer SPMD half-life for TCB demonstrates a 
greater tendency to retain the contaminant, making the device a better tool for monitoring 
periodic contaminant releases (Huckins et al. 1996). 
Kees Booij et al. (1 998) calculated the uptake rates of selected chlorobenzenes, 
polychlorinated biphenyls (PCBs), and polycyclic aromatic hydrocarbons (PAHs) using 
exposure standards. They investigated both high and low turbulence conditions in the 
water and found that decreased turbulence lowers uptake rates. The data supported the 
conclusion that flow conditions are an important factor in the uptake rates of 
contaminants. In order to compare SPMDs among sites, the devices either must be 
exposed to the same flow conditions or PRCs must be added to the triolein before 
deployment to account for flow differences (Booij et al. 1998). 
Huckins et al. (1 999b) examined the aqueous sampling rates of fifteen PAHs at 
various temperatures and concentrations for standard SPMDs. While the values for the 
sampling rates ranged from approximately 1.0 to 8.0 literslday for the compounds, these 
values were affected by the environmental conditions of temperature, biofouling, and 
current velocity-turbulence (Huckins et al. 1999b). This study found that the water 
concentrations of the PAHs did not affect SPMD uptake (Huckins et al. 1999b). 
A study monitoring organochlorine contaminants in the upper Mississippi River 
designed laboratory experiments to determine the effects of biofouling on SPMD 
sampling rates since the scientists had to laboriously dip the SPMDs in a biocide each 
week to minimize biofouling (Ellis et al. 1995). They exposed SPMDs in the field for 56 
days and then brought the SPMDs back to the laboratory for a seven-day concurrent 
exposure to radiolabeled phenanthrene along with fresh SPMDs. Comparing the SPMD 
sampling rates of the phenanthrene between fresh SPMDs and biofouled, deployed 
SPMDs revealed a decrease of 26 to 39% in biofouled SPMD sampling rates (Ellis et al. 
1995). 
1.3.5.2. Field investigations 
The multi-ringed, organochlorine properties of dioxin are shared by a host of other 
environmental contaminants. The field studies using SPMDs to monitor other dissolved 
hydrophobic compounds in aqueous environments are growing larger in number each 
year as the devices become more established as an abiotic monitoring alternative. By 
examining past comparative studies of pollutants other than dioxin, useful information on 
general SPMD sampling trends can be gained. Finding an organized way to discuss the 
most applicable of these studies is the challenge. The best way is division by principle 
biotic monitoring method used in the study along with SPMDs. Just as in our current 
investigation in Maine, bivalves and fish are the major biotic indicators of pollutant levels 
in aquatic systems used in these comparative studies. The studies will be discussed 
chronologically and are summarized in Tables 1.4 and 1.5. 
TABLE 1.4. Summary of BivalveISPMD Comparative Studies 
Other 
Study Monitoring Pollutants Deployment Deployment Analytical 
Methods Analyzed Length Location Instrument 
Examined Used 
Freshwater Pesticides Sacramento GCECD 
Prest et al. clams 
and 2 months and San 1992 (Corbicula PCDD/Fs Joaquin HRGCI 
fluminea) and PCBs Rivers HRMS 
o c s  Four lake Caged Lake including 
CHCs, watercourse Herve et al. Mussels 28 days sites in Not 1995 (Anodonta PCPs, central discussed 
piscinalis) PCAs, and 
PCVs Finland 
Mussels Corio Bay, Prest et al. 
1995a (Mytilus PCBs and 60 days Victoria, pesticides GC-ECD 
edulis) Australia 
Mussels 
(Mytilus OC 
Hofelt and edulis) and pesticides 30 days New Bedford GC-ECD Shea 1997 
and PCBs Harbor water 
samples 
Mussels Organo- 
Granmo et (Mytilus chlorine 
al. 2000 edulis) and marine 30 days Swedish bay GC-ECD 
sediment pollutants 
1.3.5.2.1. Bivalve/SPMD comparative studies 
Prest et al. (1 992; 1995a; 1995b) determined that the concentrations of PCBs in 
congener distributions differed between clams and SPMDs: bivalves had larger 
concentrations of the higher chlorinated PCB congeners than SPMDs while SPMDs had 
larger concentrations of the lower chlorinated PCBs than bivalves. Since the higher 
chlorinated PCBs have lower water solubilities, they are less likely to be in the dissolved 
phase. Therefore, while SPMDs sample the lower chlorinated PCBs at slower rates, these 
congeners have higher levels in the SPMDs because of their greater availability in the 
dissolved phase. 
One of the few SPMD lake studies was carried out by Heme et al. (1995) in order 
to compare caged lake mussels with SPMDs for monitoring organochlorine compounds. 
Another complementary result occurred and it was concluded that SPMDs preferentially 
absorb smaller lipophilic contaminants. These smaller contaminants are usually 
undetected in biota because they are eliminated through metabolic processes. The study 
concluded that by simultaneously deploying SPMDs and mussels, one could develop a 
clearer picture of contaminant distribution in the water body (Herve et al. 1995). 
Hofelt and Shea's (1997) comparative study in New Bedford Harbor found that 
the concentrations of PCBs in mussels were two times the concentrations found in 
SPMDs. Each site had significant (p<O.O 1) correlation between PCB concentrations in 
SPMDs and mussels. Hofelt and Shea (1 997) investigated the mathematical model of 
SPMD sampling and proposed that changes in the standard SPMD configuration could 
prove to be helpful in future experiments. 
In another marine setting, Granmo et al. (2000) analyzed organochlorines in 
sediments, caged mussels, and SPMDs. The goal of the study was to determine if 
pollutant levels in the sediment in an industrial area were a result of current or past 
discharges. Calculations were done on all organochlorine concentrations found in the 
three sampling matrices to determine the water concentrations of the pollutants. The 
calculated water concentrations of the organochlorines from the sediment data were 
higher than the mussel and SPMD water concentrations, leading to the conclusion that the 
sediments sequestered past discharge organochlorines (Granmo et al. 2000). Again, 
mussels and SPMDs sampled complementary pollutants. 
1.3.5.2.2. Fish/SPMD comparative studies 
TABLE 1.5. Summary of Fish/SPMD Comparative Studies 
Other 
Study Monitoring Pollutants Deployment Deployment Analytical 
Methods Analyzed Length Location Instrument 
Examined Used 
Ultrafilter 
water 
Ellis et al. permeates, Upper OCs 28 days Mississippi GC-NCI- 1995 caged fish, River MS 
and feral 
fish 
Brown Trout 
(Salmo 
Meadows trutta) and PCBs 28 days Groundwater 
et al. 1998 spring GC-ECD 
water 
Echols et al. Sediment, PCBs 28 days Saginaw 2000 caged fish River, MI GC-ECD 
Ellis et al. (1 995) conducted the first large river monitoring study of 
organochlorine contaminants (OCs) with SPMDs. The scientists had difficulty 
comparing SPMD data with ultrafilter permeate water data because there were not enough 
contaminants detected in the water samples. SPMDs were found to have nine detectable 
OCs while caged and feral fish only had five of those nine organochlorine compounds. 
This discrepancy is attributed to fish metabolism (Ellis et al. 1995). 
The caged brown trout in the study by Meadows et al. (1998) involved the 
deprivation of food for the fish in order to have them sample only dissolved PCBs 
through their gills. During the 28-day exposure process, SPMD PCB concentrations rose 
from 0.03 to 203.4 pglg and brown trout PCB concentrations rose from 0.06 to 11 8.3 
pglg. The time-deployment experimental design allowed for the calculation of PCB 
uptake rates for the two matrices. This investigation yielded similar PCB uptake rates for 
caged brown trout and SPMDs. 
The fishlSPMD comparative study conducted by Echols et al. (2000) found lower 
chlorinated PCBs in SPMDs that are easily metabolized and thus absent from fish. Fish 
and sediment concentrations had ratios between one and two for the PCBs studied. Again 
it was concluded that sediments and SPMDs provide complementary information: 
sampling period trends can be determined with SPMDs and historical trends can be 
determined with sediments (Echols et al. 2000). 
1.3.6. SPMD experiments focusing on dioxin 
1.3.6.1. Laboratory investigations 
No laboratory calibration study had been done for PCDDIFs with SPMDs until 
recently with the work of Anna-Lea Rantalainen and her colleagues (2000). Before their 
experiments, calculations from dioxin levels in SPMDs to dioxin levels in water were 
carried out using PCB experimental sampling rates (Rs) (Lebo et al. 1995; Gale et al. 
1997; and McCarthy and Gale 1999). Rantalainen et al. measured uptake rates for 
sixteen of the seventeen toxic PCDD/F congeners and seven PCB congeners in both bulk 
water and sediment at two different temperatures, 1 1 "C and 19"C, under controlled 
laboratory conditions (2000). They compared dioxin levels in the lipid, membrane, and 
whole SPMD and found that both the lipid and the membrane sequester dioxin. They 
presented their sampling rate data in liters per square meter per day. By multiplying these 
rates by the area of one SPMD in square meters, the sampling rate in liters per day can be 
obtained. These values are presented in Table 1.6 on the next page. As predicted, the 
SPMDs sample at a slower rate as the temperature decreases. 
TABLE 1.6. SPMD Uptake Rates in Water (11°C and 19°C). The uptake rates are 
presented for both lipid only and for the whole SPMD. The data from Rantalainen et al. 
(2000) were manipulated to provide uptake rates in liters per day per SPMD. 
&(L) 
Rs 
%L) 
Rs 
in in 11°C in in 19°C Dioxin Water Water 1 1°C Water Lipid + 19°C Water Lipid + Congener Lipid Membrane Lipid 
@/day) (Llday) (LIday) (Llday) membrane 
OCDD 0.4 1.1 0.6 2.6 
2378-TCDF 1.4 2.1 2.2 3.1 
12378-PeCDF 1.1 1.7 1.9 3.2 
OCDF 0.2 0.4 0.6 1.5 
The SPMD uptake rates have been provided for both lipid only and whole SPMD to 
illustrate that not only are the compounds sequestered in the lipid, but also in the 
polyethylene membrane. Therefore, in our present study, the entire SPMD was dialyzed 
and the whole SPMD mass was used in concentration calculations. 
As described in the SPMD sampling rate section, the octanol-water partition 
coefficient, log bw value, is an important parameter for each of these compounds. The 
octanol-water partition coefficient has an inverse relationship with SPMD uptake rates: as 
log b w  values increase, SPMD uptake rates decrease (Gale et al. 1997). The log bw 
values for the seventeen toxic dioxin congeners are provided in Table 1.7. 
TABLE 1.7. Log Kow Values for the Toxic Dioxin Congeners. These values are 
presented by Rantalainen et al. (2000) with the following sources cited: "Sijm et al. 1989, 
b ~ h i u  et al. 1988, d ~ a c k a y  et al. 1992, and 'Doucette and Andren, 1988. 'Denotes an 
estimation of the value using Log Kow of 1,2,3,4,7,8-HxCDD. 
Dioxin Congener Log Kow 
OCDD 8 .20~  
OCDF 7.97' 
The work by Rantalainen et al. (2000) provides the Maine DEP with the needed 
calibration data for PCDDIFs in order to calculate dioxin water concentrations from the 
SPMD data. Now water dioxin concentrations can be better estimated using actual 
PCDDIF SPMD uptake rates rather than PCB uptake rates. 
1.3.6.2. Field investigations 
While the above study (Rantalainen et al. 2000) has been the only one to focus on 
dioxin in laboratory conditions, there have been a few previous studies on monitoring 
dioxin levels in aquatic field systems (Prest et al. 1992; Lebo et al. 1995; Gale et al. 
1997; Rantalainen et al. 1998; and McCarthy and Gale 1999). Most studies with SPMDs 
are of a comparative nature due to the small database of SPMD information as compared 
to other monitoring systems such as bivalves, sediments, and fish. Table 1.8 contains a 
chronological summary of the dioxin studies involving SPMDs that will be discussed in 
this section. 
TABLE 1.8. Summary of SPMD Dioxin Field Studies 
Other 
Study Monitoring Pollutants Deployment Deployment Analytical 
Methods Analyzed Length Location Instrument 
Examined Used 
Sacramento Pesticides 
and San GCECD Prest et al. Freshwater and PCBs, 
1992 PCDDIFs 2 months Joaquin clams Rivers, HRGCI 
and PCBs California HRMS 
quadrupole Lebo et al. PCDDEs 28 days Bayou Meto, 1995 None Arkansas MS and H4IIE 
bioassay 
Caged 
Gale et al. Channel 
1997 PCDDEs 28 days Catfish and and PCBs 
sediments 
Saginaw 
River, 
Michigan 
GCECD for 
m-PCBs and 
HRGCI 
HRMS 
Infiltrex Lower Fraser 
water Rantalainen 
sampler and PCDDiFs 62 days River, HRGC / 
et al. 1998 benthic- and PCBs Vancouver, HRMS 
feeding fish BC 
PCDDIFs, 
McCarthy PCBs, Lower 
and Gale sediments PAHs and 35 days Columbia HRGC / 
1999 OC River HRMS 
pesticides 
Harry Prest (1 992) led a study that deployed SPMDs side-by-side with freshwater 
clams (Corbiculafluminea). The major finding was the presence in the SPMDs of 
significantly higher levels of 2,3,7,8-TCDD and 2,3,7,8-TCDF than in the clams. 
However both matrices did contain the full congener profile of all seventeen toxic 
PCDD/F congeners (Prest et al. 1992). 
Bayou Meto, Arkansas, was the site of a study by Lebo et al. (1995) that focused 
on upstream and downstream sites from a tributary confluence that had been a known 
source of dioxins and h a n s  (PCDDIFs). The focus of the study was to demonstrate the 
ability of SPMDs to target these compounds. Replicate samples were analyzed by either 
GCIquadrupole MS or H4IIE bioassay and the resulting data confirmed the agreement of 
these two analytical methods and the success of using SPMDs in bioassay procedures. 
Discussion of determining estimated aqueous concentrations from SPMD concentrations 
was provided and the early study used PCB SPMD sampling rates in the calculations due 
to the absence of PCDD/F calibration data (Lebo et al. 1995). 
A study led by Robert Gale (1997) compared the uptake of PCDD/Fs by caged 
channel catfish, sediments, and SPMDs in the Saginaw River, Michigan, in order to 
assess the bioavailability of the pollutants. Scientists calculated the water concentrations 
of the compounds from the SPMD data by estimating the PCDD/F SPMD sampling rates 
using the PCB SPMD sampling rates from previous laboratory calibration studies. 
Sediment-based and caged fish-based water concentration determinations were also 
calculated and all of the results were compared. The following conclusions were drawn: 
1. Sediments and SPMDs provide complementary information with 
respect to concentration. They have similar congener profiles but 
differed in absolute concentrations. The sediments tend to have higher 
levels of the higher chlorinated congeners while the SPMDs tend to 
have more of the lower chlorinated congeners. The investigators 
attributed this occurrence to the fact that as the number of chlorine 
atoms increases, the water solubility decreases. Therefore, the higher 
chlorinated compounds are more likely to fall down the water column 
to the sediment and experience difficulty in diffusing across the 
membranes (Gale et al. 1997). 
2. Metabolism of the congeners is a factor in fish. Most of the congeners 
present in fish are difficult to metabolize, e.g. the 2,3,7,8-substituted 
isomers. (Gale et al. 1997) 
Rantalainen et al. (1 998) conducted a field study in the Lower Fraser River, 
Vancouver, BC, where they deployed SPMDs both in the water column and in the 
sediments. They compared congener profiles obtained from these SPMDs with those 
from an Infiltrex resin column water sampler as well as benthic fish. All of the samples 
produced similar congener profiles with the resulting Infiltrex water sampler 
concentrations similar to SPMD concentrations. Moreover, they conducted a time series 
study of SPMD sampling of PCDD/Fs and PCBs and found that the concentration of 
these compounds in SPMDs does increase with exposure time over a sixty-day 
deployment period. 
Finally, a recent study by McCarthy and Gale (1 999) involved a large-scale 
investigation of organochlorine and polycyclic aromatic hydrocarbon compounds with 
PCDDIFs included in the Lower Columbia River. Streambed sediment samples were 
compared with SPMDs and it was found that sediments sampled more of the higher 
chlorinated PCDDIF congeners than SPMDs. 
The study yielded many helpful conclusions from the data including: 
1. Volatilization, dilution, and sedimentation of particulates reduce 
pollutant concentrations in river flow path. 
2. High discharge periods lead to dilution of high pollutant levels. 
3. "The distribution of hydrophobic organic compounds in streambed 
sediment is not necessarily indicative of their distribution in the 
dissolved-phase" (McCarthy and Gale 1999, p. 1). 
4. SPMDs succeed in detecting environmentally significant pollutant 
levels where water-sampling techniques fail. 
Creating composite samples of fifteen SPMDs, McCarthy and Gale (1 999) were able to 
bring the detection limits for the devices down to the low parts-per-quintillion level. 
1.4 Research Obiectives and Hvpotheses 
Objectives (1-6): 
1. To develop field and laboratory methods for the SPMDs. 
2. To determine the effectiveness of semipermeable membrane devices for dioxin 
sampling in Maine rivers. 
3. To examine SPMD biofouling and dioxin concentrations during high flow (June) and 
low flow (July) periods in a deployment time study. 
Hypotheses (a-e): 
(a) As deployment time increases, dioxin concentrations increase. 
(b) As biofouling increases on the SPMDs, the uptake of dioxin decreases. 
The extent of biofouling on the membrane increases as temperature 
increases. 
(c) As water velocity increases, the dilution of water dioxin concentrations 
increases and less dioxin is sequestered by the SPMDs during the 
deployment period. 
(d) As temperature increases, SPMD dioxin sampling rates increase and the 
devices sequester more dioxin. 
(e) As ambient TOC and DOC concentrations increase, dioxin concentrations 
in the SPMD decrease. 
4. To deploy SPMDs at selected upstream-downstream sites and determine if there is a 
statistical difference between upstream and downstream dioxin levels. 
5. To investigate how the SPMDs sample over an entire field season at a given site. 
This examination will allow us to determine the optimal times for SPMD 
deployments. 
Hypotheses (f and g): 
(f) There is a difference in the SPMD dioxin concentrations among the 
deployment months. 
(g) The varying environmental conditions of water velocity, temperature, 
TOC, and DOC among the deployment months influence this difference in 
SPMD dioxin concentrations. 
6. To determine how SPMD method detection limits (MDLs) are influenced by the 
number of SPMDs combined to make one sample. 
Hypothesis (h): 
(h) As the number of SPMDs combined to make one sample in a MDL 
study increases, the detection limits decrease and the sensitivity of the 
method increases. 
1.5 Scientific and Societal Importance 
The goal of this project is to determine whether or not SPMDs are effective in 
routinely monitoring surface waters for dioxin exposure. In Maine, developing a cost- 
effective and reliable method to monitor dioxin in our waterways, which can replace the 
destructive sampling of fish, will aid in determining compliance of the Kraft paper mills 
to the upstream-downstream legislation. If SPMDs are selected to be this alternate 
method, the positive impact on similar monitoring programs will be widespread. Since 
dioxin is introduced into our environment from both natural and anthropogenic processes, 
many surface waters throughout the world are potential sinks of dioxin sources. The 
toxicity of dioxin cannot be ignored and the successful use of SPMDs will improve our 
ability to monitor dioxin levels from potential point sources. Moreover, since SPMDs 
can physisorb and concentrate many different organochlorine compounds, other 
pollutants such as polychlorinated biphenyls and polyaromatic hydrocarbons can be 
examined. These multiple application possibilities make the use of SPMDs for 
monitoring our waterways potentially far-reaching and relevant. 
2. EXPERIMENTAL METHODS 
2.1 Experimental Design for Obiectives 1 and 2: The 1999 Field Season 
2.1.1. Site descriptions 
The 1999 field samples were used in the development of suitable field and 
laboratory techniques for the SPMDs (Objective 1). SPMDs were placed at nine different 
sites on the Penobscot River (Figures 2.1 and 2.2) in order to assess the dioxin monitoring 
potential of the SPMDs in a Maine river (Objective 2). These sites were chosen based on 
their range of environmental conditions and because many of these sites were the same as 
those used by DEP personnel for DMP fish collection. 
TABLE 2.1. Summary of 1999 Deployments: Penobscot River 
Deployment Deployment Date Retrieval Date Sites 
Number 
1 61 1 8/99 71 1 6/99 1.2. and 3 
2 712 1/99 81 1 8/99 3,4, and 5 
3 8120199 911 6/99 3,5,6, and 7 
4 9/28/99 10128199 3,5,8, and 9 

FIGURE 2.2. U.S.G.S. Topographical Map of the Penobscot River Sites around 
Lincoln, ME. Sites 1 through 7 were between South Lincoln and Lincoln Proper for the 
1999 field season. Sites 8 and 9 are noted in Figure 2.1 (TOPO! 2000) 
2.1.2. Water quality data 
Each site was assessed for a suite of water quality parameters at both the 
beginning and end of the deployment period. Appendix A contains all of the water 
quality and field data collected for both the 1999 and 2000 field seasons. The following 
water quality data were collected: 
J Field data, which included temperature, water velocity, and specific 
conductance measurements, were used for site selection in the field. 
Temperature measured by a field thermometer aided in determining 
uniformity between sites since temperature affects SPMD uptake of 
pollutants. Water velocity was measured with a field flow meter for the 
same reason as temperature. Specific conductance measured by a field 
conductivity probe allowed for assurance that downstream sites were 
chosen within a wastewater plume. 
J Water samples were collected in order to measure the following: Total 
organic carbon (TOC), total suspended solids (TSS), dissolved organic 
carbon (DOC), total phosphorus, chlorophyll a, apparent color, turbidity, 
and specific conductance. These data provided a comparison of the sites 
for a given deployment. Onset temperature loggers recorded hourly 
temperatures. 
2.1.3. Objective assessment 
The field and laboratory methods employed will be discussed after all of the 
experimental designs are described. The successful investigations of objectives 1 and 2 
were determined qualitatively from laboratory results. The method development section 
in this chapter explains the evolution of the SPMD cleanup methods and how objective 1 
was not met until the 2000 field season. Objective 2 was completed using the 1999 field 
season data. The dioxin congeners were detected in the environmental samples from the 
Penobscot River but could not be quantified due to excessive triolein interference 
(triolein dialyzed out of the membrane along with the dioxin). Objective 6 is addressed in 
the concluding sections of this chapter. Objectives 3,4, and 5 were investigated through 
specific field experimental designs during the 2000 field season and will be discussed in 
the next sections. 
2.2 Obiectives 3,4, and 5: The 2000 Field Season 
TABLE 2.2. Objectives of the 2000 Field Season 
Objective Deployment # Sites # of SPMDs 
Month 
> #3: Deployment Time Study: To examine 1 and 2 10-A 20 SPMDs per 
SPMD dioxin concentrations and and deployment 
biofouling over the 28-day deployment June 10-B with 5 
period. Compare high flow vs. low flow and retrieved each 
deployment environmental conditions. July week for 4 
Location: Androscoggin River at Dixfeld weeks 
> #4: Upstream/Downstream Study: To test 4 10 20 SPMDs per 
the applicability of using SPMDs to and site with all 
monitor dioxin for the upstream1 September- 13 retrieved after 
downstream law. October 28 days 
Locations: Androscoggin River at 
Rumford (1 3) and Dixfield (1 0) 
> #4: Upstream/Downstream Study: To test 3 1 1 10 SPMDs per 
the applicability of using SPMDs to and site with all 
monitor dioxin for the upstread August- 12 retrieved after 
downstream law. September the 54 days 
Locations: Kennebec River at 
Norridgewock (1 1) and Fairjeld (1 2) 
P #5: Deployment Month Comparison: To 1,2, and 4 10 5 SPMDs for 
investigate how the SPMDs sample over June, deployments 1 
an entire field season at a given site July, and and 2 and 10 
during 28-day deployment periods. September- SPMDs for 
Location: Androscoggin River at Dixjeld October deployment 4 
2.2.1. Site descriptions 
We used the SPMDs to monitor dioxin at four sites during the 2000 field season: 
two sites on the Androscoggin River and two sites on the Kennebec River (Table 2.2; 
Figures 2.3 and 2.4). 
FIGURE 2.3. U.S.G.S. Topographical Map of the 2000 Androscoggin River Sites. 
The site numbers indicate their locations (TOPO! 2000) 
FIGURE 2.4. U.S.G.S. Topographical Map of the 2000 Kennebec River Sites. The 
site numbers indicate their locations (TOPO! 2000). 
TABLE 2.3. Global Positioning Satellite (GPS) Positions for the Thirteen Sites of 
the Project: 1999 and 2000. Presented in TOPO! GPS Data Format: DegMinSec, 
NAD83. 
Site Latitude (DegMinSec) Longitude (DegMinSec) Elevation (ft) 
1 * N45O22'37" W68O30'27" 161 
2 * N45'22'33" W68O30'37" 164 
13 N44O3 1 '04" W7O033'O5" NA 
*Denotes a GPS waypoint estimation of the site. 
NA = Not Available 
2.2.2. Water quality data 
Not all of the water quality parameters tested in the 1999 field season were 
quantified in the 2000 field season. It was determined that the investigation be limited to 
only those water quality parameters that influence SPMD sampling: temperature, water 
velocity, total organic carbon (TOC), and dissolved organic carbon (DOC). 
2.2.3. Experimental design for objective 3: Deployment time studies 
2.2.3.1. Experiment description 
The 2000 field season consisted of three objectives (Table 2.2). The first 
experiment, which targeted objective 3, involved a deployment time study that was 
performed on the Androscoggin River over two 28-day deployment periods. For each 
deployment period, twenty SPMDs were placed three feet below the river surface at 
Dixfield, site 10, located approximately eight miles downstream from a bleached Kraft 
pulp and paper mill (Figure 2.3). Each week for four weeks, five of the SPMDs were 
retrieved. As a result of the small amounts of dioxin, the five SPMDs from each of the 
first three weeks were combined to make one sample. The retrieval from the fourth week 
consisted of five replicate, single SPMDs for statistical analyses. 
The goal of the study was to see not only how biofouling increased through time 
but also if SPMD dioxin levels increased linearly through time. We wanted to assess the 
validity of our five hypotheses, a through e, and thus determine the relationships existing 
between environmental conditions and SPMD dioxin concentrations. 
2.2.3.2. Statistical methods 
While graphical comparisons of the SPMD dioxin concentrations and deployment 
environmental conditions illustrate relationships between high flow (June) and low flow 
(July) deployment periods, statistical methods were employed to reinforce qualitative 
observations. It is important to note that the experimental design did not allow for a 
rigorous test of predictive relationships between environmental conditions and dioxin 
concentrations. To perform that type of analysis, natural environmental conditions would 
have to be manipulated. Each parameter would need to be tested individually for its 
effects on dioxin concentrations while all other variables remain constant. However, the 
design did allow for the preliminary investigation of correlative relationships between 
environmental conditions and SPMD dioxin concentrations. 
Three descriptive measures of linear regression were used to examine possible 
associations between each environmental condition (X) and SPMD dioxin concentration 
(Y). First, the coefficient of correlation, r, is a value between -1 and 1. The higher the 
absolute value, the more X and Y are linearly correlated. Negative values of r indicate an 
inverse relationship between the variables: as X increases, Y decreases and vice versa, 
therefore the slope of the regression line would be negative. Positive values of r indicate 
a positive slope for the linear regression model and a direct relationship: as X increases, 
so does Y and vice versa. 
The coefficient of determination, r2, has a value between 0 and 1. It is a measure 
of the reduction in variation of Y when X is used as a predictor variable. "Thus, the 
larger r2 is, the more the total variation of Y is reduced by introducing the predictor 
variable X" (Neter et al. 1996, p.81). It follows that the closer the r2 value is to 1, the 
greater the linear association between X and Y. 
The third helpful parameter to use in the investigation of possible linear 
relationships is the P-value, termed the observed level of significance. In designing an 
experiment one chooses a level of significance, alpha (a), which is compared to the 
observed level of significance, P-value. If a > P, one concludes that there is a linear 
relationship between X and Y. For this preliminary study, we chose an alpha value of 0.1 
(Neter et al. 1996). All of the comparisons between SPMD dioxin concentrations and 
environmental conditions during the June and July deployments were made using a 
Pearson Correlation Matrix. 
2.2.4. Experimental design for objective 4: Upstream-downstream deployments 
2.2.4.1. The Androscoggin River 
While the deployment time studies sought to investigate how the SPMDs sample 
a particular site over the 28-day deployment period, our second set of studies sought to 
investigate how the devices could be applied for the upstream-downstream test. This test 
involved the determination of whether a statistical difference between SPMD dioxin 
concentrations was present between upstream and downstream sites. A pair of sites was 
chosen on the Androscoggin River in western Maine. The downstream site, Site 10, was 
located in Dixfield and was the same site used in the deployment time studies. The 
upstream site, 13, was located in Rurnford (Figure 2.3). At each of these two sites, 
twenty SPMDs were deployed for a 28-day deployment period. These twenty SPMDs 
became ten composite replicate samples with two SPMDs per sample. 
2.2.4.2. The Kennebec River 
The second upstream-downstream test was conducted on the Kennebec River. The 
upstream site, 11, was in Norridgewock and the downstream site, 12, was in Fairfield 
(Figure 2.4). Similar field and water data were collected in the Kennebec River as the 
Androscoggin River. Ten SPMDs were deployed at each of these two sites for a 54-day 
deployment period. These ten SPMDs became five composite replicate samples with two 
SPMDs per sample. 
2.2.4.3. Statistical methods 
Statistically, the presence of any potential difference between upstream and 
downstream mean values can be detected using the F-test through analysis of variance 
(ANOVA) to test the null hypothesis that the sample means are equal between the two 
treatments of upstream and downstream. For the test to be valid, the data must follow 
these assumptions: 1. Residuals are randomly, independently, and normally distributed, 
sum to zero, and have constant variance; 2. The data are normally distributed; and 3.  
Treatment and environmental effects are additive (Neter et al. 1996). 
The F Test for equality of factor level means was used to evaluate the upstream- 
downstream data (Neter et al. 1996). Basically there are two alternative conclusions 
possible from the test: 
I% : upstream and downstream means are the same 
Ha : upstream and downstream means are different 
The test statistic that investigates which alternative is appropriate is deemed the F 
statistic, F*, which is the ratio of the treatment mean square to the error mean square 
(Neter et al. 1996 p.690). A large calculated F* statistic supports the alternate hypothesis 
Ha. The decision rule of this test involves a tabulated F value at a controlled level of 
significance, a ,  which has been set at 0.05. 
If F* is less than or equal to F (I-a; r-1, nT-r), conclude 
If F* is greater than F (I-a; r-1, nT-r), conclude Ha 
F (1 -a; r- 1, nT-r) is a value obtained from the (1 -a) 100 percentile F distribution chart. 
The value for r relates to the number of treatments, which would be 2 in our case for 
upstream and downstream, and n~ indicates the total sample size. Using the statistical 
program SYSTAT, ANOVA was performed on the deployment four and three data sets. 
2.2.5. Experimental design for objective 5: SPMD sampling over the 2000 Field 
Season 
2.2.5.1. Experiment description 
The Dixfield site on the Androscoggin River was monitored during three separate, 
28-day deployment periods: June, July, and September-October. This experimental 
design allowed for comparisons to be made to assess whether there was a difference in 
dioxin concentrations between the three months and to determine the optimal SPMD field 
conditions by investigating the relationships between environmental conditions and 
SPMD dioxin concentrations. 
2.2.5.2. Statistical methods 
2.2.5.2.1. Hypothesis f: Is there a difference between the months? 
As described in the upstream-downstream test statistics section, the F-Test under 
ANOVA was used to determine if there was a statistical difference between SPMD 
dioxin concentration means among the different deployment months. 
2.2.5.2.2. Hypothesis g: How are environmental conditions related to SPMD 
dioxin concentrations? 
While graphical comparisons of the different environmental conditions for June, 
July, and September-October can reveal potential relationships, statistical tools were used 
to substantiate them. To statistically compare environmental conditions and SPMD 
dioxin concentrations, we used the coefficient of correlation [r], the coefficient of 
determination [r2], and the observed level of significance [P-value]. These statistical 
parameters were described earlier in the deployment time study section. Since this 
investigation was preliminary, an alpha value of 0.1 was used (Neter et al. 1996). 
2.2.6. Tabular summary of the 2000 Field Season deployments 
TABLE 2.4. Deployment Descriptions for the 2000 Field Season 
Deployment Deployment Retrieval Deployment Sites SPMDs SPMDs # 
# Date Date Time (days) per site /sample Reps 
1 6/2/00 6/9/00 7 10-A 5 5 1 
2.2.7. Manipulating SPMD dioxin concentrations for statistical analyses 
Many of the experiments described above involved replicate SPMD samples. In 
order to perform the statistics described above on the data it was necessary to assign 
concentrations to the less than detection limit (<DL) congeners when replicates had 
detectable peaks. Less than detection limit means that peaks were not identified or could 
not be quantified. These <DL quantities affect the calculation of the Toxic Equivalency 
(TEQ). The TEQ is calculated by multiplying each congener concentration by its 
corresponding TEF. The State of Maine has adopted calculating the TEQ in three 
different ways: 1. Assigning <DL congeners a concentration of zero, TEQ (<DL = 0); 2. 
Assigning <DL congeners a concentration of one-half the detection limit, TEQ (<DL = 
0.5*DL); and 3. Assigning <DL congeners a concentration of the detection limit. 
We added three more TEQ calculations that assign those three values discussed 
above for <DL congeners. However, we removed the hexa- through octa- substituted 
congeners and focused only on tetra- and penta- substituted dioxin congeners. The 
quotient has been designated as TEQTP. When looking at the raw SPMD field data in 
Appendix B, many of the contamination-based data flags exist for the heavier substituted 
congeners, which are more prevalent than the lighter (less chlorinated) congeners. 
We chose to use the TEQ (<DL = 0) values in the statistical analyses. This 
decision was made because the method detection limits (MDLs) for the SPMDs have not 
been validated by multiple MDL studies. Moreover, most of the congeners with high 
TEF values, tetra- and penta- substituted dioxin were <DL and so the concentration 
values assigned to those congeners would dominate the TEQ value. 
2.3 Field Methods 
The standard SPMDs were purchased from Environmental Sampling 
Technologies of St. Joseph, MO. They were mounted on deployment racks in a 
regulatory level M-3.5 clean room environment and sealed in 1-gallon metal cans one day 
prior to deployment. SPMDs were kept in the freezer until use and transported to the 
field on ice. In the field, the loaded mounting racks were placed in the canisters-up to 
five SPMDs per canister. For field quality control, a field blank SPMD can was opened 
at selected sites while the SPMDs were open to air and placed in the deployment canisters 
until submersion of the canisters into the river. 
Upon retrieval of the SPMDs, the same field blank was again exposed to the 
atmosphere while the deployed SPMDs were exposed. This field blank was necessary 
since SPMDs are excellent passive air samplers (Petty et al. 1993). Total air exposure 
time for the SPMDs was less than fifteen minutes for deployment and retrieval combined. 
At retrieval, the SPMDs on their mounting racks were returned to their original gallon 
metal cans, transported to the laboratory on ice, and stored in a -20°C freezer until 
extraction and cleanup. These processes are illustrated in Figure 2.5. 
FIGURE 2.5. Photos from the Deployment (a) and Retrieval (b) Processes. Field 
blanks are in pint-sized cans while deployed SPMDs are in gallon-sized cans. 
The SPMDs were deployed in the river within a deployment apparatus developed 
for this project by Richard Dill and Heather Shoven (Figure 2.6). This apparatus could 
vertically deploy one to four canisters of SPMDs. The assembly of anchors and buoys 
provides a vertical deployment and places the canisters at a fixed depth below the water's 
surface. Because sediment sequesters dioxins and furans, the SPMD deployment 
apparatus prevented the canisters from touching the riverbed. 
FIGURE 2.6. Vertical Deployment Apparatus for SPMDs 
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2.4 Laboratow Methods 
2.4.1. Water samples 
The standard operating procedures (SOPS) of the Mitchell Center were used to 
measure a suite of characteristics for the collected water samples from each deployment 
and retrieval. The parameters quantified during the two field seasons are discussed below 
with both summaries of the method of quantification and the reported units of measure 
provided: (Data presented in Appendix A.) 
J Dissolved Ornanic Carbon (DOC): The water sample was first filtered through a 
0.4 micron filter in order to measure only the dissolved organic carbon present in 
the sample. After filtering, the sample was acidified with two drops of 1 : 1 
H20:H2S04 per 60 ml sample. An 01 Model 700 Total Organic Carbon Analyzer 
was used in the analysis of water samples for DOC. The DOC was determined by 
the measurement of carbon dioxide released by persulfate oxidation of the organic 
carbon in the acidified sample. [mg/L] 
J Total Organic Carbon (TOC): This was measured with the same method as DOC 
except the sample was not filtered. [mg/L] 
J Specific Conductance (SC): It is a measure of the total dissolved, electrically- 
charged species in a water sample. It was quantified with a Yellow Springs 
Instrument (YSI) Model Number 35 digital conductivity meter and YSI probe 
340 1 at 25OC. [pS/cm] 
In addition to DOC, TOC, and SC, total suspended solids (TSS), total phosphorus, 
chlorophyll a, apparent color, and turbidity levels were measured during the 1999 field 
season. 
2.4.2. Final SPMD method 
2.4.2.1. Extraction of dioxin from SPMDs 
Biofouling, which consists of exterior debris and periphyton, was removed from 
the SPMDs before extraction by scrubbing the membrane with a toothbrush (Huckins et 
al. 1999a). After this initial cleanup, the devices were then spiked with a cocktail of 
surrogates consisting of 13c-labeled analogs of the toxic native dioxin congeners in order 
to monitor recovery. The surrogate cocktail, made exclusively for EPA Method 161 3B, 
was purchased from Cambridge Isotope Laboratories (CIL) of Andover, MA. These 
surrogates were necessary for providing validity to high-resolution gas chromatography / 
high-resolution mass spectrometry (HRGC/HRMS) findings because the preparation of 
the SPMDs for analysis on the HRGC/HRMS involved many analytical transfers and 
cleanups, which always result in the loss of some sample. The surrogates provided a way 
to determine how much sample was lost throughout the process (Telliard 1994). 
Moreover, these compounds were essential in peak detection and in assuring that lab 
blanks were in fact blank. The surrogates were added with a microsyringe injection and 
the resulting hole was repaired with a heat sealer. The SPMD was then exposed to a 1 N 
HC1 solution for thirty seconds. 
After surrogate addition and exterior cleaning, individual SPMDs were dialyzed 
into hexane. The dialysis process consisted of two consecutive 24 hour incubation 
periods. Each SPMD was dialyzed separately in a solvent-rinsed, pint-sized Mason jar 
with 125 mL of hexane. The jars were covered with solvent-rinsed aluminum foil and 
with the screw caps placed over the foil, rubber side of the lid facing outwards. After 24 
hours, the dialysate was transferred to another hexane-rinsed, pint-sized Mason jar and 
another 125 mL of fresh solvent was added to the jar with the SPMD (Huckins et al. 
1999a). After this second 24 hour dialysis period the two dialysates were combined and 
concentrated with Kuderna-Danish (K-D) apparatus to a ten-milliliter volume. The K-D 
is a standard evaporation/concentration technique for solvents like hexane and methylene 
chloride and involves boiling off of the solvent in a hot water bath. A condensation 
system is used to recover the evaporated solvent for appropriate disposal. 
2.4.2.2. Cleanup of the SPMD extracts 
If the SPMDs were to be made into composite samples, they were combined after 
extraction. The resulting extract samples were then cleaned by acidified silica gel slurry. 
The extract was added to 100 mL of hexane and 500 pL of dioxin cleanup standard. The 
cleanup standard was obtained from CIL and it is 3 7 ~ l , e  labeled 2,3,7,8-TCDD (all four 
chlorine atoms are 3 7 ~ 1  labeled). As described in the introduction, the cleanup standard 
allowed us to monitor sample lost during the cleanup steps while surrogates allowed us to 
monitor sample lost throughout the entire sample manipulation process. A stirbar was 
added to the beaker and when uniform mixing was established about 10 grams of 
acidified silica gel was added. The mixing continued for approximately one hour. This 
process hydrolyzed and removed residual triolein from solution. 
The sample was then filtered through crystallized, anhydrous sodium sulfate and 
concentrated by a Kuderna-Danish apparatus. In preparation for gel permeation 
chromatography, the sample was filtered through a Whatman puradiscTM 25 TF 
disposable filter device using dichloromethane. The filter removed any particles that 
could clog the valves of the instrument. For gel permeation chromatography, an 
automated Autoprep 500 GPC using a 70 gram Biobeads SX-3 column was used (0.1. 
Analytical, ABC Instruments, Columbia, MO). The GPC is a size exclusion 
chromatographic method that targets dioxin-sized particles for recovery (Telliard 1994). 
The samples were recovered from the GPC in 150 mL Erlenmeyer flasks. Each sample 
was then concentrated to 10 pL in a GC autosampler vial and stored at -20°C until 
HRGC / HRMS analysis. 
For laboratory quality assurance and quality control (QAIQC) of the extraction 
and cleanup procedures, three controls were run through the laboratory methods 
concurrently with deployed samples and field blanks. These controls included: (1) a 
process blank to determine the possible background concentrations in the solvents, 
glassware, and equipment used in the procedures, (2) a dialysis blank to determine the 
background in a fresh SPMD, and (3) a matrix spike to determine the efficiency of the 
sample preparation and analysis (McCarthy and Gale 1999). 
FIGURE 2.7. Flow Diagram of SPMD Extraction and Cleanup Processes 
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2.4.2.3. HRGC I HRMS dioxin analysis 
With the theory of the instrument established in the introduction we can now 
describe the fundamentals of the standard operating procedure used for analyzing the 
seventeen toxic dioxin congeners established by our dioxin laboratory as outlined by the 
EPA (Telliard 1994). The basis of the process lies in the continual introduction of 
perfluorokerosene (PFK) to the source. PFK is a compound that fragments into known 
ions that provide lock masses for the mass analyzer. These lock masses provide for mass- 
drift corrections that are needed due to the demands of the high-resolution process. There 
are five PFK lock masses involved in the single ion monitoring process, one for each 
homologue group investigated. PFK ion at m/z 304.9824 was used to tune the instrument 
prior to every run or every twelve hours of operation. Adjusting the various lenses and 
electric and magnetic fields involved in the instrument to optimally detect this ion 
allowed us to adjust the resolving power of the instrument up to the minimum of 10,000 
resolution (Telliard 1994). 
The calibration standards were purchased from CIL and consisted of a mixture of 
the native and ' 3 ~ 1 2  labeled dioxin congeners at known concentrations. A run began with 
the injection of 2 pL of calibration standard into the GC column injector port. Tables 2.5 
through 2.9 show the exact d z ' s  monitored during a run (* indicates I3cl2 labeled). The 
GC retention times for each descriptor scan were predetermined by running a retention 
time check standard that was a window-defining mixture. This standard contained all of 
the congeners and allowed the analyst to determine the window times for each descriptor 
group. Whenever the GC column was clipped or replaced for maintenance, the retention 
times changed and the retention time check standard was re-run. Thus the times offered 
in the following tables were only good for the GC column under certain conditions and 
are included to provide estimated ranges of the gas chromatography column retention 
times. 
TABLE 2.5. Descriptor One Ions: scanned between GC retention times 3 1 :00 and 
5 1 :45 
Ion Exact d z  Substance Identity ( d z  type) 
303.9016 TCDF (M) 
305.8987 TCDF (M+2) 
315.9419 TCDF* (M) 
3 16.9824 PFK Lock Mass 
3 17.9389 TCDF* (M+2) 
3 19.8965 TCDD (MI 
321.8936 TCDD (M+2) 
327.8847 C1-37 TCDD 
33 1.9368 TCDD* (M) 
333.9339 TCDD* (M+2) 
375.8364 HxCDPE = hexachlorodi~henvlether 
TABLE 2.6. Descriptor Two Ions: scanned between GC retention times 5 1 :45 and 
61:45 
Ion Exact d z  Substance Identity ( d z  type) 
339.8597 PeCDF (M+2) 
341.8568 PeCDF (M+4) 
3 5 1.9000 PeCDF* (M+2) 
353.8970 PeCDF* (M+4) 
355.8546 PeCDD 
357.8521 PeCDD 
366.9792 PFK Lock Mass 
367.8948 PeCDD* 
369.8919 PeCDD* 
TABLE 2.7. Descriptor Three Ions: scanned between GC retention 
66:30 
76 
times 61 :45 and 
Ion Exact d z  Substance Identity ( d z  type) 
373.8207 HxCDF (M+2) 
375.8178 HxCDF (M+4) 
380.9760 PFK Lock Mass 
383.8639 HxCDF* (M) 
385.8610 HxCDF* (M+2) 
389.8156 HxCDD (M+2) 
391.8127 HxCDD (M+4) 
401.8559 HxCDD* (M+2) 
403.8530 HxCDD (M+4) 
445.7555 OCDPE = octachlorodi~henvlether 
TABLE 2.8. Descriptor Four Ions: scanned between GC retention times 66:30 and 
71:OO 
- - 
Ion Exact d z  Substance Identity ( d z  type) 
407.78 18 HpCDF (M+2) 
409.7788 HDCDF (M+4) 
419.8220 HpCDF* (M+2) 
423.7767 HpCDD 
430.9728 PFK Lock Mass 
435.8169 HvCDD* (M+2) 
437.8140 HpCDD* (M+4) 
479.7165 NCDPE = nonachlorodiphenylether 
TABLE 2.9. Descriptor Five Ions: scanned between GC retention times 71:OO and 
75:OO 
Ion Exact m/t Substance Identity (I& type) 
441.7428 OCDF (M+2) 
443.7398 OCDF (M+4) 
454.9728 PFK Lock Mass 
457.7377 OCDD (M+2) 
459.7348 OCDD (M+4) 
469.7780 OCDD* (M+2) 
Ion Exact d z  Substance Identity ( d z  type) 
47 1.7750 OCDD* (M+41 
5 13.6775 DCDPE = decachlorodi~henvlether 
Descriptor is the term used for the group of ions scanned for a given period of 
time in relation to the GC retention time. There are five descriptors, established by the 
five homologue group windows, involved in dioxin analyses as outlined in tables 2.5 
through 2.9. During the allotted times of GC retention these ions in each descriptor were 
continuously scanned and directed by the analyzers to the detector for quantification. The 
resulting peaks detected started at zero abundance, reached a maximum, and then 
returned to a value of zero abundance (Skoog and Leary 1992). The diphenylether ions 
were included in the scans because they each have ion fragments that interfere with the 
furan ions. Therefore, one could examine the diphenylether ion scans and if there was a 
distinguishable peak, then the furan peaks in the descriptor group were flagged (Telliard 
1994). 
As described in this section, the quantification process involved a few equations 
and the EPA provides guidelines for identification of peaks (Telliard 1994). These 
processes were the same for both the calibration standards and the actual environmental 
samples run. The detector generates a mass spectrum of the collected data for each ion 
specified. The spectra are presented as ion abundance versus time. For each set of ions 
(M and M+2 or M+2 and M+4), ion abundance ratios are compared and must fall within 
the parameters listed in Table 2.10. 
TABLE 2.10. Theoretical Ion Abundance Ratios and QC Limits (Telliard 1994) 
CDDICDF Type M/Z ratio Theoretical QC Limits 
ratio Lower U D D ~ ~  
TCDD/F and 1 3 ~ 1 2 - ~ ~ ~ ~ / F  . - M / (M+2) 0.77 0.65 0.89 
PeCDD/F and "c~~-P~CDD/F (M+2) / (M+4) 1.55 1.32 1.78 
HxCDD/F and 1 3 ~ 1 2 - ~ x ~ ~ ~  (M+2) / (M+4) 1.24 1.05 1.43 
HpCDD/F and 1 3 ~ 1 2 - ~ p ~ ~ ~  (M+2) / (M+4) 1.05 0.88 1.20 
1 3 ~ 1 2 - H p ~ D ~  M / (M+2) 0.44 0.37 0.5 1 
OCDD/F and 1 3 ~ 1 2 - ~ ~ ~ ~  (M+2) / (M+4) 0.89 0.76 1.02 
Not only must the above QC limits be met but also the signals for the two m/z types for a 
congener must maximize within the same two seconds of GC retention time. Moreover 
the signal-to-noise ratio must be 2 2.5 for each compound and 2 10 for each standard. 
Finally, qualitative determination of MS peaks involves the Relative Retention Time 
(RRT) falling within the limits set in Table 2.1 1. 
TABLE 2.11. Retention and Quantitative Standards and Relative Retention Times 
(RRT) outlined in EPA Method 16 1 3B 
Congener Retention Time 1 RRT 
Quantification Standard 
- - 
Compounds using " c ~ ~ - ~ , ~ , ~ , ~ - T c D D  as the injection internal standard 
2,3,7,8-TCDF 13c 1 2 - 2 , 3 , 7 , 8 - ~ ~ ~ ~  .999 - 1.003 
13 Compounds using C12-1,2,3,7,8,9HxCDD as the injection internal standard 
1 ,2,3,4,7,8-HxCDF l3C12-l ,2,3,4,7,8-HXCDF .999 - 1.001 
Avg. 13c12-1 ,2,3,4,7,8- 
HxCDD and 13c12-1 ,2,3,6,7,8- 
- 
OCDF 13c 1 YOCDD .999 - 1.008 
.- 
OCDD 1 3 ~ 1 2 - ~ ~ ~ ~  .999 - 1 .OO 1 
13c12-1 , 2 ,3 ,4 ,7 ,8 -~xc~F  I3cl2-1 ,2,3,7,8,9HxCDD .944 - .970 
13c 12-1 ,2 ,3 ,6 ,7 ,8-~x~DF 13c 12-1 ,2,3,7,8,9HxCDD .949 - .975 
What are the internal standards in table 2.1 l ?  An internal standard is a C-13 
labeled dioxin congener that is not present in the surrogate cocktail. There were two 
internal standard compounds, I 3 c 1 2 - 1 , 2 , 3 , 4 - ~ c ~ ~  and I3c12-l ,2,3,7,8,9-HxCDD, present 
in a mixture of known concentrations added just prior to sample analysis on the HRGC I 
HRMS. The ion abundance values obtained from the internal standards allowed for the 
determination of surrogate recoveries and the subsequent quantification of the native 
congener concentrations (Telliard 1994). 
Quantification of native dioxin congener concentrations involves mastery of some 
important vocabulary. The raw data spreadsheets in Appendices B and C present all of 
the parameters discussed below which were needed to calculate the SPMD dioxin 
concentrations. Calibration by isotope dilution was the method used for native congener 
quantification. The first sample of every run contained both a window-defining mixture 
and a midpoint calibration standard which was a mixture of the native compounds, 
labeled surrogates, cleanup standards, and labeled internal standards. The retention times 
were recorded in a spreadsheet along with ion abundance values (M and M+). The ion 
abundance values were then manipulated to find the relative response (RR) of each native 
compound relative to its labeled analog. (Telliard 1994) 
RR=(Al ,  + A2,) * (CI) I (All + A29 * (C,) (2.1) 
where: 
Al,  and A2, = the areas of the primary and secondary m/z S for the dioxin congener 
A l l  and A2, = the areas of the primary and secondary d z  S for the labeled analog 
CI = the concentration of the labeled analog in the calibration standard (Table 2.12) 
C, = the concentration of the native compound in the calibration standard (Table 2.12) 
TABLE 2.12. Concentration of CDD/Fs in the Midpoint Calibration Standard 
Native CDD/F Concentration Labeled CDD/F Analog Concentration 
-- 
OCDF 100 l3c12-1 . . , 2 , 3 , 4 , 7 , 8 , 9 - ~ ~ ~ ~ ~  100 
OCDD 100 l3Cl2-1 , 2 , 3 , 4 , 6 , 7 , 8 - ~ ~ ~ ~ ~  100 
"C~~-OCDD 200 
is = internal standard cu = cleanup standard 
The RR values calculated in the calibration standard were then used to quantify the native 
dioxin congener concentrations in the extract for the subsequent samples in the run. 
C,, (ng/mL) = (Al, + A2,) * (CI) / (A1 + A21) * RR (2.2) 
where: 
C,, = concentration of compound in extract 
Al, and A2, = areas of primary and secondary d z  's for the native dioxin congener 
Al ,  and A2, = areas of primary and secondary d z  's for the labeled analog 
RR = relative response 
CI = concentration of the labeled analog (surrogate) 
The surrogate concentrations recovered in a sample were quantified by calibration 
by an internal standard. The equations closely resemble those used to quantify the native 
dioxin congener concentrations. Instead of calculating a relative response (RR) with the 
calibration run data, we calculated a response factor (RF) defined by the following 
equation: 
RF =[(Als + A2,) * Cis] 1 [(Al Is + A2is) * Cs] 
where: 
Al, and A2, = areas of the primary and secondary d z ' s  for the labeled analog and 
cleanup standard congeners 
Ali, and A2i, = areas of the primary and secondary d z  S for the appropriate internal 
standard (Table 2.1 1 provides the pairing of the labeled analogs with the appropriate 
internal standard) 
Cis = concentration of the internal standard (Table 2.12) 
C, = concentration of the compound in the calibration standard (Table 2.12) 
With these calculated response factors, the concentrations of the surrogates 
recovered in each sample extract were calculated with the following equation: 
Cex (ng/mL) = [(Als + A2J * Cis] I [(Al is + A2is) * RF] (2.4) 
With the extract concentrations of the surrogates and cleanup standards calculated, the 
percent recovery was determined. For all of the surrogates except OCDD, the percent 
surrogate recovery was identical to the concentration in the extract. However, for OCDD 
the percent surrogate recovery was calculated by dividing the concentration in the extract 
by two. For the cleanup standard, the percent recovery was calculated by multiplying the 
concentration in the extract by two. 
The final calculation in dioxin analysis was used to relate the anlount of dioxin 
present in the extract to the original environmental matrix: in our study, the SPMD. 
CSPMD = (Cex * Vex) WSPMD (2.5) 
where: 
CsPm = Concentration in SPMD (nglkg) 
Cex = ng dioxin per mL of extract 
Vex = 10 pI = 0.01 mL = total volume of extract 
WsPm = weight of the SPMD in kg = membrane + lipid 
All of the parameters involved in HRGC I HRMS dioxin congener quantification 
have now been discussed. The process was rigorous and involved the need for quality 
assurance and quality control (QAIQC) measures. After each calibration standard and 
window defining mixture sample began a twelve-hour run, a solvent blank of 
dichloromethane was run as the next sample to check for possible sample carry-over. The 
solvent blank was then followed by the day's samples. The time following a given 
calibration and tuning of the instrument was no longer than twelve hours in order to 
assure the quality of the results. 
2.4.3. SPMD method development phases 
Figure 2.7 outlines the final SPMD method developed in this study. However, 
that method was only adopted after several others were attempted. While the extraction 
method remained constant throughout the process, the cleanup steps changed. This 
section documents the evolution of the SPMD cleanup method. 
When this project began, high-performance gel permeation chromatography 
(GPC) was assumed to be an appropriate cleanup step. GPC has been successfully used 
with the fish samples in the Dioxin Monitoring Program and it had been used in previous 
SPMD studies for its size exclusion abilities (Ellis et al. 1995; Gale et al. 1997; Meadows 
et al. 1998; and Echols et al. 2000). It was determined that GPC alone was not sufficient 
for removing interferences and resulted in lengthy retention time shifts of the dioxin 
peaks. These retention time shifts were most likely caused by the presence of residual 
triolein in the sample that sequestered the dioxin molecules in the GC column, thus 
lengthening the retention times. 
This retention time shift produced the need for more cleanup of the SPMD 
dialysates. We did not adopt the rest of the fish method, which consisted of an acidified 
silica gel slurry, because we were hoping to develop a less time-consuming method with 
the SPMDs. Therefore, we explored the possibility of adding a solid-phase extraction 
procedure by using pre-packed Bakerbond speTM Glass Florisil@ columns from J.T. 
Baker of Phillipsburg, NJ. The columns are available with 500 mg of Florisil packed in 
the column to 2 g. The SPMD study conducted by Prest et al. (1 995) used Florisil 
fractionation and also the Florisil method is outlined in EPA Method 161 3-B. 
We found that when using 500-mg Florid@ spe columns in conjunction with 
GPC, it is best to keep each SPMD as a single sample and then composite the samples as 
needed after cleanup. This cleanup step is illustrated in Figure 2.8. 
FIGURE 2.8. Intermediate Cleanup Methods: GPC and Florisil@ 
I Initial cleanup I 
I Singly put through gel permeation chromatography I 
Singly put through FlorisilB SPE 
Samples combined and internal standards added 
Retention 
time 
shift 
The lingering retention time shift even with the addition of the Florisil cleanup 
step fostered the need to alter the chromatographic techniques in order to quantify the 
SPMD results. Therese Anderson developed a set of two runs that could scan for the 
tetra-substituted through hexa-substituted dioxin congeners. These HRGC/HRMS runs 
were set up to scan for the desired ion fragments for longer periods of time, lengthening 
the windows for selective ion monitoring. This altered method did detect the peaks; 
however, only one lock mass was used and only one of the two masses, M, for each 
surrogate was monitored, compromising the integrity of peak identification as outlined in 
EPA Method 1613-B. For this reason, none of the 1999 field season data were 
quantifiable. 
Process blanks from the Fig. 2.8 cleanup method, which were scanned by EPA 
methods on the HRGC/HRMS due to lack of triolein, revealed a substantial loss of the C- 
13 labeled OCDD surrogate: 50% to 70% less than the other surrogates in the cocktail. 
This occurrence was discussed with scientists at the Columbia Environmental Research 
Center in MO. It is possible that OCDD becomes sequestered in the Florisil SPEB, 
which would explain lower surrogate recoveries. This lower surrogate yield coupled with 
the still present retention time shift steered us back to the basics of the fish method used 
at the Mitchell Center. The SPMD symposium talks focused on the need to remove 
triolein reactively. The acidified silica gel column could replace FlorisilB. However, we 
decided to try the acidified silica gel slurry since that was the method already used with 
fish sample cleanup (Figure 2.7). The trial was a success (Figure 2.9). 
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FIGURE 2.9. Before and After Chromatograms for the Acidified Silica Gel Slurry. 
The two sets of chromatograms presented here each contain the four ions selected for 
2,3,7,8-TCDD and C-13 labeled 2,3,7,8-TCDD. 3 19.8965 and 321.8936 are the two 
major ions for 2,3,7,8-TCDD while 33 1.9368 and 333.9339 are the two major ions for the 
internal standard C- 13 1,2,3,4-TCDD internal standard and C- 13 2,3,7,8-TCDD 
surrogate. The (b) chromatogram has less interference and smoother peaks. 
(a) The TCDD window of a deployed SPMD sample run before silica gel cleanup 
File:000801-1 81-1269 Acq: 1-AUG-2000 13:05:42 GC EIt Voltage SIR Autospec-UltimaE 
319.8965 S:4 S1110(2,3) BSUB(128,15,-3.0) PKD(3,3,3,0,50%,144,010.00%IFlP) Exp:DIOXH Noise:36 
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File:000801-1 11-1269 Acq: 1-AUG-2000 13:05:42 GC EIt Voltage SIR Autospec-UltimaE 
333.9339 S:4 SM0(2,3) BSUB(128,15,-3.0) PKD(3,3,3,0.50%,724.010000%IPIP) Exp:DIOXH Noise:181 
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(b) The TCDD window of a deployed SPMD sample run after silica gel cleanup 
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*The chromatograms represent % abundance on left y-axis, abundance height on the right 
y-axis, and the x-axis goes by scan number which is smaller divisions of retention time. 
The retention times are indicated above the peaks. 
Therefore, extraction followed by acidified silica gel slurry and high performance 
gel permeation chromatography cleanup achieved elimination of the retention time shift. 
However, diphenylether interferences still persist and may be addressed in further SPMD 
studies. These interferences were scanned and identified through EPA method 161 3-By 
allowing the actual dioxin peaks to be distinguished from the interferences in the furan 
windows. 
Because the Gel Permeation Chromatograph malfunctioned before deployment 
two and four samples could be cleaned by this method, the chromatograms indicate the 
return of a retention time shift due to residual lipid. However, the target peaks remained 
in the defined chromatographic windows and positive identification of the compounds 
could still be made. Samples that visibly had a great deal of lipid after the silica gel 
slurry were put through a subsequent, small-scale silica gel cleanup in a test-tube. 
2.4.4. Experimental design for objective 6: Method detection limit studies 
2.4.4.1. Study one: Single SPMDs 
Method detection limits (MDLs) vary among different environmental matrices 
used to sample dioxin. An important factor in determining an appropriate upstream- 
downstream test will be the varying MDLs among the methods. Our first study involved 
spiking seven SPMDs with surrogates and the seventeen native toxic dioxin congeners at 
concentrations equal to about three times the estimated detection limit of the instrument. 
These SPMDs then went through the same processing steps as deployed SPMDs 
and the resulting dioxin concentrations recovered from the devices were quantified. 
Basic statistical parameters were calculated for the seven replicates including the mean, 
standard deviation, and percent relative statistical difference (%RSD also known as 
coefficient of variation). The %RSD value is equal to the standard deviation divided by 
the mean then multiplied by 100. Statistically, the MDL for each congener is calculated 
by examining the reproducibility among the seven replicates. The 99% t-value is 
multiplied by the standard deviation of the replicates to calculate the MDL of the 
congener (40 CFR part 13 6). 
2.4.4.2. Study two: Composites of two SPMDs 
The MDL study was repeated with two SPMDs combined to form one sample. 
The same amount of dioxin was spiked in each composite as the first study. This study 
was initiated because many of the samples from the 2000 field season consisted of 
composites of two SPMDs in order to aid in detection and increase the sensitivity of the 
method. We wanted to test our hypothesis that as more SPMDs are combined to form 
one sample, the method detection limits decrease for all of the congeners. 
3. RESULTS 
The following sections of this chapter focus on each of the deployments of the 
2000 field season. The concentrations of the seventeen toxic dioxin congeners were 
calculated for each sample and are provided in both graphical and tabular format. The 
results of the statistical analyses are also presented. 
3.1 Research Obiective 6: Method Detection Limit Studies 
3.1.1. Study one: Single SPMDs 
This method detection limit (MDL) study is the basis for the detection limits 
(DLs) presented in each of the dioxin concentration data tables. The MDLs and basic 
statistical parameters of mean, standard deviation, and percent relative statistical 
difference (%RSD also known as coefficient of variation) are provided for this MDL 
study in Table 3.1 on the following page. 

3.1.2. Study two: Composites of two SPMDs 
The results of this study are provided in Table 3.2. It is important to note that this 
study was done when the gel permeation chromatograph was not operating and thus these 
samples did not go through the appropriate, full cleanup procedure. This is why these 
MDLs are not applied to the field sample results. Gel permeation chromatography 
eliminates many of the diphenyl ether interference that can hinder peak identification. It 
is recommended that this study be repeated in order to test the theory further. 
TABLE 3.2. Method Detection Limit Study Two: SPMD Concentrations (ng congenerlkg SPMD) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
TEQ (<DL = 0) 
TEQTP (<DL = 0) 
21.32 
14.81 
15.22 
9.05 
15.54 
10.39 
64.94 
46.16 
40.11 
28.50 
29.98 
20.06 
17.04 
11.07 
19.61 
13.46 
6.05 
4.66 
30.87 
34.63 
2 1.90 
16.43 
3.2 Research Objective 3: Deplovment Time Studies 
3.2.1. Deployment one: June 2 to June 30,2000 
The data are presented in Figure 3.1. The x-axis features each of the seventeen 
toxic dioxin congeners, the y-axis features each retrieval week, and the z-axis features the 
concentration of the dioxin congener in nanograms per kilogram of whole SPMD. A 
general increase in dioxin levels is demonstrated by the figure. The fluctuations between 
weeks two and three could be generated by the small sample size of n=l and a general 
increasing trend can be discerned since the week four data points are reinforced with an 
n=5. Figure 3.1 was created by assuming that those congeners not detected were at a 
concentration of zero. 
Figure 3.1. SPMD Concentrations from the Four Weeks of Deployment One, Andmscoggin River, ME. Concentrations are provided as 
nmograms per kilogram of SPMD to create uniformity among the weeks. The absence of a bar on the graph indicates that the congener was 
not detected The mean concentrations are provided for week 4 (n=5) and the mean was calculated under the assumption that those congeners 
present at less than the detection limit were a concentration of zero. 
Concentration 
(nglkg SPMD) 
W e e k  2 
Retrieval 
Dioxin Congener \ 3- 
There are three different ways to treat the data for each deployment. Tables 3.3 
through 3.5 each provide all six TEQ values described in the methods chapter and the 
SPMD concentrations for all seventeen toxic congeners. Their differences lie in the way 
the <DL congeners were used in the statistical analyses: Table 3.3 assigns the <DL 
congeners with zero concentrations; Table 3.4 assigns them half the detection limit 
concentration; and Table 3.5 assigns them the detection limit concentration. In tables 3.3 
to 3.5, several parameters are presented for week 4 replicates: 1. The standard deviation, 
2. The 95% confidence intervals using the student t-value along with the standard 
deviation (Harris 1995), and 3. The percent relative statistical difference (%RSD) which 
provides the ratio of the standard deviation to the mean. EPA methods call for the %RSD 
among replicates to generally be less than 25 to 30%. 
TABLE 3.3. SPMD Dioxin Concentrations (nglkg SPMD) for Deployment One: <DL = 0 for Statistics 
NOTES NA = Not Applicable S = surrogate levels above or below EPA Method 1613B recovery range 
DL = Detection Limits Means are calculated with <DL having a zero concentration. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid). 
Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 

TABLE 3.5. SPMD Dioxin Concentrations (nglkg SPMD) for Deployment One: <DL = DL for Statistics 
NOTES NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having DL concentrations. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
The trends in Figure 3.1 are not uniform among all of the seventeen congeners. 
Therefore, in order to compare the dioxin concentrations in the field sample mixtures, the 
toxic equivalency (TEQ) is used. A general increase in TEQ levels over the four week 
period with the TEQ (<DL=O) on the y-axis and the retrieval on the x-axis (Figure 3.2). 
The y-axis error bar on week 4 indicates the 95% confidence interval for the five 
replicates. 
FIGURE 3.2. TEQ 
(<DL=O) over the 4- 
Week Deployment One 
Period. With exception to 
the TEQTp (<DL=O), this 
was the only TEQ method 
where an increase 
occurred over the 28-day 
deployment period. 
6 6 0.00 1 - 3 
Week 1 Week 2 Week 3 Week 4, N=5 
Retrieval 
3.2.2. Deployment two: June 30 to July 28,2000 
Figure 3.3 has been assembled just as Figure 3.1 for comparative purposes. The 
only difference is that the scale of the z-axis, dioxin concentration, is from 0 to 4 in 
Figure 3.1 while it ranges from 0 to 20 in Figure 3.2. Thus, it is important to note the 
jump in dioxin concentrations detected by the devices: July levels more than doubling the 
June levels in 2,3,7,8-TCDF. Just as for the first deployment, Tables 3.6 through 3.8 
provide the data from this deployment. Figure 3.3 was generated from Table 3.6 data 
(<DL = 0). 
F u r  3.3. SPMD Concentrations from the Four Weeks of Deployment Two, Androscoggin River, ME. Concentrations are provided as 
nanograms per kilogram of SPMD to create uniformity among the weeks. The absence of a bar on the graph indicates that the congener was 
not detected The mean concentrations are provided for week 4 (n=5) and the mean was calculated under the assumption that those congeners 
present at less than the detection limit were a concentration of zero. 
I 
Dioxin Congener <." 
Week I m 
Retrieval 
TABLE 3.6. SPMD Dioxin Concentrations (nglkg SPMD) for Deployment Two: <DL = 0 for Statistics 
NOTES NA = Not Applicable S = surrogate levels above or  below EPA Method 1613B recovery range 
DL = Detection Limits. Means are calculated with <DL having a zero concentration. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
TABLE 3.7. SPMD Dioxin Concentrations (nglkg SPMD) for Deployment Two: <DL = 0.5*DL for Statistics 
NOTES NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having 0.5*DL concentrations. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
TABLE 3.8. SPMD Dioxin Concentrations (ngkg SPMD) for Deployment Two: <DL = DL for Statistics 
NOTES 
TEQ (<DL = 0.5DL) 
TEQ (<DL = DL) 
TEQTp (<DL = 0) 
TEQTp(<DL=0.5DL) 
TEQ, (<DL = DL) 
NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having DL concentrations. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
NA 
NA 
NA 
NA 
NA 
4.02 
7.51 
0.42 
3.32 
6.23 
4.39 
7.10 
1.53 
3.65 
4.51 
7.28 
1.54 
3.71 
5 . 7 8 ,  5.89 
4.46 
7.13 
1.55 
3.72 
5.90 
4.72 
7.86 
1.13 
4.04 
6.94 
4.27 
7.43 
0.73 
3.68 
6.64 
7.65 
6.17 
1.24 
5.59 
5.59 
4.46 
6.81 
1.69 
3.86 
6.04 
5.11 
7.08 
1.27 
4.18 
6.22 
1.43 
0.64 
0.38 
0.80 
0.56 
1.78 
0.79 
0.47 
0.99 
27.99 
9.03 
29.73 
19.14 
0.69 8.94 
Figure 3.3 does not exhibit a significant linear increase throughout the 
deployment period for the tetra- through penta- substituted congeners as Figure 3.1. A 
comparison of the TCDF concentrations between the two deployment time studies is 
useful since 2,3,7,8-TCDF is a congener most likely to originate from a water point 
source. Figure 3.4 below presents these concentrations for each week of the June and 
July deployments. The 2,3,7,8-TCDF concentrations are provided on the y-axis in ng per 
kg of SPMD while the retrievals are provided chronologically on the x-axis. The error 
bars for the week 4 data points represent the 95% confidence interval among the five 
replicate samples collected that week. 
FIGURE 3.4. Comparison of TCDF Concentrations Sampled during June and July. 
1 A 0.00 6 v I I I 1 
Week 1 Week 2 Week 3 Week 4, N=5 
Retrieval 
Again, July levels of TCDF are at least twice as high as June levels. The trends 
are different between the two months. June has a slow liner increase while July has the 
opposite: a quick linear increase followed by a possible plateau by week four. This trend 
for July is also evident when we examine the TEQ values over the July deployment 
period. Figure 3.5 is set up just as Figure 3.2 and it illustrates the TEQ values over each 
deployment week in July. On the y-axis is the TEQ (<DL=O) and on the x-axis is the 
retrieval week chronologically. Again the y-axis error bar on the week 4 data point 
represents the 95% confidence interval among the replicates. 
FIGURE 3.5. TEQ 
(<DL=O) over the 4- 
Week Deployment Two 
Period. The other TEQ 
indices provided in tables 
3.6 to 3.8 demonstrate the 
same closeness in week 
2,3, and 4 TEQ values. 
0.00 L ! 
Week 1 Week 2 Week 3 Week 4, N=5 
Retrieval 
These TEQ values are together than the June deployment values. However, when taking 
into account the upper error bar on the fourth data point, an increasing trend can be 
indicated. 
3.2.3. A comparative look at the two deployment time studies 
3.2.3.1. Graphical comparisons of environmental conditions 
Appendix A contains the water quality data collected from these two deployment 
periods. While it would have been ideal to monitor water velocity conditions 
continuously, we collected water velocity data during deployment and retrievals (Figure 
3.6). Mean water velocity during the indicated week deployment period is on the y-axis 
in feet per second while the retrieval is on the x-axis. 
FIGURE 3.6. 
Water Velocity vs. 
Time for June and 
July SPMD 
Deployments. 
Week 1 Week 2 Week 3 Week 4 
Retrieval 
As demonstrated by the graph, the water velocity was higher in June than July. 
Another environmental variable to examine is temperature (hypothesis d), (Figure 
3.7). The temperature values represent the mean temperatures to which the SPMDs were 
exposed during each deployment period length (weeks 1,2,3,  and 4) as measured by the 
deployed temperature loggers. 
FIGURE 3.7. 
Temperature vs. Time 
June and July 
Deployments. 
for 
I 
Week I Week 2 Week 3 Week 4 
Retrieval 
In addition to water velocity and temperature, dissolved organic carbon (DOC) 
and total organic carbon (TOC) levels are important environmental conditions during 
SPMD dioxin sampling (Hypothesis e), (Figures 3.8a and b). The TOC and DOC 
concentrations are provided on the y-axis in mg/L and the retrieval week is provided on 
the x-axis. 
FIGURE 3.8. (a) TOC 1 (b) DOC vs. Time for June and July Deployments 
Week 1 Week 2 Week 3 Week 4 Week 1 Week 2 Week 3 Week 4 
Retrieval Retrieval 
Both TOC and DOC concentrations were higher in July than June even though there were 
higher dioxin concentrations in July. 
3.2.3.2. Statistical comparisons of environmental conditions 
All of the environmental conditions were correlated with their corresponding TEQ 
(<DL=O) values for the June and July data in a Pearson Correlation Matrix provided 
(Table 3.9). The Coefficient of Correlation, r, between each parameter is provided in the 
cell where the parameters intersect. There is only one dependent variable, Y, in our study 
which is TEQ (<DL-0) and there are five predictor variables (X) which are month, water 
velocity, TOC, DOC, and temperature. However, it is helpful to see the possible linear 
relationships between each pair of variables to determine possible interactions between 
terms. 
TABLE 3.9. r Values for June and July Deployment Data Set. 
- - - 
Parameter 
TEQ (<DL=O) 
Month 
Water Velocity 
TOC 
DOC 
Temperature 
- .. . ... 
- - - - --- - -- - 
Month Water TOC DOC Temperature 
Velocity 
It is important to note that we only have an n=8 and that we are making 15 different 
comparisons. The table illustrates that in June and July, many of the variables are 
correlated with each other. What the r tells us that r2 does not is the type of relationship 
between the variables. Water velocity has an inverse relationship with all of the 
parameters in the study. The r2 values and P-values are in the following Tables 3.10 and 
TABLE 3.10. r2 Values for June and July Deployment Data Set. The Coefficient of 
Determination, r2, between each parameter is provided in the cell where the parameters 
intersect. 
Parameter TEQ Month Water TOC DOC Temperature 
-- - -  (<DL=Ql _ _ Velocity - - __ .- - - -  -- 
TEQ (<DL=O) 1 .OOO 
Month 0.663 1 .OOO 
Water Velocity 0.587 0.734 1 .OOO 
TOC 0.560 0.741 0.922 1 .OOO 
DOC 0.338 0.740 0.781 0.895 1 .OOO 
0.704 0.777 0.672 1 .OOO 
TABLE 3.11. P-Values for June and July Deployment Data Set. The Observed Level 
of Significance, P-value, between each parameter is provided in the cell where the 
parameters intersect. 
Parameter 
- - -  
TEQ (<DL=O) 
Month 
Water Velocity 
TOC 
DOC 
Temperature 
- -  7 - -  - 
TEQ Month Water TOC DOC Temperature 
0.020 0.000 
0.027 0.006 0.000 
0.033 0.006 0.000 0.000 
0.131 0.006 0.004 0.000 0.000 
We have set the alpha level at 0.1 since these are preliminary investigations (Neter et al. 
1996). Due to the small sample size and lack of a statistical design for testing each 
parameter separately, a linear regression model for SPMD dioxin concentrations taking 
all of these environmental condition parameters into account is not possible. 
3.3 Research Obiective 4: Upstream-Downstream Studies 
3.3.1. Androscoggin River: Deployment Four, September 19 to October 17,2000 
The comparison data between upstream and downstream are presented in Figure 
3.9 while Tables 3.12 through 3.17 provide the dioxin concentrations for all seventeen 
toxic dioxin congeners along with all six TEQ values. Tables 3.12 through 3.14 provide 
the upstream data while Tables 3.15 through 3.17 provide the downstream data. Again 
there are three different ways to treat the tabular data. Their differences lie in the way the 
<DL congeners were used in the statistical analyses (calculating the mean, standard 
deviation and percent relative statistical difference): 1. Tables 3.12 and 3.1 5 assign the 
<DL congeners with zero concentrations; 2. Tables 3.13 and 3.1 6 assign them half the 
detection limit concentrations; and 3. Tables 3.14 and 3.17 assign them the detection 
limit concentration. Figure 3.9 presents the mean concentrations for all seventeen 
congeners with the <DL congeners given a concentration of zero for statistical purposes 
(Tables 3.12 and 3.1 5 data). Concentrations are provided on the y-axis in nanograms per 
kilogram of whole SPMD while the seventeen dioxin congeners quantified are provided 
on the x-axis. The y-axis error bars represent the 95% confidence interval for the mean 
concentrations with an n=10. 

TABLE 3.12. SPMD Dioxin Concentrations (ngkg SPMD) for Deployment Four Upstream: <DL = 0 for Statistics 
NOTES S = surrogate levels above or  below EPA Method 1613B recovery range C = interfering, co-eluting peak present 
DL = Detection Limits NA = Not Applicable Means are calculated with <DL having a zero concentration. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
TABLE 3.13. SPMD Dioxin Concentrations (nglkg SPMD) for Deployment Four Upstream: <DL = O.S*DL for Statistics 
NOTES NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having 0.5*DL concentrations. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
TABLE 3.14. SPMD Dioxin Concentrations (nglkg SPMD) for Deployment Four Upstream: <DL = DL for Statistics 
NOTES NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having DL concentrations. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 

TABLE 3.16. SPMD Dioxin Concentrations (ngkg SPMD) for Deployment Pour Downstream: <DL = O.SkDL for Statistics 
~ T E Q ~ ~ ( < D L = D L )  1 NA 1 6.07 1 5.03 1 6.55 1 3.80 1 5.35 1 5.38 1 5.21 1 5.35 1 5.28 1 5.24 1 5.24 1 0.70 1 0.50 1 13.28 1 I 
NOTES NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having 0.5*DL concentrations. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 

Figure 3.9 does not offer any evidence that there is a difference between upstream and 
downstream dioxin concentrations. The toxic equivalency (TEQ) becomes an important 
tool that allows us to compare all the dioxin congeners concentrations in one value for 
upstream and one value for downstream. The TEQ values are available in Tables 3.12 to 
3.17 and the mean TEQ values are illustrated in the Figure 3.10 bar graph below. The 
TEQ value is on the y-axis while the x-axis provides the TEQ calculation method. The y- 
axis error bars represent the 95% confidence intervals for the mean TEQ values with an 
FIGURE 3.10. Upstream-Downstream TEQ Values for Androscoggin River 
Deployment Four 
TEQ TEQ TEQ TEQn TEQTP TEQTP 
(<DL=O) (<DL=O.SeDL) (<DL=DL) (<DL=O) (<DL=O.SeDL) (<DL=DL) 
TEQ Calculation Method 
For each of the TEQ methods shown, the error bars overlap for upstream and 
downstream, demonstrating no differences between the sites. 
ANOVA was performed on the deployment four data set. The TEQ (<DL=O) was 
chosen to be the dependent variable in the ANOVA and the independent variable was 
upstream or downstream. The F* value of 0.077 is below the cutoff of 4.42 (F (0.95; 1, 
18) = 4.42), thus supporting the null hypothesis that there is no difference between 
upstream and downstream dioxin levels for this deployment period. All of the criteria 
were met to substantiate the ANOVA F test conclusion: There was constancy of variance, 
a normal probability distribution of residuals, and no outliers were present. The P-value 
is 0.784, which is well above the alpha of 0.05. 
3.3.2. Kennebec River: Deployment Three, August 3 to September 26,2000 
The comparison data between upstream and downstream are presented in Figure 
3.1 1 while Tables 3.18 through 3.23 provide the dioxin concentrations for all seventeen 
toxic dioxin congeners along with all six TEQ values. Tables 3.18 through 3.20 provide 
the upstream data while Tables 3.21 through 3.23 provide the downstream data. Again 
there are three different ways to treat the tabular data. Their differences lie in the way the 
<DL congeners were used in the statistical analyses (calculating the mean, standard 
deviation and percent relative statistical difference): 1. Tables 3.18 and 3.2 1 assign the 
<DL congeners with zero concentrations; 2. Tables 3.19 and 3.22 assign them half the 
detection limit concentrations; and 3. Tables 3.20 and 3.23 assign them the detection 
limit concentration. Figure 3.1 1 presents the mean concentrations for all seventeen 
congeners with the <DL congeners given a concentration of zero for statistical purposes 
(Tables 3.18 and 3.2 1 data). Concentrations are provided on the y-axis in nanograms per 
kilogram of whole SPMD while the seventeen dioxin congeners quantified are provided 
on the x-axis. The y-axis error bars represent the 95% confidence interval for the mean 
concentrations with an n=5. 

TABLE 3.18. SPMD Dioxin Concentrations (nglkg SPMD) for Deployment Three Upstream: <DL = 0 for Statistics 
NOTES NA = Not Applicable 
DL = Detection Limits. Means are calculated with <DL having a zero concentration. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
TABLE 3.19. SPMD Dioxin Concentrations (ngkg SPMD) for Deployment Three Upstream: <DL = 0.5*DL for Statistics 
NOTES NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having 0.5*DL concentrations. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
TABLE 3.20. SPMD Dioxin Concentrations (ngkg SPMD) for Deployment Three Upstream: <DL = DL for Statistics 
NOTES NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having DL concentrations. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
TABLE 3.21. SPMD Dioxin Concentrations (nglkg SPMD) for Deployment Three Downstream: <DL = 0 for Statistics 
NOTES 
1,2,3,4,6,7,8-HpCDD 
OCDD 
TEQ (<DL = 0) 
TEQ (<DL = 0.5DL) 
TEQ (<DL = DL) 
TEQTp (<DL = 0) 
TEQTp (<DL = 0.5DL) 
- 
TEQ, (<DL = DL) 
NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having a zero concentration. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
2.3 1 
6.70 
N A 
NA 
NA 
NA 
NA 
NA 
0.42 
1.99 
0.46 
2.52 
4.58 
0.33 
2.2 1 
4.10 
0.4 1 
<DL 
0.3 1 
3.77 
7.23 
0.24 
3.20 
6.16 
0.42 
1.34 
0.55 
3.66 
6.77 
0.45 
3.40 
6.36 
0.62 
2.30 
0.35 
3.90 
7.45 
0.28 
3.23 
6.19 
0.44 
1.69 
0.39 
3.69 
7.00 
0.29 
3.24 
6.20 
0.46 
1.46 
0.41 
3.51 
- 6.6 1 
0.32 
3.06 
5.80 
0.09 
0.41 
0.09 
0.56 
1.16 
0.08 
0.48 
0.96 
0.1 1 
0.5 1 
0.1 1 
0.70 
1.44 
0.10 
0.59 
1.19 
19.73 
27.99 
22.48 
15.98 
17.58 
24.72 
15.66 
16.48 
NOTES NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having 0.5*DL concentrations. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
TABLE 3.23. SPMD Dioxin Concentrations (ngkg SPMD) for Deployment Three Downstream: <DL = DL for Statistics 
'con~ener~ple ID 
2,3,7,8-TCDF 
1 -2.3.7.8-PeCDF 
2,3,4,6,7,8-HxCDF 
1 ,2,3,7,8,9-HxCDF 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
OCDF 
NOTES 
(nn/kg) 
0.80 
2.08 
TEQTp (<DL = 0) 
TEQTp (<DL = O.5DL) 
TEOTD (<DL = DL) 
NA = Not Applicable 
DL = Detection Limits Means are calculated with <DL having DL concentrations. 
All concentrations are given in parts per trillion as ng of the congener per kg of whole SPMD (membrane + lipid) 
*Data points are only rejected if they are proven to be outliers by the Q Test for Bad Data with 95% Confidence. 
Values less than the MDLs are to be considered estimated values. 
2.88 
1.68 
2.65 
1 .56 
7.18 
76-s 
1.99 
2.08 
NA 
NA 
NA 
0.4 1 
0.17 
2.65 
1 .56 
0.26 
- 77-S
2.43 
2.08 
0.33 
2.21 
4.10 
0.33 
0.16 
2.65 
1.56 
7.18 
78-S 
4.46 
2.08 
0.24 
3.20 
6.16 
2.88 
0.12 
2.65 
0.14 
7.18 
- 79-S
2.77 
2.08 
0.45 
3.40 
6.36 
0.50 
1.68 
2.65 
1.56 
7.18 
- 804
2.91 
2.08 
0.28 
3.23 
6.19 
0.39 
0.16 
2.65 
1 .56 
7.18 
Mean 
2.91 
2.08 
0.29 
3.24 
6.20 
0.90 
0.46 
2.65 
1.28 
5.80 
Std Dev 
0.93 
0.00 
0.32 
3.06 
5.80 
1.10 
0.68 
0.00 
0.64 
3 .09 
0.08 
0.48 
0.96 
Rejected* - 95% CI 
1.16 
0.00 
1.37 
0.85 
0.00 
0.79 
3.84 
O h  RSD 
32.09 
0.00 
122.43 
148.55 
0.00 
49.78 
53.38 
0.10 
0.59 
1.19 
24.72 
15.66 
16.48 
The graphical and tabular results indicate that there is no difference between the 
upstream-downstream dioxin concentrations. Figure 3.12 provides a graphical 
presentation of the various TEQs calculated for both upstream and downstream. The 
mean TEQ is provided on the y-axis and the TEQ calculation method is provided on the 
x-axis. The bars represent the mean TEQ value among the five replicates for each site. 
The y-axis error bars represent the 95% confidence interval for the mean TEQs. 
FIGURE 3.12. Upstream-Downstream TEQ Values for Kennebec River 
TEQ Calculation Method 
There is no difference between upstream and downstream dioxin concentration means 
(Figure 3.12). Statistically, the analysis of variance (ANOVA) F-test supports the null 
hypothesis that there is no statistical difference between upstream and downstream 
treatments at a level of significance, a = 0.05 with a P-value of 0.505. 
3.4 Research Obiective 5: Investigation of the Dixfield, ME Site 
3.4.1. Deployment month 
Figure 3.13 on the following page presents the dioxin concentrations for all three 
Androscoggin River deployment months. The concentrations in nanograms of the dioxin 
congener per kilogram of whole SPMD are provided on the y-axis while the seventeen 
dioxin congeners are provided on the x-axis. The y-axis error bars represent the 95% 
confidence intervals for the concentration means: for June and July, n=5 and for 
September-October, n=10. 

For most of the congeners, the concentrations are highest in July, followed by September- 
October, and then June (Figure 3.13; Figure 3.14). 
FIGURE 3.14. Comparison of 28-Day Deployment Period TEQ Values: 
Androscoggin River at Dixfield 
TEQ Calculation Method 
The statistical difference in SPMD dioxin concentrations between months was 
proven through ANOVA. The dependent variable used was TEQ (<DL=O) and the 
predictor variable was month with three different treatments of June, July, and 
September-October, nT=l 8. The F* value was 7.647 compared to a critical F value of 
3.68. Therefore, we conclude Ha, that there is a statistical difference between dioxin 
concentrations among the three treatments. It is important to note that there were two 
outliers removed from the September-October data set, thus n=8 (97-S and 100-S). They 
are noted as outliers on the data sheet by the 95% Q test for Bad Data (Harris 1995). This 
ANOVA test is conclusive because all criteria for ANOVA were met. The P-value for 
the test was 0.005, which is well below the alpha of 0.05. 
3.4.2. Environmental conditions 
3.4.2.1. Graphical comparisons 
Figures 3.15 to 3.17 graphically present the data in the Appendix A for these 
water quality parameters. 
2.5 
FIGURE 3.15. Water Velocity A g 2  vs. Deployment Month for the 
Dixfield Site. The water velocity .$ -- 
is an average for each deployment = 
period. f a 1 
.d 
FIGURE 3.16. 
Temperature vs. 
Deployment Month for the 
Dixfield Site. The 
temperature is an average of 
the hourly temperature logger 
data for each deployment 
~er iod.  
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FIGURE 3.17. TOC and --.- 4 
.-- -- 
DOC Concentrations vs. 
Deployment Month for the - 
Dixfield Site. Each data point c o I 
.- 
represents the mean 6.5 -- - 
concentration for the 
- 
deployment period. 
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Deployment Month 
3.4.2.2. Statistical comparisons 
To statistically compare environmental conditions and dioxin concentrations, we 
used the coefficient of correlation [r], the coefficient of determination [r2], and the 
observed level of significance [P-value] (Tables 3.24 to 3.26). The number of 
observations is equal to 18. There is only one dependent variable, Y, in our study which 
is TEQ (<DL-0) and there are four predictor variables, X, which are water velocity, TOC, 
DOC, and temperature. 
TABLE 3.24. r Values for the Dixfield Data Set. The Coefficient of Correlation, r, 
between each parameter is provided in the cell where the parameters intersect. 
DOC Temperature 
Water Velocity -0.425 1 .OOO 
TOC 0.242 -0.957 1 .OOO 
DOC 0.22 1 -0.948 1 .OOO 1 .OOO 
TABLE 3.25. r2 Values for the Dixfield Data Set. The Coefficient of Determination, 
r2, between each parameter is provided in the cell where the parameters intersect. 
Parameter Water TOC DOC Temperature 
water Velocity 0.181 1 .OOO 
TOC 0.059 0.916 1 .OOO 
DOC 0.049 0.899 1 .OOO 1 .OOO 
1 .ooo 
- . -.-, . . . .,.r. 
TABLE 3.26. P-Values for the Dixfield Data Set. The Observed Level of 
Significance, P-value, between each parameter is provided in the cell where the 
parameters intersect. 
Water Velocity 0.079 0.000 
TOC 0.334 0.000 0.000 
DOC 0.377 0.000 0.000 0.000 
Compared with the deployment time study statistical parameters, these data differ for 
some of the variables. Not only will these current correlations be discussed, but also they 
will be compared with the deployment time study correlations in our discussion chapter. 
4. DISCUSSION 
This'chapter will examine each of our objectives and hypotheses and apply the 
results from the last chapter to each of them. This chapter will also discuss the questions 
for future work. 
4.1 Obiective 1: Method Development 
To developjeld and laboratory methods for the SPMDs. 
The sample data presented in the results chapter coupled with the quality control 
data spreadsheets in the appendices demonstrate the effectiveness of the final SPMD 
extraction and cleanup methods developed in this project. Retention time shifts were 
eliminated with the combined cleanup steps of silica gel slurry and gel permeation 
chromatography. The significance of the GPC was reinforced when the instrument 
malfunctioned and the samples from deployments two and four of the 2000 field season 
could not be cleaned with the final method. Samples from these two deployments had 
more diphenylether (DPE) interference than samples from the other deployments. This 
interference is noted in the data flag column of each spreadsheet. 
It is helpful at this point to discuss the causes of some of the other data flags in the 
quality control data in Appendices C and D: dioxin detected in laboratory blanks (B), 
syringe contamination (Y), and carryover from the HRGC / HRMS calibration standard 
(0). Mostly the dioxin detected in the laboratory blanks, B, was associated with 
diphenylether interference. One isolated incident involved the contamination of an 
internal standard syringe with the perforinance and recovery standard (Y-flag). This 
contamination was found in some of the QC blanks but the pattern of contamination was 
not exhibited in the accompanying field SPMD samples; therefore, those field samples 
were not flagged. The HRGC / HRMS calibration standard contamination was a difficult 
source of contamination because it only affected the first sample of each of the SPMD 
runs. The first sample was usually a process blank and that is why most of these samples 
are flagged. The sample order in the run was always calibration standard, fresh solvent 
blank, and then process blank. The contamination was attributed to the syringe because 
the same peaks were found in the fresh solvent blank run prior to the process blank. 
While analytical problems occurred, noted by the data flags, the final SPMD 
extraction and cleanup method was successful and is ready to be used in future SPMD 
work. The analytical issues have subsequently been eliminated by the HRGC /HRMS 
analyst. 
4.2 Obiective 2: SPMD Performance 
To determine the effectiveness of semipermeable membrane devices 
for sampling dioxin in Maine rivers. 
While this objective was met with preliminary results from the 1999 field season 
data, it was reinforced by the quantitative data from the 2000 field season. For all of the 
2000 field season deployments, the tetra- through hexa-chlorinated dibenzofurans 
(TCDFs, PeCDFS, and HxCDFs) and the hepta- and octa-chlorinated dibenzo-p-dioxins 
(HpCDD and OCDD) were detected by the SPMDs. The detection of HpCDD and 
OCDD in all of the samples substantiates the discussion of Czuczwa and Hites (1986) 
about the atmospheric abundance of these two congeners produced by the reactions of the 
wood preservative pentachlorophenol. 
A key unrelated issue is whether the SPMDs are able to sample TCDD. Previous 
dioxin studies using the SPMDs have been able to detect TCDD (Prest et al. 1992; Lebo 
et al. 1995; Gale et al. 1997; and Rantalainen et al. 1998), so it is unlikely that an 
inability to sample TCDD is a shortfall of the devices. Most likely, the compound was 
not present during the deployment periods in a dissolved form. Another interesting trend 
is for only the lower chlorinated PCDFs to be sampled by the SPMDs. This occurrence 
was noted in many previous SPMD studies with polychlorinated biphenyls and dioxin: 
the SPMDs sampled more of the lower chlorinated congeners than the higher chlorinated 
ones (Prest et al. 1995; Gale et al. 1997; McCarthy and Gale 1999; and Echols et al. 
2000). Our SPMD data follow the trends exhibited in previous studies. 
4.3 Obiective 3: Deployment Time Studies 
Examine the efects of environmental conditions on SPMD dioxin concentrations 
during June and July deployment time studies 
The SPMD deployment parameters and environmental conditions scrutinized 
under this objective are identified with each of the hypotheses provided in the following 
subsections. 
4.3.1. Hypothesis a: Deployment time 
As deployment time increases, dioxin concentrations increase. 
We developed this hypothesis, which was reinforced by the deployment time 
studies executed by Rantalainen et al. (1 998), to determine if SPMD saturation occurred 
during our deployment periods. While we performed the calculations and found that we 
were well within the linear iampling period for dioxin, we wanted to substantiate the 
calculation with experimental data as well as investigate the biofouling of the membranes 
throughout the deployment time period. A quick review of the results presented in 
chapter three reveals that our two deployment time studies validated hypothesis a. For 
both June and July, there was a general trend of increasing dioxin levels as deployment 
time increased. However, the lack of a substantial increase in dioxin concentrations in 
the fourth week of the July deployment indicates the presence of other factors influencing 
dioxin concentrations: the factor of increased biofouling. 
4.3.2. Hypothesis b: Biofouling 
As biofouling increases on the SPMDs, the uptake of dioxin decreases. 
The extent of biofouling on the membrane increases as temperature increases. 
Scientists working with SPMDs have long recognized that biofouling on the 
device slows the SPMD sampling rate of pollutants (Gale 1998; Huckins et al. 1999a). 
The environmental condition of temperature influences biofouling because as 
temperature increases, so does biological activity and thus biofouling. Biofouling could 
not quantified; however, it was qualitatively observed. More growth was noted in July 
than in June. For July, tiny periphyton was observed on the SPMDs in the first week, 
leaving no stain when cleaned during processing. However, the growth on the membrane 
surface became darker and larger with increased exposure and brown staining of the 
membranes occurred. Perhaps this increase in biofouling slowed the SPMD sampling 
rate in July, validating hypothesis b. The June deployment TEQ and TCDF 
concentrations (Figures 3.2 and 3.4) do not indicate a plateau in the concentrations over 
the four-week period while the July deployment values do (Figures 3.4 and 3.5). This 
plateau may be nonexistent or not be attributed to biofouling. However, these 
observations reflect the need for more research on the effects of biofouling on SPMD 
performance. 
4.3.3. Hypothesis c: Water velocity 
As water velocity increases, the dilution of water dioxin concentrations increases and 
less dioxin is sequestered by the SPMDs during the deployment period. 
While Booij et al. (1998) found that increased water velocity-turbulence causes an 
increase in SPMD sampling rate, our water velocity hypothesis focused on what occurs in 
the river during high velocity periods. Even though SPMD sampling rate increases 
during high water velocity conditions, the water being sampled would contain less dioxin 
than during low water velocity conditions due to the presence of more water and thus 
dilution. Was this hypothesis validated by our deployment time studies? 
Water velocity was higher in June than in July and dioxin concentrations were 
higher in July than in June. Is this inverse relationship real? Statistically, the relationship 
between water velocity and TEQ (<DL=O) in the Pearson Correlation Matrix had an r of 
-0.766 and a P-value of 0.027. With an alpha value set at 0.1 for preliminary 
investigations, the inverse relationship between water velocity and dioxin concentrations 
for the two deployment time studies was validated statistically. However, the small 
sample size and lack of a statistical design for testing water velocity separate from the 
other environmental conditions. Therefore, these results warrant the need for further 
investigations into this hypothesis. 
4.3.4. Hypothesis d: Temperature 
As temperature increases SPMD dioxin sampling rates increase 
and the devices sequester more dioxin. 
Previous calibration studies with the SPMDs have validated this hypothesis in the 
laboratory (Huckins et al. 1999a and Rantalainen et al. 2000). We wanted to see if this 
direct relationship between temperature and dioxin concentrations occurred in the field 
during our deployment time studies. Temperatures in the water were three to five 
degrees Celsius higher in July than in June and dioxin concentrations were higher in July 
than in June as well. Was a direct relationship between temperature and dioxin 
concentrations statistically significant? The coefficient of correlation, r, was 0.852 
between temperature and TEQ (<DL=O) and the P-value was 0.007 which is well below 
an alpha of 0.1. Therefore, the relationship was proven to be statistically significant and 
warrants further study. 
4.3.5. Hypothesis e: Total organic carbon and dissolved organic carbon 
As TOC and DOC concentrations in the water sampled increase, 
dioxin concentrations in the SPMD decrease. 
In addition to biofouling, water velocity, and temperature, TOC and DOC 
concentrations influence the SPMD dioxin concentrations (J.N. Huckins, personal 
communication; McCarthy and Gale 1999). Dioxin is highly hydrophobic and prefers to 
be bound to particulate matter. TOC and DOC chelate dioxin and reduce the availability 
of the dioxin for the sequestered by the SPMDs during deployment. High levels of TOC 
and DOC theoretically suggest lower levels of dioxin sampled by the devices. TOC and 
DOC levels were higher in July than in June (Figure 3.8). Therefore, in July both 
TOC/DOC and dioxin concentrations were higher; thus instead of the hypothesized 
inverse relationship, a direct one is presented. Does this disprove our original 
hypothesis? Statistically, a correlation between TOC/DOC concentrations and dioxin 
concentrations was not evident, especially DOC with a P-value of 0.13 1. There are many 
interactions occurring between the environmental conditions, making it difficult to 
adequately test all of these hypotheses. Further studies will need to be done that isolate 
these conditions. 
4.4 Obiective 4: Upstream-Downstream Test 
To deploy SPMDs at selected upstream-downstream sites and determine 
if there is a statistical difference between upstream and downstream dioxin levels. 
This objective was the main focus of our project. The sample sizes were bigger 
for this investigation than for the environmental condition investigations. We wanted to 
see if these devices could be used for the upstream-downstream test. The larger sample 
size allowed for statistical analyses to be done on the results. Through graphical and 
statistical analyses we found that there was no difference between upstream and 
downstream dioxin concentrations at both pairs of sites tested. 
A great deal of information was provided by these two deployments. The 
statistical parameter of percent relative statistical difference (%RSD), also known as the 
coefficient of variation, relates the standard deviation and mean of a set of replicate 
deployment samples. In determining the presence of a statistical difference between 
upstream and downstream it is important to have the least amount of variability among 
the replicate SPMD samples as possible. An important factor that must be worked out by 
the Maine DEP is the determination of what value to assign for <DL because it affects the 
%RSD. While the %RSD values presented in the previous chapter are promising, 
subsequent SPMD studies should focus on investigating multiple replicates at each site to 
fiu-ther assess method variability. The Maine DEP has been evaluating fish variability so 
it would be beneficial to look at SPMD performance for the same sites over multiple field 
seasons since environmental conditions are variable from year to year. 
4.5 Obiective 5: SPMD Field Season 
To investigate how the SPMDs sample over an entire field season at a given site. 
This examination will allow us to determine the optimal times for SPMD deployments. 
4.5.1. Hypothesis f: Deployment month 
There is a difference in the SPMD dioxin concentrations 
among the deployment months. 
As we planned the 2000 field season we expected that deployment month would 
be significant because environmental conditions vary from month to month (Figure 3.13). 
Through ANOVA, the hypothesis was statistically validated: Dioxin concentrations in the 
SPMDs vary by deployment month, with the highest dioxin concentrations in July. 
Therefore, it is helpful to characterize a given deployment site throughout a given field 
season in order to gain understanding of how the varying monthly conditions influence 
SPMD dioxin concentrations. For example, the environmental condition trends found in 
the 2000 field season are most likely going to be different from previous and subsequent 
field seasons. As far as an optimal deployment month, that is hard to assess. For the 
2000 field season, July looked to be the best month for deployment because one could 
have shorter deployment periods due to less dilution of the pollutant examined. 
4.5.2. Hypothesis g: Environmental conditions 
The varying environmental conditions of water velocity, temperature, TOC, and DOC 
among the deployment months influence this difference in SPMD dioxin concentrations. 
While each environmental condition will be briefly discussed, it is evident that all 
of these conditions influence the SPMD dioxin concentrations through an interactive 
effort: no one parameter controls the SPMD sampling. For this reason, it is difficult to 
establish the presence of statistical relationships without a set experimental design that 
can hold the other environmental conditions constant while the investigated parameter is 
varied. These designs cannot be achieved in the field, which is why they were not 
pursued in this current study. 
4.5.2.1. Water velocity 
For dioxin concentrations, July had the highest followed by September-October 
and then June. For water velocity, June had the highest, followed by July then 
September-October. Therefore, an inverse relationship is possible between dioxin 
concentrations and water velocity. However, statistically, the coefficient of correlation 
between water velocity and TEQ (<DL=O) was -0.425 with a P-value of 0.079 which is 
just under an alpha of 0.1, indicating the presence of a possible negative correlation. 
4.5.2.2. Temperature 
The relationship in the deployment time study between temperature and SPMD 
dioxin concentrations is reinforced by this deployment month investigation. July had 
both the highest temperatures and the highest dioxin concentrations. The coefficient of 
correlation between the two variables was 0.408 and the P-value of 0.092 is below an 
alpha of 0.1, indicating the presence of a possible positive correlation. 
4.5.2.3. TOC and DOC 
A linear association between TOCIDOC and TEQ was not significant with this 
data set. The P-values were 0.334 and 0.377 for TOC and DOC respectively when each 
was correlated with TEQ (<DL=O). 
4.6 Obiective 6, Hypothesis h: Method Detection Limits 
To determine if SPMD method detection limits (MDLs) are influenced 
by the number of SPMDs combined to make one sample. 
Hypothesis (h): 
As the number of SPMDs that are combined to make one sample in 
a MDL study increases, the detection limits decrease and the 
sensitivity of the method increases. 
Tables 3.1 and 3.2 in the previous chapter do not validate this hypothesis. Most 
of the MDLs for the different dioxin congeners increased as we went from one SPMD to 
two. Why did the experimental results diverge from the hypothesis? 
It is important to note that the second MDL study was done when the gel 
permeation chromatograph was not operating and thus these samples did not go through 
the appropriate, full cleanup procedure. This is the reason why these MDLs are not 
applied to the field sample results. Gel permeation chromatography eliminates many of 
the diphenyl ether interference that can hinder peak identification. Therefore, the peaks 
in the second MDL study were not as defined as in the first study. It is recommended 
that this study be repeated in order to test the theory further. 
5. CONCLUSION 
5.1 Summary 
This thesis project evaluated an alternate method for determining Kraft pulp and 
paper mill compliance to the upstream-downstream test of the 1997 Dioxin Law. This 
new method that utilizes semipermeable membrane devices (SPMDs) circumvents many 
of the problems present with the current upstream-downstream fish test. 
Over the course of two field seasons, we assessed the feasibility of using SPMDs 
to monitor dioxin concentrations in Maine rivers. First, the 1999 field season focused on 
developing viable field and laboratory SPMD methods. Field methods included design of 
the vertical deployment apparatus for the SPMDs and determination of which 
environmental conditions to monitor: biofouling, temperature, water velocity, dissolved 
organic carbon, total organic carbon, and specific conductance. In the laboratory, the 
final SPMD extraction and cleanup methods included extraction by dialysis of the entire 
SPMD in hexane followed by two cleanup methods: acidified silica gel slurry to remove 
residual lipids and gel permeation chromatography to remove interferences through size 
exclusion. The laboratory analysis involved EPA Method 1613B and high resolution gas 
chromatography / high resolution mass spectrometry (HRGCIHRMS). 
Second, for the 2000 field season we applied the developed methods to assess the 
effects of varying environmental conditions on SPMD sampling and to test two pairs of 
upstream-downstream sites: one pair on the Androscoggin River and one pair on the 
Kennebec River. A pair of deployment time studies allowed for us to investigate the 
effects of biofouling on SPMD sampling and to determine if SPMD dioxin concentrations 
increase linearly over the 28-day deployment period. 
5.2 Conclusions 
We developed viable field and laboratory methods for using semipermeable 
membrane devices to monitor dioxin levels in Maine rivers. Over the past two field 
seasons, we have demonstrated the ability of the devices to monitor dioxin. Moreover, 
we have provided the Maine Department of Environmental Protection with SPMD 
upstream-downstream data from two Maine Rivers with replicate SPMD samples. These 
data will be compared by DEP staff with data from the other dioxin monitoring methods. 
Since laboratory investigations were not part of this project, the relationships 
between environmental conditions, such as water velocity, temperature, total organic 
carbon, and dissolved organic carbon, and SPMD dioxin concentrations could not be 
examined. The Pearson Correlation Matrices demonstrated the existence of relationships 
that need to be validated in further studies: a negative correlation between water velocity 
and dioxin concentration and a positive correlation between temperature and dioxin 
concentration. While there are many advantages in using the SPMDs, the varying 
environmental conditions and their effects on SPMD dioxin concentrations do present the 
fundamental limitation of the devices: the SPMD sampling rate depends on water 
velocity, temperature, and biofouling. Scientists are working hard to circumvent this 
limitation (Booij et al. 1998; Huckins et al. 1999a). Our earlier discussion about 
permeability reference compounds (PRCs) addresses this issue. Adding a PRC to the 
SPMD before deployment will allow for corrections to be made between sites for these 
varying environmental conditions. Using these PRCs, we will not need to investigate 
complex experimental designs to establish the statistical relationships between each 
environmental variable and dioxin concentrations. 
The method detection limit (MDL) studies presented in this thesis illustrate the 
reproducibility of the SPMD results. The questionable MDL study involving the two 
SPMDs per sample warrants the need for further composite studies to test our hypothesis. 
5.3 Proposed Future Work 
Since this is the first attempt to use SPMDs in the State of Maine in a possible 
regulatory situation, there are many areas that need to be further investigated. 
1. More SPMDs should be processed to test the effectiveness of the extraction 
and cleanup methods. 
2. A permeability reference compound (PRC) should be developed for SPMD 
dioxin monitoring. In a possible regulatory situation, we need to be assured 
that upstream and downstream sites can be directly compared; therefore, 
environmental conditions must be identical or corrections must be made 
through use of the PRCs. Our studies controlled site selection for water 
velocity and temperature, however TOC and DOC concentration analyses 
must be performed in the laboratory and thus are not good screening data. 
3. If a PRC is not used, laboratory experiments should be performed where other 
environmental conditions are held constant and each parameter is tested 
separately on how it affects SPMD dioxin concentrations. It would be 
difficult to perform these tests in the field. 
4. Repeat the deployment time studies with more replicates in the first three 
weeks to refine the recommendations for optimal time of deployment. 
5. Repeat the upstream-downstream tests at the same sites as the 2000 
deployments so that we can begin to establish a historical record of SPMD 
concentrations. Adding more replicates will allow for a fuller examination of 
upstream-downstream differences and variability. 
6. Compare SPMD data with the other dioxin monitoring methods from the 2000 
field season for the same sites and deployment periods to determine how our 
SPMD test measures up to the alternatives: How does the variability of our 
samples compare with fish and mussel variability? 
REFERENCES 
Baker JI, Hites RA. 2000a. Is combustion the major source of polychlorinated 
dibenzo-p-dioxins and dibenzofurans to the environment? A mass balance 
investigation. Environmental Science and Technology 34: 2879-2886. 
Baker JI, Hites RA. 2000b. Siskiwit Lake revisited: Time trends of polychlorinated 
dibenzo-p-dioxin and dibenzofuran deposition at Isle Royale, MI. Environmental 
Science and Technology 34: 2887-2891. 
Bertazzi PA, Pesatori AC, Consonni D, Tironi A, Landi MT, Zocchetti C. 1993. Cancer 
incidence in a population accidentally exposed to 2,3,7,8-tetrachlorodibenzo-para- 
dioxin. Epidemiology 4: 398-406. 
Bierbaum VM, Boyd RK, Busch KL, Cepa SP, Charles MJ, Cotter RJ, Enke CG, Fales 
HM, Haney CA, Lehrnan, TA. 1995. What is Mass Spectrometry? The American 
Society for Mass Spectrometry. Los Gatos, CA; pgs. 1-23. 
Birnbaum LS, DeVito MJ. 1995. Use of toxic equivalency factors for risk 
assessment for dioxins and related compounds. Toxicology 105: 391-401. 
Booij K, Sleiderink HM, Smedes F. 1998. Calibrating the uptake kinetics of 
semipermeable membrane devices using exposure standards. Environmental 
Toxicology and Chemistry 17: 1236- 1245. 
Carey F. 1996. Organic Chemistry. Third Edition. New York: McGraw-Hill 
Companies. 
Colburn T, vom Saal FS, Soto AM. 1993. Developmental effects of endocrine- 
disrupting chemicals in wildlife and humans. Environmental Health Perspectives 
101 (5): 378-387. 
Czuczwa JM and Hites RA. 1984. Environmental fate of combustion-generated 
polychlorinated dioxins and furans. Environmental Science and Technology 
18: 444-450. 
Czuczwa JM, Hites RA. 1986. Airborne dioxins and dibenzofurans: sources 
and fates. Environmental Science and Technology 20: 195-200. 
Doucette WJ, Andren AW. 1988. Estimation of octanol1 water partition coefficients: 
evaluation of six methods for highly hydrophobic aromatic hydrocarbons. 
Chemosphere 17: 345-359. 
Echols KR, Gale RW, Schwartz TR, Huckins JN, Williams LL, Meadows JC, Morse D, 
Petty JD, Orazio CE, Tillitt DE. 2000. Comparing polychlorinated biphenyl 
concentrations and patterns in the Saginaw River using sediment, caged fish, and 
semipermeable membrane devices. Environmental Science and Technology 34: 
4095-4102. 
Eitzer BD. 1993. Comparison of point and nonpoint sources of polychlorinated 
dibenzo-p-dioxins and polychlorinated dibenzofurans to sediments of the 
Housatonic River. Environmental Science and Technology 27: 1632- 1637. 
Ellis GS, Huckins JN, Rostad CE, Schrnitt CJ, Petty JD, MacCarthy P. 1995. Evaluation 
of lipid-containing semipermeable membrane devices for monitoring 
organochlorine contaminants in the Upper Mississippi River. Environmental 
Toxicology and Chemistry 14: 1875- 1884. 
EPA. 1994. Exposure and Human Health Reassessment of 2,3,7,8-TCDD and related 
Compounds. DRAFT. URL: http://www.epa.gov/nceddioxin.htm. 
EPA. 2000. Exposure and Human Health Reassessment of 2,3,7,8-TCDD and related 
Compounds. DRAFT. URL:http://www.epa.gov/ncedpdfs/dioxiddioxreass.htm. 
Last updated: 61810 1, 1 1 :42am 
Ferrario JB, Byrne CJ, Cleverly DH. 2000. 2,3,7,8-Dibenzo-p-dioxins in mined 
clay products from the US: Evidence for possible natural origin. Environmental 
Science and Technology 34: 4524-4532. 
Fries GF. 1995. A review of the significance of animal food products as potential 
pathways of human exposure to dioxins. Journal of Animal Science 73 (6): 1639- 
1650. 
Gale RW, Huckins JN, Petty JD, Peterman PH, Williams LL, Morse D, Schwartz TR, 
Tillitt DE. 1997. Comparison of the uptake of dioxin-like compounds by caged 
channel catfish and SPMDs in the Saginaw River, MI. Environmental Science 
and Technology 31: 178-1 87. 
Gale RW. 1998. Tree-compartment model for contaminant accumulation by 
semipermeable membrane devices. Environmental Science and Technology 32: 
2292-2300. 
Granmo A, Ekelund R, Berggren M, Brorstrom-Lunden E, Bergqvist P-A. 2000. 
Temporal trend of organochlorine marine pollution indicated by concentrations in 
mussels, semipermeable membrane devices, and sediment. Environmental 
Science and Technology 34: 3323-3329. 
Harris, DC. 1995. Quantitative Chemical Analysis. Fourth Edition. New York, NY: 
W.H. Freeman and Company, pp. 65-71. 
Heme S, Prest HF, Heinonen P, Hyotylainen T, Koistinen J, Paasivirta J. 1995. Lipid- 
filled semipermeable membrane devices and mussels as samplers of 
organochlorine compounds in lake water. Environmental Science and Pollution 
Research 2: 24-30. 
Hofelt CS, Shea D. 1997. Accumulation of organochlorine pesticides and PCBs by 
semipermeable membrane devices and mytilus edulis in New Bedford Harbor. 
Environmental Science and Technology 31 : 154- 1 59. 
Huckins JN, Tubergen MW, Manuweera GK. 1990. SPMDs containing model 
lipid: A new approach to monitoring the availability of lipophilic contaminants 
and estimating their bioconcentration potential. Chemosphere 20: 533-552. 
Huckins JN, Manuweera GK, Petty JD, Mackay D, Lebo JA. 1993. Lipid-containing 
semipermeable membrane devices for monitoring organic contaminants in water. 
Environmental Science and Technology 27: 2489-2496. 
Huckins JN, Petty JD, Lebo JA, Orazio CE, Prest HF, Tillitt DE, Ellis GS, Johnson, BT, 
Manuweera GK. 1996. Semipermeable membrane devices (SPMDs) for 
the concentration and assessment of bioavailable organic contaminants in aquatic 
environments. Techniques in Aquatic Toxicology. G.K. Ostrander. Boca Raton, 
FL: CRC Press, Inc., pp. 625-655. 
Huckins JN, Petty JD, Lebo JA, Orazio CE, Clark RC, Gibson VL. 1999a. SPMD 
Technology: Tutorial (2"d Edition). U.S. Department of Interior, National 
Biological Service, Columbia, MO. (http://wwwaux.cerc.cr.usgs.gov/SPMD) 
Huckins JN, Petty JD, Orazio CE, Lebo JA, Clark RC, Gibson VL, Gala WR, Echols KR. 
1999b. Determination of uptake kinetics (sampling rates) by lipid-containing 
semipermeable membrane devices (SPMDs) for polycyclics aromatic 
hydrocarbons (PAHs) in water. Environmental Science and Technology 33: 391 8- 
3923. 
Larsson P, Anderson A, Broman D, Nordback J, Lundberg E. 2000. Persistent 
organic pollutants (POPS) in pelagic systems. Ambio 29: 202-209. 
Lebo JA, Gale RW, Petty JD, Tillitt DE, Huckins JN, Meadows JC, Orazio CE, 
Echols KR, Schroeder DJ. 1995. Use of the SPMD as an in situ sampler 
of waterborne bioavailable PCDD and PCDF residues at sub-parts-per-quadrillion 
concentration. Environmental Science and Technology 29: 2886-2892. 
MacDonald RW, Cretney WJ, Crewe N, Patton D. 1992. A history of the 
octachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlordibenzofuran, and 3,3',4,4'- 
tetrachlorobiphenylcontamination in Howe Sound, British Columbia. 
Environmental Science and Technology 26: 1544-1 550. 
Mackay D, Shiu WY, Ma KC. 1992. Illustrated handbook of physical-chemical 
properties and environmental fate for organic chemicals. Volume 11. Polynuclear 
aromatic hydrocarbons, polychlorinated dioxins, and dibenzofurans. Chelsea, MI: 
Lewis. 597 p. 
Maczka C, Pang S, Policansky D, Wedge R. 2000. Evaluating impacts of 
horrnonally active agents in the environment. Environmental Science and 
Technology 2: pp. 136A-141 A. 
Marple L, Brunck R, Lewis T. 1986. Water solubility of 2,3,7,8- tetrachlorodibenzo-p- 
dioxin. Environmental Science and Technology 20: 180- 182. 
McCarthy KA, Gale RW. 1999. Investigations of the distribution of organochlorine 
and polycyclic hydrocarbon compounds in the Lower Columbia River using 
semipermeable membrane devices. Portland, OR, U.S. Geological Survey. 
Water-Resources Investigations Report 99-405 1. 
Meadows JC, Echols KR, Huckins JN, Borsuk FA, Carline RF, Tillitt DE. 1998. 
Estimation of uptake rate constants for PCB congeners accumulated by 
semipermeable membrane devices and brown trout (salmo trutta). Environmental 
Science and Technology 32: 1847-1 852. 
Mower B. 2000. Dioxin Monitoring Program: 1999 Report. Maine DEP, 
Augusta, ME. 
Neter J, Kutner MH, Nachtsheim CJ, Wasserman W. 1996. Applied Linear Statistical 
Models. Fourth Edition. Boston, MA: McGraw-Hill Companies, Inc. 
Petty JD, Huckins JN, Zajicek JL. 1993. Application of semipermeable membrane 
devices (SPMDs) as passive air samplers. Chemosphere 27 (9): 1609- 1624. 
Prest HF, Jmnan WM, Burns SA, Weismuller T, Martin M, Huckins JN. 1992. Passive 
water sampling via semipermeable membrane devices (SPMDs) in concert with 
bivalves in the SacramentoISan Joaquin River Delta. Chemosphere 25: 18 11- 
1823. 
Prest HF, Richardson BJ, Jacobson LA, Vedder J, Martin M. 1995a. Monitoring 
organochlorines with semi-permeable membrane devices (SPMDs) and mussels 
(mytilus edulis) in Corio Bay, Victoria, Australia. Marine Pollution Bulletin 
30:543-554. 
Prest HF, Huckins JN, Petty JD, Heme S, Paasivirta J, Heinonen P. 1995b. A 
survey of recent results in passive sampling of water and air by semipermeable 
membrane devices. Marine Pollution Bulletin 31 (4-1 2): 306-3 12. 
Rantalainen AL, Ikonomou MG, Rogers IH. 1998. Lipid-containing semipermeable 
membrane devices (SPMDs) as concentrators of toxic chemicals in the 
Lower Fraser River, Vancouver, British Columbia. Chemosphere 37 (6): 
11 19-1 138. 
Rantalainen AL, Cretney W, Ikonomou MG. 2000. Uptake rates of semipermeable 
membrane devices (SPMDs) for PCDDs, PCDFs, and PCBs in water and 
sediment. Chemosphere 40: 147-1 58. 
Rohr AC, Hall ER, Hall KJ. 1996. Use of semipermeable membrane devices for 
monitoring pulp mill effluents: a preliminary assessment. Water Quality 
Resource Journal of Canada 31: 85-100. 
Shiu WY, Doucette W, Gobas FAPC, Andren A, Mackay D. 1988. Physical-chemical 
properties of chlorinated dibenzo-p-dioxins. Environmental Science and 
Technology 22: 65 1-658. 
Sijm DTHM, Wever H, de Vries PJ, Opperhuizen A. 1989. Octan-1-01 / water partition 
coefficients of polychlorinated dibenzo-p-dioxins and dibenzofurans: 
Experimental values determined with a stirring method. Chemosphere 19: 263- 
266. 
Skoog DA, Leary JJ. 1992. Principles of Instrumental Analysis. Fourth Edition. 
Orlando, FL: Harcourt Brace Publishers, pp. 420-46 1. 
Telliard WA. 1994. Method 16 13: Tetra-through-octa-chlorinated dioxins and furans 
by isotope dilution HRGCMRMS-Revision B. Washington, DC, US EPA. 
Thomas VM, Spiro TG. 1996. The US dioxin inventory: Are there missing sources? 
Environmental Science and Technology 30: 82A-85A. 
TOPO! 2000. URL: http://maps.nationalgeographic.com/topo/cdroms.ch. 
Last accessed 611 5/01 
University of California at Davis website: http://dioxins-r- 
us.ucdavis.edu/TCDDAhR.HTML. Accessed 611 510 1 
Van den Berg M, Birnbaum L, Bosveld AT, Brunstrom B, Cook P, Feeley M, Giesy JP, 
Hanberg A, Hasegawa R, Kennedy SW, Kubiak T, Larsen JC, van Leeuwen FX, 
Liem AK, Nolt C, Peterson RE, Poellinger L, Safe S, Schrenk D, Tillitt D, 
Tysklind M, Younes M, Waern F, Zacharewski T. 1998. Toxic equivalency 
factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. 
Environmental Health Perspectives 106 (12): 775-792. 
Wagrowski DM, Hites RA. 2000. Insights into the global distribution of polychlorinated 
dibenzo-p-dioxins and dibenzofurans. Environmental Science and Technology 
34: 2952-2958. 
APPENDICES 
Appendix A 
WATER QUALITY DATA FROM 1999 AND 2000 FIELD SEASONS 
Table A. 1 Field and Laboratory Water Quality Data from the 1999 Field Season 
Table A.2 Field and Laboratory Water Quality Data from the 2000 Field Season 
Figure A. 1 Hourly Temperature Logger Data from the 1999 Field Season 
Figure A.2 Hourly Temperature Logger Data from the 2000 Field Season 
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TABLE A.l continued 
b. Deployment Two 
Penobscot River 12 SPMDs 6 at site 3 ,3  at sites 4 and 5: 7/21/99 to 8/18/99 
Deployment: 712 1 Retrieval: 81 1 8 
Field Data: Site 3 Site 4 Site 5 Site 3 Site 4 Site 5 
Water Temperature (*C) 24 23.5 24.5 
Temp Logger (*C) 24.67 24.88 22.45 22.96 
Avg. Temp Logger for Deployment (*C) 23.82 23.73 
Air Temperature (*C) 26 28.5 27.5 2 1 22 2 1 
Depth (feet) 5 5 5 6 6 6 
Water Velocity (Ws) NA NA NA 1.8 2.3 2.8 
Conductivity (mslcm) 200-225 85 -100 NA NA NA 
Air Exposure Time (minutes) 7: 12 2:34 1:57 6:55 2:45 2: 53 
Laboratory Data: 
Closed-cell pH NA NA NA NA NA NA 
Total Organic Carbon (mg/L) 14 8.1 7.6 14 7.8 8.3 
Dissolved Organic Carbon ( m a )  NA NA NA 13 7.4 7.6 
Total Suspended Solids (mg/L) 4 0.61 1 2.2 0.6 1.2 
Apparent Color (PCU) NA NA NA 150 48 53 
Chlorophyll a (ppb) 3.1 2.1 2.6 2.1 2.3 2 
Specific Conductance (mslcm) 3 00 100 8 9 260 63 83 
Total Phosphorus (ppb) 140 3 6 32 79 23 26 
Turbidity (NTU) 1.7 0.6 0.55 1.5 1.2 1.2 
NA = Not Available 
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TABLE A.2. Field and Laboratory Water Quality Data from the 2000 Field Season 
a. Deployment One 
Androscoggin River 20 SPMDs deployed at Site 10,4 Weekly Retrievals: 6/2/00 to 6130100 
Deployment: 612 Deployment: 612 Retrieval 1: 619 Retrieval 2: 6/16 Retrieval 3: 6/23 Retrieval 4: 6/30 
Field Data: Site 10-A Site 10-B Site 10-A Site 10-B Site 10-A Site 10-B 
GPS Location N44*3OY 10" W70*23'53" same as A 
Water Temperature (*C) 16 14 15 20 23 
Temp Logger (*C) 17.09 17.08 16.29 17.08 20.64 23.46 
-- - 
Avg. Temp Logger for Deployment (*C) 17.23 18.64 16.15 15.68 17.23 18.64 
Air Temperature (*C) 21.5 18.5 19 18 24 
Depth (feet) 12.5 12.5 12 11 13 
Water Velocity (Ws) 2.7 NA 1.75 NA NA 
Air Exposure Time (min:sec) 3:45 4:15 5:OO 3:OO 3:54 3:OO 
Laboratow Data: 
Total Organic Carbon (mg/L) 5.5 5.5 5.6 7.7 7.3 7.7 
Dissolved Organic Carbon (mg/L) 5.6 5.5 5.6 7 6.6 6.5 
Specific Conductance (mslcm) 73.7 73.2 65.3 77.5 10 1 106 
NA = Not Available 
TABLE A.2 continued 
b. Deployment Two 
Androscoggin River 20 SPMDs deployed at Site 10,4 Weekly Retrievals: 6130100 to 7/28/00 
Deployment:6/30 Deployment: 717 Retrieval 1: 7/14 Retrieval 2: 7/14 Retrieval 3: 7/28 Retrieval 4: 7/28 
Field Data: Site 10-B Site 10-A Site 10-A Site 10-B Site 10-A Site 10-B 
GPS Location N44*30710" 
W70*23'53" 
Water Temperature (*C) 23 20 2 1 2 1 2 1 2 1 
Temp Logger (*C) 23.63 21.29 22.63 22.62 21.13 21.12 
Avg. Temp Logger for Deployment (*C) 21.12 21.84 20.74 21.16 
Air Temperature (*C) 24 19 2 1 2 1 19 19 
Depth (feet) 13 11 10.3 10.3 10.7 10.7 
Water Velocity (ftls) NA 0.86 1.19 1.19 1.43 1.43 
Air Exposure Time (min: sec) 3:54 5:OO 2:05 0:30 2: 50 2:20 
Laboratory Data: 
Total Organic Carbon (mg/L) 7.7 8.5 7.3 7.3 7.4 7.4 
Dissolved Organic Carbon (mg/L) 6.5 8.3 7.4 7.4 6.4 6.4 
Specific Conductance (mslcm) 106 110 112 112 110 110 
NA = Not Available 
TABLE A.2 continued 
c. Deployment Three 
Kennebec River 
Field Data: 
20 SPMDs deployed, 10 per site, 1 Retrieval after 54 days: 8/3/00 to 9/26/00 
Deployment: 813 Retrieval: 9/26 
Site 11-U~stream Site 12-Downstream Site 11-U~stream Site 12-Downstream 
GPS Location 
Water Temperature (*C) 2 1 22 15 15 
Temp Logger (*C) 2 1.46 22.96 16.29 16.61 
Avg. Temp Logger for Deployment (*C) 20.35 22.96 
Air Temperature (*C) 24 29 8 9 
Depth (feet) 12 12 6.8 13.6 
Water Velocity (ftfs) NA NA 0.45 1.17 
Air Exposure Time (min: sec) 9:28 3:OO 4: 10 4:15 
Total Organic Carbon ( m a )  4.9 6.4 4.5 6 
Dissolved Organic Carbon ( m a )  4.6 5.8 4.5 6.5 
Specific Conductance (mslcm) 35.6 67.9 3 6 72.5 
w NA = Not Available o\ 
0\ 
TABLE A.2 continued 
d. Deployment Four 
Androscoggin River 40 SPMDs deployed, 20 per site, 1 retrieval after 28 days: 9/19/00 to 10/17/00 
Deployment: 911 9 Retrieval: 1 01 1 7 
Field Data: Site 10-Downstream Site 13-Upstream Site 10-Downstream Site 13-Upstream 
GPS Location N44*33'10.4" N44*3 1'4.1" 
W70*23'52.9" W70*33'5.3" 
Water Temperature (*C) 15 18 9 8 
Temp Logger (*C) 
Avg. Temp Logger for Deployment (*C) 13.71 13.22 
Air Temperature (*C) 18 22 5 10 
Depth (feet) 14 11.5 11.7 11.8 
Water Velocity (fils) 1.15 1.1 1.1 1.1 
-- 
Air Exposure Time (min: sec) 
Laboraton, Data: 
-- -- - - 
Total Organic Carbon ( m a )  7.4 6.8 8 6.2 
Dissolved Organic Carbon ( m a )  6.6 6.1 7.4 5.6 
Specific Conductance (mslcm) 102 5 3 117.7 71.3 
NA = Not Available 
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Appendix B 
SPMD FIELD SAMPLE INFORMATION AND RAW DATA SPREADSHEETS 
FROM THE 2000 FIELD SEASON 
Table B. 1 
Table B.2 
Table B.3 
Table B.4 
Table B.5 
ND 
SPMD Field Sample Information Log, 2000 
SPMD Raw Data Calculation Spreadsheets for Deployment One Field 
Samples 
SPMD Raw Data Calculation Spreadsheets for Deployment Two Field 
Samples 
SPMD Raw Data Calculation Spreadsheets for Deployment Three Field 
Samples 
SPMD Raw Data Calculation Spreadsheets for Deployment Four Field 
Samples 
Peak was not detected 
Data Flag Information Key: 
C Co-eluting peak 
DPE Diphenyl ether interference with the dioxin peak 
S Percent surrogate recoveries were either above or below the established 
limits set by the EPA in method 16 13-B (Telliard 1994) 
APPENDIX B.1. SPMD Field Sample Information Log, 2000 
Deployment One: Androscoggin River at Dixfield, ME Site 10 
Retrieval I Samples: 6/2/00 to 6/9/00 10-A Site 
Sample ID# Descriptor SPMDs per Sample # replicates 
1 9 4  10-A Composite 5 1 
Retrieval 2 Samples: 6/2/00 to 6/16/00 10-B Site 
2 7 4  10-B Composite 5 1 
Retrieval 3 Samples: 6/2/00 to 6/23/00 10-A Site 
3 4 4  10-A 1 5 1 
Retrieval 4 Samples: 6/2/00 to 6/30/00 10-B Site 
4 2 4  10-B 1 1 5 
4 3 4  2 1 
4 4 4  3 1 
4 5 4  4 1 
46-S 5 1 
Deployment Two: Androscoggin River at Dixfield, ME Site 10 
Retrieval I Samples: 7/7/00 to 7/14/00 I &A Site 
Sample ID# Descriptor SPMDs per Sample # replicates 
4 9 4  10-A Composite 5 1 
Retrieval 2 Samples: 6/30/00 to 7/14/00 10-B Site 
5 2 4  10-B Composite 5 1 
Retrieval 3 Samples: 7/7/00 to 7/28/00 10-A Site 
5 6 4  10-A Composite 5 1 
Retrieval 4 Samples: 6/30/00 to 7/28/00 10-B Site 
6 0 4  10-B 1 1 5 
61-S 2 1 
6 2 4  3 1 
6 3 4  4 1 
64-S 5 1 
Deployment Three: Upstream-Downstream on the Kennebec River 
Upstream Site I I in Norridgewock, ME: 8/3/00 to 9/26/00 
Sample ID# Descriptor SPMDs per Sample # replicates 
6 8 4  Deployed 1 I 1 2 5 
6 9 4  Deployed 11 2 2 
7 0 4  Deployed 11 3 2 
7 1 4  Deployed 11 4 2 
7 2 4  Deployed 11 5 2 
Deployment Three: Upstream-Downstream on the Kennebec River 
Downstream Site 12 in Fairfield, ME: 8/3/00 to 9/26/00 
Sample ID# Descriptor SPMDs per Samule # replicates 
7 6 4  Deployed 12 1 2 5 
7 7 4  Deployed 12 2 2 
7 8 4  Deployed 12 3 2 
7 9 4  Deployed 12 4 2 
80-S Deployed 12 5 2 
Deployment Four: Upstream-Downstream on the Androscoggin River 
Upstream Site 13 in Rumford, ME: 9/19/00 to 10/17/OO 
Sample ID# Descriptor SPMDs per Sample # replicates 
83-S Deployed 13 1 2 10 
84-S 2 2 
85-S 3 2 
8 6 4  4 2 
8 7 4  5 2 
9 0 4  6 2 
91-S 7 2 
92-S 8 2 
9 3 4  9 2 
9 4 4  10 2 
Deployment Four: Upstream-Downstream on the Androscoggin River 
Downstream Site I0 in Dixfeld, ME: 9/19/00 to 1 O/17/00 
Sample ID# Descriptor SPMDs per Sample # replicates 
9 7 4  Deployed 10 1 2 10 
9 8 4  2 2 
9 9 4  3 2 
1 0 0 4  4 2 
101-S 5 2 
104-S 6 2 
1 0 5 4  7 2 
106-S 8 2 
107-S 9 2 
1 0 8 4  10 2 
TABLE B.2. SPMD Raw Data Calculation Spreadsheets for Deployment One Field Samples 
a. Sample 19-S 
Deployment 1, Retrieval 1 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS- 13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C- 1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C- I ,2,3,4,7,8-HxCDF 
13C- 1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010402-1 Run 
Retention Time 
ND 
41.52 
43.43 
ND 
44.32 
44.35 
56.13 
58.02 
56.12 
58.00 
ND 
58.48 
ND 
63.03 
63.52 
64.45 
62.53 
63.01 
63.50 
64.43 
ND 
64.12 
ND 
64.05 
64.12 
64.33 
ND 
ND 
66.47 
68.19 
67.57 
67.56 
71.26 
71.25 
71.32 
SAMPLE 1 
M ion area 
222836000 
644447000 
204999000 
99252600 
673772 
690952 
635619000 
593562000 
556953000 
3 19247 
454467 
198746 
398989000 
4 19466000 
436120000 
376335000 
244092 
532430000 
603089000 
1083390000 
284767000 
245301000 
522485 
552862000 
21 13600 
7 183 84000 
429964 
Composite 
M+ ion area 
284372000 
838405000 
265033000 
44082 1 
468783 
395933000 
371347000 
355328000 
251308 
319123 
186683 
760897000 
789469000 
8271 56000 
718721000 
203907 
427028000 
481581000 
87276 1000 
626238000 
545780000 
585406 
532558000 
2491680 
837443000 
510581 
5 SPMDs--5*IS and 5*Sun 
Concentration 
Cex (ngtextract) 
2 1.99 
30.58 
6.35 
0.12 
0.12 
39.21 
33.17 
37.20 
0.04 
0.05 
0.03 
8 1.49 
84.70 
115.28 
60.01 
0.04 
108.35 
146.06 
59.94 
63.70 
0.11 
72.37 
0.57 
137.18 
0.1 1 
% Surrogate 
Recovery 
21.99 
30.58 
63.50 
39.21 
33.17 
37.20 
81.49 
84.70 
115.28 
60.01 
108.35 
146.06 
59.94 
63.70 
72.37 
68.59 
[SPMD] 
(ngW 
0.05 
0.05 
0.02 
0.02 
0.01 
0.02 
0.04 
0.24 
0.05 
RR and RF 
0.93 
1.56 
1 .O7 
1.04 
2.42 
0.94 
1.01 
1.77 
1.96 
0.94 
1.65 
1.20 
1.25 
1.12 
1.24 
0.73 
0.73 
0.56 
0.93 
1.08 
0.95 
1.01 
0.45 
0.38 
1.42 
1.39 
0.78 
0.63 
0.95 
0.77 
1 .O4 
0.58 
1.11 
Peak Ratio Data Flags 
TABLE B.2 continued 
b. Sample 27-S 
Deployment I, Retrieval 2 000821 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1 ,2,3,7,8,9-HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
1 3C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7&HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-1 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 6 
M ion area 
123842 
13918600 
20376700 
10675800 
3810210 
24223 
22891600 
22883 100 
21465100 
29088.5 
18736000 
19564600 
21281100 
18633600 
23047300 
24917400 
40413300 
36460.3 
11454600 
8587410 
45674.3 
28823000 
15080.5 
3042820 
Deployed Sample Composite of 5 SPMDs 
M+ ion area 
154027 
I8 177200 
25807000 
14453200 
18367.6 
14371000 
14693000 
13592600 
21186.1 
37044300 
38041 700 
4 1465200 
36154200 
18268600 
19534100 
31831100 
30727.2 
25334500 
20223200 
4 1709 
27783400 
15411 
3370080 
Concentration 
Cex (ngtextract) 
0.94 
48.23 
53.14 
39.55 
0.12 
47.82 
39.74 
46.33 
0.07 
65.99 
66.21 
77.03 
81.18 
66.32 
60.59 
0.12 
65.58 
59.09 
0.17 
90.83 
0.96 
11.94 
% Surrogate 
Recovery 
48.23 
53.14 
79.10 
47.82 
39.74 
46.33 
RR and RF 
0.91 8439986 
1.441030096 
1.077109761 
1.023857862 
2.364085374 
0.927874023 
0.9697091 58 
1.687362997 
2.047482477 
1.025891246 
1.638485797 
1.219966561 
1.192602772 
1.113743836 
1.232706056 
1,169972968 
1.204344463 
1.127538571 
0.934144448 
1.079402 1 1 1 
0.93 19421 17 
1.012454733 
0.86229618 
1.015565858 
1.5071 18302 
1.468323939 
0.776561886 
0.674918165 
0.905840161 
0.862603 199 
0.992801567 
0.743342442 
1.16695644 
Peak Ratio Data Flags 
0.80 
0.77 
0.79 
0.74 
1.32 
1.59 
1.56 
1.58 
1.37 
TABLE B.2 continued 
c. Sample 34-S 
Deployment 1, Retrieval 3 00082 1 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 8 
M ion area 
1 15023 
203 17500 
4 1429000 
18707100 
4961 110 
50819.8 
52328.8 
49833200 
46 197700 
47620300 
74763.1 
13860.5 
14334.6 
43537300 
38263600 
45325900 
35547000 
44246200 
54120100 
76181200 
33442.9 
10995.6 
24842700 
14690800 
69701.3 
61725800 
14826.1 
6798980 
Composite of 5 deployed SPMDs 
M+ ion area 
158740 
25883800 
51611500 
23904500 
35041 
36364.1 
31017400 
28982500 
29994500 
69753.1 
11875.4 
10107.5 
85933 100 
746 13600 
88050700 
68747100 
35061200 
435 1 1000 
6076 1500 
38102.5 
11310 
57659500 
34590800 
64873.6 
59953300 
16464.1 
7722140 
Concentration 
Cex (nglextract) 
0.65 
34.46 
44.73 
5.07 
0.11 
0.12 
51.50 
39.46 
50.91 
0.09 
0.02 
0.02 
80.81 
68.44 
86.38 
81.53 
67.16 
70.20 
0.06 
0.03 
77.58 
53.32 
0.12 
103.01 
0.43 
14.27 
% Surrogate 
Recovery 
34.46 
44.73 
50.70 
51.50 
39.46 
50.91 
RR and RF 
0.92 
1.44 
1.08 
1.02 
2.36 
0.93 
0.97 
1.69 
2.05 
1 .O3 
1.64 
1.22 
1.19 
1.11 
1.23 
1.17 
1.20 
1.13 
0.93 
1.08 
0.93 
1.01 
0.86 
1.02 
1.51 
1.47 
0.78 
0.67 
0.91 
0.86 
0.99 
0.74 
1.17 
Peak Ratio Data Flags 
TABLE B.2 continued 
d. Sample 42-S 
Deployment 1, Retrieval 4 000808 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37Cl-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1 ,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C- 1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C- 1,2,3,4,7,8-HxCDD 
13C-1 ,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-l,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 3 
M ion area 
349049 
28485400 
7343340 
7944500 
20087400 
88962.9 
48508700 
4656 1800 
37255000 
53473 
20998600 
19588200 
2001 9600 
13354500 
29985000 
29294400 
24346400 
12288200 
5635800 
27506700 
36398000 
I Deployed SPMD 
M+ ion area 
4 10346 
36904300 
9142330 
10342500 
63954.8 
30653300 
29849900 
25308000 
39407.4 
42209200 
38843600 
40329700 
270 1 1600 
23561500 
22380400 
19236700 
28524300 
13371000 
25690600 
40432 100 
Concentration 
Cex (nglextract) 
1.26 
275.25 
108.34 
115.71 
0.21 
284.58 
226.38 
23 1.62 
0.12 
123.96 
111.32 
122.81 
99.15 
142.48 
116.75 
120.59 
64.62 
141.50 
237.15 
% Surrogate 
Recovery 
275.25 
108.34 
23 1.42 
284.58 
226.38 
23 1.62 
123.96 
11 1.32 
122.81 
99.15 
142.48 
116.75 
120.59 
64.62 
141.50 
118.58 
RR and RF 
0.92 
1.44 
1.08 
1.02 
2.36 
0.93 
0.97 
1.69 
2.05 
1 .O3 
1.64 
1.22 
1.19 
1.11 
1.23 
1.17 
1.20 
1.13 
0.93 
1.08 
0.93 
1.01 
0.86 
1.02 
1.51 
1.47 
0.78 
0.67 
0.91 
0.86 
0.99 
0.74 
1.17 
Peak Ratio 
0.85 
0.77 
0.80 
0.77 
1.39 
1.58 
1.56 
1.47 
1.36 
0.50 
0.50 
0.50 
0.49 
1.27 
1.31 
1.27 
0.43 
0.42 
1.07 
0.90 
Data Flags 
S 
S 
S 
S 
S 
S 
S 
TABLE B.2 continued 
e. Sample 43-S 
Deployment I, Retrieval 4 000808 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1 ,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
1 3C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-1 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 4 
M ion area 
353726 
38077200 
53813400 
33676600 
53359600 
189542 
213102 
58158000 
57866500 
40337400 
50154.1 
128310 
27790100 
21950900 
23877300 
10941 100 
3845 1600 
33068700 
46490500 
7057130 
658027 
6370250 
209905 
40708300 
1 Deployed SPMD 
M+ ion area 
389146 
497791 00 
68 165600 
43547200 
1 17884 
148349 
37060300 
37027600 
27804100 
42156.6 
114195 
56691 900 
43653300 
48287800 
2 1442400 
30077700 
25926200 
36832000 
16728300 
1366730 
6125620 
241522 
46139100 
Concentration 
Cex (nglextract) 
0.92 
49.98 
61.83 
41.94 
0.35 
0.39 
46.26 
38.00 
34.09 
0.12 
0.30 
86.66 
65.38 
76.81 
41.61 
95.38 
69.72 
36.76 
3.60 
17.39 
1.05 
140.22 
% Surrogate 
Recovery 
49.98 
61.83 
83.89 
46.26 
38.00 
34.09 
RR and RF 
0.92 
1.44 
1.08 
1.02 
2.36 
0.93 
0.97 
1.69 
2.05 
1.03 
1.64 
1.22 
1.19 
1.11 
1.23 
1.17 
1.20 
1.13 
0.93 
1.08 
0.93 
1.01 
0.86 
1.02 
1.51 
1.47 
0.78 
0.67 
0.91 
0.86 
0.99 
0.74 
1.17 
Peak Ratio Data Flags 
TABLE B.2 continued 
f. Sample 44-S 
Deployment 1, Retrieval 4 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8HxCDF 
1,2,3,7,8,9-HKDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1 ,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
000808 run 
Retention Time 
44.42 
44.36 
46.36 
ND 
47.27 
47.32 
57.43 
59.18 
57.43 
59.16 
ND 
59.59 
63.47 
63.56 
64.40 
ND 
63.46 
63.54 
64.42 
65.32 
ND 
ND 
ND 
64.55 
65.01 
65.22 
ND 
ND 
67.31 
69.04 
ND 
68.40 
ND 
72.15 
ND 
SAMPLE 5 
M ion area 
369857 
1921 1600 
27494800 
17359000 
26261400 
150678 
150468 
44576600 
43766800 
35314100 
59518.7 
29435.1 
107127 
16876700 
15777200 
16316100 
9866040 
23557000 
25213600 
34329400 
7567890 
685263 
45 14030 
1210700 
I Deployed SPMD 
M+ ion area 
565873 
25131100 
35239600 
22592700 
109937 
106262 
28521900 
27999700 
24357600 
48164.1 
22020.8 
91994.6 
34862 100 
32121300 
32839800 
20163100 
18260700 
19737700 
271 17700 
18089500 
1589610 
4392210 
1268150 
Concentration 
Cex (nglextract) 
2.30 
49.05 
62.20 
40.40 
0.38 
0.37 
69.05 
55.87 
58.05 
0.17 
0.09 
0.36 
71.97 
64.72 
70.95 
52.32 
78.92 
72.03 
53.77 
5.49 
16.80 
5.43 
% Surrogate 
Recovery 
49.05 
62.20 
80.80 
69.05 
55.87 
58.05 
RR and RF 
0.9 18439986 
1.44lO3OO96 
1.077109761 
1.023857862 
2.364085374 
0.927874023 
0.969709158 
1.687362997 
2.047482477 
1.025891246 
1.638485797 
1.219966561 
1.192602772 
1.1 13743836 
1.232706056 
1.169972968 
1.204344463 
1.127538571 
0.934144448 
1.0794021 1 1 
0.931942117 
1 .Ol2454733 
0.8622961 8 
1.015565858 
1.5071 18302 
1.468323939 
0.77656 1886 
0.674918165 
0.905840161 
0.862603199 
0.992801567 
0.743342442 
1.16695644 
Peak Ratio Data Flags 
TABLE B.2 continued 
g. Sample 45-S 
Deployment 1, Retrieval 4 000808 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
1s-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1 ,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 6 
M ion area 
279564 
11151300 
15615900 
9706330 
11 165500 
113888 
86435.1 
21773100 
20995400 
19292900 
82156 
71749.8 
3 1603.3 
12635900 
13047800 
11985200 
6734950 
41842.5 
58548.3 
17887300 
18942100 
26976500 
7030650 
686953 
5093 150 
954094 
I Deployed SPMD 
M+ ion area 
329427 
14499000 
19864600 
12634700 
86391.3 
60889 
14076900 
13656300 
133 14400 
63079.8 
60103.5 
28693.5 
25684 100 
26026100 
24733600 
137 18400 
29717.5 
46336.7 
1402 1300 
14708500 
21381300 
16592200 
1544690 
4787580 
1025130 
Concentration % Surrogate 
Cex (nglextract) Recovery 
2.59 
50.17 50.17 
RR and RF 
0.92 
1.44 
1.08 
1.02 
2.36 
0.93 
0.97 
1.69 
2.05 
1 .O3 
1.64 
1.22 
1.19 
1.11 
1.23 
1.17 
1.20 
1.13 
0.93 
1.08 
0.93 
1.01 
0.86 
1.02 
1.51 
1.47 
0.78 
0.67 
0.91 
0.86 
0.99 
0.74 
1.17 
Peak Ratio Data Flags 
TABLE B.2 continued 
h. Sample 46-S 
Deployment 1, Retrieval 4 000808 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
1 3C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
1 3C-1,2,3,4,7,8-HxCDD 
13C-1 ,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 7 
M ion area 
381545 
21610000 
32665000 
18363700 
24 122000 
154834 
133279 
42823700 
42646 100 
38567000 
51346.8 
20311.5 
23407300 
19674600 
2 1036400 
10899900 
32989900 
3 1622500 
51916400 
10055100 
1 104370 
8422980 
247100 
53007000 
I Deployed SPMD 
M+ ion area 
568099 
27571300 
421 56000 
24495 100 
109067 
78055.4 
27624000 
27686200 
26269200 
41802.3 
16891 
48076500 
39939400 
42676500 
22180300 
25762500 
24634500 
40535600 
235 18300 
2421 110 
8001 850 
320036 
59147100 
Concentration 
Cex (nglextract) 
2.10 
45.61 
55.95 
31.24 
0.40 
0.31 
55.80 
45.91 
52.89 
0.13 
0.09 
66.09 
53.54 
61.12 
38.30 
73.70 
59.92 
46.76 
5.65 
20.60 
1.02 
163.20 
% Surrogate 
Recovery 
45.61 
55.95 
62.47 
55.80 
45.91 
52.89 
RR and RF 
0.92 
1.44 
1 .O8 
1.02 
2.36 
0.93 
0.97 
1.69 
2.05 
1 .O3 
1.64 
1.22 
1.19 
1.11 
1.23 
1.17 
1.20 
1.13 
0.93 
1.08 
0.93 
1.01 
0.86 
1.02 
1.51 
1.47 
0.78 
0.67 
0.91 
0.86 
0.99 
0.74 
1.17 
Peak Ratio Data Flags 
0.67 
0.78 
0.77 
0.75 
1.42 
1.71 
1.55 
1.54 
1.47 
TABLE B.3. SPMD Raw Data Calculation Spreadsheets for Deployment Two Field Samples 
a. Sample 49-S 
Deployment 2, Retrieval 1 0 10402- 1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1 ,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1 ,2,3,7,8,9-HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1 ,2,3,7,8,9-HxCDD 
13C-1 ,2,3,4,7,8-HxCDD 
13C-1 ,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 7 
M ion area 
15313100 
167153000 
15 1852000 
148933000 
159226000 
1415180 
2 18549000 
173652000 
1257 16000 
878683 
1037270 
5 lO6O2OO 
27450700 
33942800 
21801000 
38342200 
44545700 
46225000 
33563300 
32944200 
599394 
60063900 
1447580 
978 15500 
Composite of 5 Deployed SPMDs 1 *Sum and IS 
M+ ion area 
19400 100 
2 18783000 
195362000 
196331000 
1046100 
136905000 
107444000 
92883300 
7025 18 
83 1996 
97303200 
52216300 
64004 100 
41810000 
29709700 
34337800 
37304600 
73687900 
73707100 
594068 
56960500 
1486590 
109565000 
. . 
Concentration 
Cex (nglextract) 
9.65 
71.44 
95.92 
43.25 
0.74 
57.70 
41.26 
38.07 
0.89 
1.71 
244.10 
130.71 
209.3 1 
81.64 
179.97 
248.75 
165.24 
201.12 
1.07 
182.73 
2.71 
428.22 
% Surrogate 
Recovery 
71.44 
95.92 
86.49 
57.70 
41.26 
38.07 
244.10 
130.71 
209.3 1
8 1.64 
179.97 
248.75 
165.24 
201.12 
182.73 
214.11 
RR and RF 
0.93 
1.56 
1.07 
1.04 
2.42 
0.94 
1.01 
1.77 
1.96 
0.94 
1.65 
1.20 
1.25 
1.12 
1.24 
0.73 
0.73 
0.56 
0.93 
1.08 
0.95 
1.01 
0.45 
0.38 
1.42 
1.39 
0.78 
0.63 
0.95 
0.77 
1 .O4 
0.58 
1.11 
Peak Ratio 
0.79 
0.76 
0.78 
0.76 
1.35 
1.60 
1.62 
1.35 
1.25 
1.25 
0.52 
0.53 
0.53 
0.52 
1.29 
1.30 
1.24 
0.46 
0.45 
1.01 
1 .O5 
0.97 
0.89 
Data Flags 
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TABLE B.3 continued 
c. Sample 5 6 4  
Deployment 2, Retrieval 3 010402-1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C- 1 ,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 6 
M ion area 
5484860 
23856600 
2 1864500 
21789100 
17601 100 
730 158 
34674500 
29407800 
24003500 
157520 
307232 
7070730 
6618250 
5025900 
9530850 
6072920 
6524070 
16203500 
7009580 
4728980 
271490 
1 lO797OO 
80634 1 
1 l74OlOO 
Composite of 5 Deployed SPMDs I *Sum and IS 
M+ ion area 
6808 160 
30278200 
26226600 
27035900 
485392 
2 1440800 
18857600 
15940800 
118532 
263070 
1294 1000 
133 10800 
93290 10 
1795 1800 
4757440 
5004520 
13292900 
15200800 
98090 10 
267989 
101 16700 
940043 
13279500 
Concentration 
Cex (ngtextract) 
24.37 
72.35 
97.94 
33.20 
2.49 
65.77 
51.15 
50.22 
1.11 
3.56 
93.24 
92.60 
86.87 
99.89 
81.11 
102.95 
96.91 
77.64 
2.68 
93.73 
13.37 
146.30 
% Surrogate 
Recovery 
72.35 
97.94 
66.40 
65.77 
51.15 
50.22 
Peak Ratio Data Flags 
0.81 
0.79 
0.83 
0.81 
TABLE B.3 continued 
d. Sample 6 0 4  
Deployment 2, Retrieval 4 020 10 1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C- 1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1 ,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-H~CDD 
13C-1,2,3,6,7,8-HxCDD 
IS-I3C-I ,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 4 
M ion area 
3212410 
75098000 
1040 14000 
677 1 1600 
57055800 
540495 
95765900 
96 152200 
88835300 
264719 
509604 
155640 
43505500 
5 lo92600 
47362200 
43450 100 
72576200 
94908100 
141 775000 
79281.8 
26404200 
24271 200 
5 I5856 
68038500 
2284530 
1028 18000 
293402 
Deployed SPMD at Site 10-B 
M+ ion area 
4210830 
96282800 
135253000 
867 19900 
3422 15 
6028 1000 
6 1480300 
54798700 
250703 
387257 
125946 
86376200 
102520000 
93688000 
84974500 
58612300 
77484800 
1 l6Ol9OOO 
76527.9 
61044100 
57490800 
48745 1 
67962600 
263 1890 
1 I92O4OOO 
350193 
Concentration 
Cex (nglextract) 
4.66 
52.44 
0.00 
60.79 
24.30 
0.00 
0.55 
55.24 
55.63 
0.00 
62.52 
0.30 
0.00 
0.54 
0.21 
55.06 
47.47 
52.96 
54.00 
0.00 
0.00 
0.00 
69.11 
61.24 
0.00 
0.14 
43.58 
47.88 
0.78 
57.39 
4.38 
112.32 
0.52 
% Surrogate 
Recovery 
52.44 
60.79 
48.60 
55.24 
55.63 
62.52 
RR and RF 
0.93 
1.37 
0.99 
1.06 
2.26 
0.95 
1.02 
1.18 
1.18 
1.02 
0.96 
1.31 
1.21 
1.18 
1.03 
0.92 
1.26 
1.03 
0.92 
1.14 
1.01 
1.07 
0.74 
1 .O9 
1.40 
1.38 
0.78 
0.66 
0.95 
0.92 
1.01 
0.77 
1.11 
Peak Ratio Data Flags 
0.76 
0.78 
0.77 
0.78 
TABLE B.3 continued 
e. Sample 61-S 
Deployment 2, Retrieval 4 010202 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
lS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37Cl-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 7 
M ion area 
1907580 
36485900 
64356800 
36060200 
82525000 
370860 
46339800 
49020600 
46 155900 
191061 
352012 
22485600 
26786900 
25252600 
22 162600 
103862 
195757 
175340 
38255400 
5 1 194300 
90245200 
13754000 
10830700 
375824 
34875400 
1685610 
56173000 
Deployed SPMD at Site 10-B 
M+ ion area 
2556340 
46472400 
84692600 
47754800 
282248 
29000600 
30499200 
284 10300 
184060 
304581 
45475300 
52935400 
49829800 
44347400 
85679 
176003 
152797 
30304400 
41545800 
74828500 
32759000 
261 10300 
377722 
3470 1000 
1833330 
66952300 
Concentration 
Cex (@extract) 
4.98 
40.46 
57.02 
22.14 
0.87 
42.37 
44.35 
50.00 
0.39 
0.69 
59.73 
56.42 
55.46 
41.71 
0.23 
0.40 
0.38 
65.48 
61.95 
36.14 
31.10 
1 .O9 
46.27 
5.51 
80.41 
% Surrogate 
Recovery 
40.46 
57.02 
44.26 
42.37 
44.35 
50.00 
59.73 
56.42 
55.46 
41.71 
65.48 
61.95 
36.14 
31.10 
46.27 
40.21 
RR and RF 
1.08 
1.38 
0.91 
0.99 
2.50 
1 .oo 
1 .O3 
1.19 
1.20 
0.98 
1 .oo 
1.40 
1.27 
1.27 
1.14 
0.69 
0.86 
0.82 
0.97 
1.19 
1 .oo 
1 .O8 
0.63 
0.91 
1.43 
1.44 
0.78 
0.72 
1 .oo 
0.91 
1.04 
0.93 
1.20 
Peak Ratio Data Flags 
TABLE B.3 continued 
f. Sample 62-S 
Deployment 2, Retrieval 4 020101 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1 ,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1 ,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1 ,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 6 
M ion area 
966712 
29249700 
26993300 
32282900 
12827200 
36605000 
39980400 
40634800 
104019 
27491 1 
105844 
20046 100 
23519800 
21265100 
19557300 
58117.2 
97844.8 
34725600 
47479900 
36729000 
12 169600 
11217800 
43 1742 
30318100 
2450620 
53139800 
235262 
Deployed SPMD at Site 10-B 
M+ ion area 
1190010 
37265100 
35292300 
42989300 
23389600 
25357000 
31073300 
8764 1 
234823 
83506.9 
401 40500 
47 120400 
42589600 
38867400 
50860.6 
95917.1 
28703300 
38875100 
30621600 
28705900 
26055600 
462302 
30523200 
2941280 
62254500 
293690 
Concentration 
Cex (nglextract) 
3.49 
78.18 
113.83 
21.05 
8 1.59 
88.58 
119.90 
0.24 
0.68 
0.32 
97.66 
83.55 
91.77 
94.04 
0.15 
0.24 
127.89 
11 7.42 
77.98 
83.55 
1.55 
98.28 
9.25 
223.45 
0.83 
% Surrogate 
Recovery 
78.18 
113.83 
42.10 
81.59 
88.58 
119.90 
[SPMD1 RR and RF 
(ng'w 
7.30 0.93 
Peak Ratio Data Flags 
0.81 
0.78 
0.76 
0.75 
TABLE B.3 continued 
g. Sample 63-S 
Deployment 2, Retrieval 4 020 10 1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37Cl-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9HxCDF 
1 3C-1,2,3,4.7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1 ,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C- I,2,3,4,6,7,8-HpCDF 
13C- I ,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 7 
M ion area 
753706 
14081500 
22324800 
14056800 
12380400 
342586 
15884000 
16737100 
16797600 
330966 
273 163 
8317130 
9392040 
8925880 
7786470 
155117 
317171 
29 1925 
15284400 
18693900 
2738 1600 
238436 
4829740 
4334880 
286467 
1 1752900 
637452 
18747100 
223092 
Deployed SPMD at Site 10-B 
M+ ion area 
1002040 
17852200 
28684500 
19952200 
234462 
10471300 
10477800 
ll2537OO 
237422 
2401 26 
16249900 
18299800 
17192900 
15352600 
141180 
260978 
204382 
12563600 
15480200 
22972500 
201212 
1 I401600 
9578160 
282550 
1 1952200 
780269 
22001400 
359794 
Concentration 
Cex (nglextract) 
5.91 
45.83 
62.80 
24.56 
2.08 
43.77 
45.05 
57.27 
1.85 
2.16 
53.32 
43.81 
50.21 
49.81 
0.93 
1.67 
1.50 
75.10 
62.15 
2.28 
41.41 
41.71 
2.54 
51.22 
6.88 
105.54 
2.59 
% Surrogate 
Recovery 
45.83 
62.80 
49.12 
43.77 
45.05 
57.27 
53.32 
43.81 
50.21 
49.81 
75.10 
62.15 
41.41 
41.71 
51.22 
52.77 
RR and RF 
0.93 
1.37 
0.99 
1.06 
2.26 
0.95 
1.02 
1.18 
1.18 
1.02 
0.96 
1.31 
1.21 
1.18 
1 .O3 
0.92 
1.26 
1.03 
0.92 
1.14 
1.01 
1 .O7 
0.74 
1.09 
1.40 
1.38 
0.78 
0.66 
0.95 
0.92 
1.01 
0.77 
1.11 
Peak Ratio Data Flags 
0.75 
0.79 
0.78 
0.70 
TABLE B.3 continued 
h. Sample 64-S 
Deployment 2, Retrieval 4 020101 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1 ,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C- 1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 8 
M ion area 
2041680 
46105300 
74483600 
4943 1600 
40589700 
397578 
578 14700 
59240500 
59769900 
171682 
105642 
374133 
137634 
28365900 
34798900 
3 1837400 
28744700 
143542 
11 1735 
56490200 
67706 100 
103131000 
18768400 
16895800 
5 19507 
48352800 
36923 10 
804 10800 
371065 
Deployed SPMD at Site 10-B 
M+ ion area 
2676630 
6001 9200 
9871 1400 
66602300 
255171 
36483 100 
37749100 
41268900 
152582 
85056.9 
303257 
2 17047 
56005300 
68203700 
63 102000 
56928500 
133164 
105264 
41537500 
59902700 
85720400 
44052400 
39836700 
612010 
48227000 
4579140 
95362800 
567964 
Concentration 
Cex (nglextract) 
4.78 
44.86 
63.10 
24.14 
0.66 
46.12 
47.29 
60.76 
0.29 
0.15 
0.61 
0.40 
48.82 
43.45 
48.66 
49.18 
0.21 
0.18 
70.49 
61.88 
42.74 
45.35 
1.24 
55.64 
9.3 1 
121.39 
0.97 
% Surrogate 
Recovery 
44.86 
63.10 
48.28 
46.12 
47.29 
60.76 
48.82 
43.45 
48.66 
49.18 
70.49 
61.88 
42.74 
45.35 
55.64 
60.69 
RR and RF 
0.93 
1.37 
0.99 
1.06 
2.26 
0.95 
1.02 
1.18 
1.18 
1.02 
0.96 
1.31 
1.21 
1.18 
1.03 
0.92 
1.26 
1.03 
0.92 
1.14 
1.01 
1.07 
0.74 
1.09 
1.40 
1.38 
0.78 
0.66 
0.95 
0.92 
1.01 
0.77 
1.11 
Peak Ratio Data Flags 
0.76 
0.77 
0.75 
0.74 
TABLE B.4. SPMD Raw Data Calculation Spreadsheets for Deployment Three Field Samples 
a. Sample 68-S 
Deployment 3, Upstream 0 102 10 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1 ,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 7 
M ion area 
3918430 
220940000 
230622000 
185542000 
141 124000 
268430000 
2680 10000 
22965 1000 
3 13908 
329734 
1019870 
308992 
130406000 
1467 16000 
135042000 
126 165000 
3 18799 
267254 
179969000 
204131000 
262903000 
85407600 
68793300 
694990 
1688 14000 
878495 
1 l23OOOOO 
199576 
Deployed SPMD 
M+ ion area 
5481810 
282583000 
29494 1000 
243274000 
l6689OOOO 
16586 1000 
l45O27OOO 
277272 
265300 
829535 
267487 
249572000 
27690 1000 
260430000 
240090000 
260090 
204404 
144577000 
163 178000 
213365000 
193883000 
I58657000 
684639 
161368000 
1093900 
I25754000 
196305 
Concentration 
Cex (nglextract) 
2.17 
72.42 
75.72 
26.75 
73.03 
71.72 
74.14 
0.12 
0.12 
0.41 
0.13 
73.06 
75.28 
75.62 
78.56 
0.16 
0.13 
76.58 
77.21 
69.88 
59.47 
0.45 
73.72 
1.69 
72.59 
0.26 
% Surrogate 
Recovery 
72.42 
75.72 
53.50 
73.03 
71.72 
74.14 
Peak Ratio Data Flags 
0.71 
0.78 
0.78 
0.76 
TABLE B.4 continued 
b. Sample 69-S 
Deployment 3, Upstream 0 102 10 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37Cl-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 8 
M ion area 
4661690 
287267000 
205542000 
241 245000 
13 I784000 
34701 1000 
327286000 
288399000 
363435 
1570300 
165874000 
1 75932000 
166877000 
156777000 
253 127 
381989 
646528 
2 19294000 
264450000 
226940000 
101337000 
79002300 
683566 
I97687000 
729988 
1 I7999000 
Deployed SPMD 
M+ ion area 
6159340 
366404000 
263728000 
316701000 
2 16938000 
205289000 
199228000 
283851 
1237450 
321596000 
336321000 
32 1999000 
302765000 
215548 
308084 
557851 
I76464000 
210753000 
182261000 
228850000 
18255 1000 
606796 
l8822OOOO 
754001 
13201 1000 
Concentration 
Cex (nglextract) 
1.93 
105.29 
110.35 
28.03 
105.97 
98.60 
108.07 
0.11 
0.51 
109.10 
105.95 
108.80 
114.72 
0.11 
0.15 
0.26 
108.69 
116.26 
96.15 
79.60 
0.36 
100.29 
1.21 
88.73 
% Surrogate 
Recovery 
105.29 
110.35 
56.05 
105.97 
98.60 
108.07 
Peak Ratio Data Flags 
0.76 
0.78 
0.78 
0.76 
TABLE B.4 continued 
c. Sample 7 0 4  
Deployment 3, Upstream 0 102 10 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
1 3C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1 ,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 9 
M ion area 
2008440 
lO2694OOO 
99877000 
83296800 
65560700 
1 19663000 
126945000 
107097000 
185643 
207320 
1599690 
139981 
64264500 
66942300 
64842200 
58800100 
87437800 
99748 100 
122161000 
41521400 
33920900 
3523380 
76742400 
1545500 
55674700 
1 196560 
Deployed SPMD 
M+ ion area 
2721060 
l3O2OOOOO 
12930 1000 
109 I57000 
74133600 
779 1 1700 
66593300 
167349 
158100 
1223480 
131553 
120928000 
134850000 
125719000 
113518000 
69973500 
80152400 
98075800 
93340100 
79648900 
3559820 
73801000 
1697410 
62638800 
1452410 
Concentration 
Cex (ndextract) 
2.36 
76.81 
77.94 
28.69 
74.56 
77.66 
78.82 
0.15 
0.15 
1.31 
0.13 
77.01 
77.54 
78.80 
79.93 
80.32 
81.78 
72.97 
64.22 
5.09 
72.69 
5.58 
78.02 
3.45 
% Surrogate 
Recovery 
76.8 1 
77.94 
57.39 
74.56 
77.66 
78.82 
[SPml RR and RF (ng/kg) 
Peak Ratio Data Flags 
0.74 
0.79 
0.77 
0.76 
1.61 
1.11 
1.31 
1.31 
1.06 
0.53 
0.50 
0.52 
0.52 
DPE 
1 .25 
1.24 
1.25 
DPE 
TABLE B.4 continued 
d. Sample 71-S 
Deployment 3, Upstream 010210 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-1 3C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1 ,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 10 
M ion area 
3734690 
201 435000 
207979000 
l7O5O5OOO 
13 1746000 
239718000 
239852000 
209886000 
331179 
314813 
962773 
ll6975OOO 
122624000 
122358000 
112317000 
394279 
304299 
162 177000 
l943O2OOO 
2395 10000 
72525200 
55943700 
558680 
124538000 
642904 
930 13600 
Deployed SPMD 
M+ ion area 
4884720 
2581 18000 
26920 1000 
2 l9O82OOO 
15 1747000 
152024000 
132476000 
281206 
241 750 
779556 
228 154000 
236798000 
236185000 
2 l6O84OOO 
284244 
255822 
129836000 
15501 7000 
191336000 
164587000 
128079000 
495560 
118319000 
765849 
104335000 
Concentration 
Cex (ngtextract) 
2.18 
72.79 
75.77 
27.69 
72.34 
71.35 
74.62 
0.14 
0.13 
0.43 
73.36 
70.60 
75.79 
77.86 
0.20 
0.17 
76.17 
81.17 
65.58 
53.19 
0.47 
59.94 
1.45 
66.52 
% Surrogate 
Recovery 
72.79 
75.77 
55.38 
72.34 
71.35 
74.62 
[SPMD1 RR and RF 
(ngW 
Peak Ratio Data Flags 
0.76 
0.78 
0.77 
0.78 
1.58 
1.18 
1.30 
1.24 
DPE 
0.51 
0.52 
0.52 
0.52 
DPE 
1.39 
1.19 
1 .25 
1 .25 
1 .25 
TABLE B.4 continued 
e. Sample 72-S 
Deployment 3, Upstream 010210 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-l3C-l,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8NxCDD 
1,2,3,7,8,9HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-I ,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-I,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 1 1 
M ion area 
2642750 
1 l35OOOOO 
113010000 
91964600 
7461 8800 
134765000 
1346 13000 
1 l8OOlOOO 
31 1192 
883 174 
215604 
66177900 
73766400 
66 187300 
64999000 
184559 
97410400 
1065 12000 
I35993000 
43359800 
34666500 
527671 
81567100 
45852000 
Deployed SPMD 
M+ ion area 
3693 170 
146 l8OOOO 
146181000 
122859000 
82857400 
84640300 
72854500 
249691 
73 1848 
193722 
I28568000 
142339000 
127826000 
125 145000 
142582 
77909800 
848 17300 
109757000 
99083700 
80324500 
4765 15 
77392 100 
5 1893700 
Concentration 
Cex (nglextract) 
2.84 
75.73 
76.92 
28.86 
74.03 
73.49 
76.58 
0.23 
0.74 
0.18 
72.57 
74.42 
71.90 
79.04 
0.17 
80.17 
77.94 
69.07 
58.27 
0.68 
68.79 
57.77 
% Surrogate 
Recovery 
75.73 
76.92 
57.73 
74.03 
73.49 
76.58 
[SPMD1 RR and RF 
(ngW 
Peak Ratio Data Flags 
0.72 
0.78 
0.77 
0.75 
1.62 
1 .25 
DPE 
1.21 
1.11 
0.5 1 
0.52 
0.52 
0.52 
DPE 
DPE 
1.29 
1 .25 
1.26 
1.24 
DPE 
0.44 
0.43 
1.11 
1.05 
TABLE B.4 continued 
f. Sample 76-S 
Deployment 3, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS- 13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C- 1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1 ,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
1 3C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010211 Run 
Retention Time 
36.40 
36.37 
38.07 
ND 
38.48 
38.50 
ND 
ND 
51.15 
54.26 
55.38 
55.36 
60.39 
60.50 
61.48 
62.42 
60.38 
60.48 
61.45 
62.40 
ND 
62.11 
62.34 
62.02 
62.09 
62.32 
ND 
ND 
64.56 
66.32 
66.12 
66.1 1 
69.20 
69.19 
69.25 
SAMPLE 7 
M ion area 
1725770 
10542 1000 
859 18900 
78419600 
50755400 
1 14226000 
107590000 
9 1549 
81773500 
193288 
16229 1 
420336 
179949 
52462400 
56966200 
56838700 
55023300 
125699 
133620 
70 187800 
79643600 
99953700 
42303300 
37183800 
300 188 
82449200 
888968 
98042 100 
171202 
Deployed SPMD Site 12: Fairfield, ME 
M+ ion area 
2243690 
129560000 
108848000 
100206000 
64985500 
62440800 
62154.5 
50478500 
146975 
128155 
339090 
162552 
102 143000 
1 lO394OOO 
1 1  l6O3OOO 
108341000 
107303 
103690 
5368 1300 
60756500 
75719700 
94356400 
845 1 1200 
302216 
78482300 
11 12730 
10974 1000 
179361 
Concentration 
Cex (nglextract) 
1.90 
83.82 
85.35 
25.50 
77.14 
63.47 
0.12 
61.25 
0.17 
0.14 
0.39 
0.16 
79.74 
80.85 
87.63 
97.52 
0.17 
0.18 
78.33 
76.20 
90.18 
94.25 
0.40 
101.47 
1.90 
1 80.79 
0.25 
% Surrogate 
Recovery 
83.82 
85.35 
51.01 
77.14 
63.47 
61.25 
79.74 
80.85 
87.63 
97.52 
78.33 
76.20 
90.18 
94.25 
101.47 
90.39 
[SPMD1 RR and RF 
(ngflcg) 
Peak Ratio Data Flags 
0.77 
0.81 
0.79 
0.78 
DPE 
DPE 
DPE 
TABLE B.4 continued 
g. Sample 77-S 
Deployment 3, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1 ,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1 ,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
01021 1 Run 
Retention Time 
36.34 
36.30 
38.00 
ND 
38.39 
38.43 
ND 
ND 
51.05 
54.20 
ND 
55.32 
60.36 
ND 
6 1.46 
62.40 
60.34 
60.46 
6 1.42 
62.38 
ND 
ND 
ND 
61.59 
62.07 
62.29 
ND 
ND 
64.54 
66.30 
66.09 
66.09 
ND 
69.17 
ND 
SAMPLE 8 
M ion area 
806233 
40094700 
34069800 
27502000 
20654100 
43598000 
423 10300 
28899000 
60249.7 
122996 
6987 1 
19234300 
20745900 
20677600 
20244200 
26043200 
3 1396000 
39684800 
17925700 
167 18000 
136233 
35025400 
46926900 
M+ ion area 
1026250 
48907900 
43298500 
36637400 
24934000 
24228200 
18241800 
55709.6 
105592 
49716.7 
38230400 
40925800 
4 lOO42OO 
39925200 
20050000 
23830600 
2922 1000 
41 203700 
39035200 
1 16687 
33832200 
52882000 
Concentration 
Cex (ng/extract) 
2.32 
79.93 
77.15 
26.17 
74.26 
62.53 
54.96 
0. I6 
0.32 
0.16 
75.56 
75.95 
81.81 
91.57 
74.31 
76.4 1 
99.48 
110.09 
0.39 
110.69 
221.40 
% Surrogate 
Recovery 
79.93 
77.15 
52.35 
74.26 
62.53 
54.96 
75.56 
75.95 
81.81 
91.57 
74.3 1 
76.41 
99.48 
110.09 
110.69 
110.70 
RR and RF 
(ng'w 
2.43 0.89 
Deployed SPMD Site 12: Fairfield, ME 
Peak Ratio Data Flags 
0.79 
0.82 
0.79 
0.75 
DPE 
DPE 
DPE 
DPE 
DPE 
DPE 
DPE 
TABLE B.4 continued 
h. Sample 78-S 
Deployment 3, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-I ,2,3,4,7,8-HxCDF 
13C-I,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-I,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
010211 Run 
Retention Time 
36.34 
36.29 
38.00 
ND 
38.38 
38.41 
ND 
ND 
51.03 
54.20 
ND 
55.30 
60.36 
60.46 
ND 
62.39 
60.34 
60.45 
6 1.42 
62.37 
62.00 
62.07 
62.30 
61.58 
62.07 
62.29 
ND 
66.32 
64.54 
66.29 
66.09 
66.08 
69.17 
69.16 
ND 
SAMPLE 9 
M ion area 
1042960 
29920600 
2922 1200 
20509200 
19905300 
33288400 
33 176800 
22955500 
57224.5 
52568.3 
4 1822.9 
16596600 
18303500 
18539600 
I7508200 
26229.6 
43297.7 
48053.3 
23376000 
28485000 
42537500 
48395.8 
15373500 
145 18000 
108378 
30530500 
264284 
40455300 
Deployed SPMD Site 12: Fairfield, ME 
M+ ion area 
1462780 
36385 100 
37480300 
27333700 
19200400 
18750700 
14085200 
44496.1 
49250.6 
36791.1 
32143700 
35759000 
36477500 
345 12300 
24516 
37997.3 
40881 
17365300 
21210000 
3 1936800 
43684.7 
34386400 
333 1 1900 
1 14636 
29085800 
2907 17 
44898600 
Concentration 
Cex (nglextract) 
4.26 
69.07 
66.75 
29.41 
65.97 
56.60 
50.09 
0.16 
0.15 
0.12 
59.30 
61.60 
67.5 1
73.25 
0.12 
0.17 
0.19 
60.77 
63.62 
0.13 
77.46 
87.38 
0.40 
88.67 
1.28 
175.18 
% Surrogate [SPMD] 
Recovery (np/kg) 
4.46 
69.07 
RR and RF 
0.89 
1.44 
0.98 
1.07 
2.32 
0.97 
1 .O4 
1.19 
1.38 
0.95 
1.11 
1.27 
1.27 
1.16 
1.28 
1.10 
1.18 
1.09 
0.95 
1.08 
0.96 
1.01 
0.90 
1.05 
1.48 
1.44 
0.86 
0.73 
0.94 
0.90 
1.01 
0.65 
1.35 
Peak Ratio Data Flags 
0.71 
0.82 
0.78 
0.75 
DPE 
DPE 
DPE 
TABLE B.4 continued 
i. Sample 79-S 
Deployment 3, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C- 1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1 ,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010211 Run 
Retention Time 
36.30 
36.27 
37.56 
ND 
38.36 
38.39 
ND 
ND 
50.58 
54.17 
ND 
55.28 
ND 
60.45 
61.44 
ND 
60.32 
60.43 
61.41 
62.36 
ND 
ND 
ND 
61.57 
62.05 
62.27 
ND 
ND 
64.53 
66.27 
66.09 
66.07 
69.15 
69.14 
ND 
SAMPLE 10 
M ion area 
382892 
16846000 
15174100 
1 1524800 
8814640 
17804700 
17972900 
11915700 
29121.8 
65715.4 
7445400 
7828500 
7703710 
7448900 
9360880 
11 183000 
15698400 
7229220 
6958380 
78934 
13907100 
205910 
18387500 
Deployed SPMD Site 12: Fairfield. ME 
M+ ion area 
481314 
1999 1800 
l9457OOO 
14864200 
101 11200 
9860280 
7093590 
22162.6 
59981.5 
13908300 
15829300 
14770400 
14823400 
64270 10 
8887850 
1 1609800 
16538300 
15980300 
75102.2 
136 18000 
232790 
20944900 
Concentration 
Cex (nglextract) 
2.64 
73.90 
70.92 
25.08 
67.58 
58.43 
49.51 
0.17 
0.48 
70.85 
73.52 
75.21 
85.53 
64.22 
70.07 
100.90 
114.29 
0.60 
11 1.64 
2.20 
220.15 
% Surrogate WMDI 
Recovery (ng'w 
2.77 
73.90 
RR and RF 
0.89 
1.44 
0.98 
1.07 
2.32 
0.97 
1 .O4 
1.19 
1.38 
0.95 
1.11 
1.27 
1.27 
1.16 
1.28 
1.10 
1.18 
1.09 
0.95 
1 .O8 
0.96 
1.01 
0.90 
1.05 
1.48 
1.44 
0.86 
0.73 
0.94 
0.90 
1.01 
0.65 
1.35 
Peak Ratio Data Flags 
0.80 
0.84 
0.78 
0.78 
DPE 
DPE 
TABLE B.4 continued 
j. Sample 80-S 
Deployment 3, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8NxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1 ,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
010211 Run 
Retention Time 
36.30 
36.26 
37.56 
ND 
38.35 
38.38 
ND 
ND 
50.58 
54.16 
ND 
55.28 
60.33 
ND 
61.44 
62.38 
60.32 
60.43 
61.41 
62.36 
61.58 
ND 
ND 
61.57 
62.05 
62.27 
ND 
ND 
64.53 
66.28 
66.08 
66.07 
69.16 
69.15 
ND 
SAMPLE I I 
M ion area 
844125 
34835600 
31085600 
23558800 
19785200 
36419800 
37499900 
24823900 
60934.1 
133601 
56781.2 
16946700 
17777400 
18262800 
17935400 
46640.9 
23354300 
27850300 
37705700 
16568400 
15990700 
127696 
33260200 
379282 
47379400 
Deployed SPMD Site 12: Fairfield, ME 
M+ ion area 
1053180 
42182100 
38881 100 
3075 1800 
2 1542500 
20705400 
15054300 
55941.8 
103694 
48673.4 
33279700 
34478900 
35759600 
35541000 
35619.1 
1748 1900 
202 12200 
285 16400 
382 15900 
36893500 
130178 
31435800 
436707 
52066800 
Concentration 
Cex (nglextract) 
2.78 
76.48 
72.24 
27.48 
69.45 
60.48 
51.41 
0.18 
0.38 
0.15 
68.72 
66.97 
74.56 
84.68 
0.19 
68.50 
69.20 
95.91 
108.66 
0.42 
108.21 
1.62 
229.54 
% Surrogate [SPMD] 
Recovery (ngk) 
2.91 
76.48 
RR and R.F 
0.89 
1.44 
0.98 
1 .O7 
2.32 
0.97 
1 .O4 
1.19 
1.38 
0.95 
1.11 
1.27 
1.27 
1.16 
1.28 
1.10 
1.18 
1.09 
0.95 
1.08 
0.96 
1.01 
0.90 
1.05 
1.48 
1.44 
0.86 
0.73 
0.94 
0.90 
1.01 
0.65 
1.35 
Peak Ratio Data Flags 
0.80 
0.83 
0.80 
0.77 
DPE 
DPE 
DPE 
DPE 
TABLE B.5. SPMD Raw Data Calculation Spreadsheets for Deployment Four Field Samples 
a. Sample 83-S 
Deployment 4, Upstream 010222 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-1 3C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 4 
M ion area 
2371340 
204955000 
78040500 
23968000 
66767900 
6467 19 
1054580 
260022000 
l5798OOOO 
188865000 
386935 
84497000 
53088300 
7 1420300 
61399800 
101621000 
103715000 
10399 1000 
31774100 
27540400 
67424800 
48 182900 
Deployed SPMD 
M+ ion area 
2723680 
256796000 
92457200 
29443400 
165686000 
8991 4300 
288013000 
29275 1 
165766000 
101693000 
139499000 
120912000 
8 1229400 
82453600 
8 1823900 
7 1 194300 
63320800 
64746800 
54274600 
Concentration 
Cex (nglextract) 
1.20 
189.30 
30.67 
35.47 
216.00 
122.72 
344.19 
0.23 
131.27 
65.46 
102.53 
100.91 
144.00 
84.08 
70.1 1 
86.77 
103.54 
93.10 
% Surrogate 
Recovery 
189.30 
30.67 
70.94 
216.00 
122.72 
344.19 
[SPMD1 RR and RF 
(ngkz) 
1.26 0.92 
Peak Ratio 
0.87 
0.80 
0.84 
0.81 
1.57 
1.76 
0.66 
1.32 
0.5 1
0.52 
0.51 
0.51 
1.25 
1.26 
1.27 
0.45 
0.43 
1.04 
0.89 
Data Flags 
S 
DPE 
DPE 
S 
s,c 
TABLE B.5 continued 
b. Sample 84-S 
Deployment 4, Upstream 010404 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
'1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 10 
M ion area 
34587400 
342193000 
230042000 
253282000 
253873000 
3842140 
6734040 
466275000 
410352000 
27020 1000 
1415460 
656568 
1183270 
93 l4OOOO 
61 138100 
63803900 
1 18296000 
649626 
880171 
952283 
157 147000 
18246 1000 
187533000 
70687600 
66036100 
1248560 
138833000 
2755340 
l8OO85OOO 
973994 
Deployed SPMD 
M+ ion area 
43935300 
421354000 
292452000 
323340000 
2461980 
4724990 
292042000 
255723000 
l85Ol8OOO 
1023130 
528110 
1058080 
176833000 
1 l437lOOO 
1 17884000 
219394000 
616887 
726554 
8521 19 
128149000 
148646000 
152822000 
152800000 
147267000 
1216070 
132354000 
3 134330 
205067000 
1095930 
Concentration 
Cex (@extract) 
11.04 
99.89 
103.17 
45.97 
114.05 
11 1.50 
98.79 
0.76 
0.56 
0.54 
72.68 
47.73 
49.42 
110.65 
0.42 
0.53 
0.60 
94.72 
101.36 
94.03 
107.71 
0.97 
117.53 
3.10 
187.33 
1 .oo 
% Surrogate 
Recovery 
99.89 
103.17 
91.94 
114.05 
111.50 
98.79 
RR and RF 
0.93 
1.46 
1.06 
1 .O7 
2.40 
0.92 
1 .oo 
1.27 
1.14 
0.95 
0.88 
1.19 
1.21 
1.12 
1.23 
1 .O9 
1.08 
1.08 
0.90 
1.06 
0.92 
0.98 
0.88 
0.96 
1.40 
1.39 
0.70 
0.58 
0.94 
0.68 
0.99 
0.60 
1.07 
Peak Ratio Data Flags 
0.79 
0.81 
0.79 
0.78 
TABLE B.5 continued 
c. Sample 85-S 
Deployment 4, Upstream 010227-1- Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C- 1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C- 1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 2 
M ion area 
1 110890 
1504 19000 
147571000 
139923000 
l365O5OOO 
1612310 
203638000 
181237000 
137282000 
353058 
276093 
382978 
71224300 
49401600 
60973400 
53 136400 
78581000 
1 l5748OOO 
1 12224000 
25641600 
21282100 
50423900 
36693000 
Deployed SPMD 
M+ ion area 
1429870 
183494000 
18227100 
170791 000 
949673 
123930000 
1 l3O23OOO 
300410 
229754 
339185 
I34792000 
1 lO255OOO 
123869000 
109208000 
61977900 
88337300 
87797000 
59325500 
49576600 
48468600 
41003300 
Concentration 
Cex (nglextract) 
0.88 
145.70 
182.83 
41.32 
0.88 
190.91 
145.14 
80.34 
0.25 
0.24 
0.38 
116.79 
59.62 
86.73 
87.48 
115.27 
80.71 
55.90 
56.5 1 
61.26 
59.69 
% Surrogate 
Recovery 
145.70 
182.83 
82.65 
190.91 
145.14 
80.34 
Peak Ratio Data Flags 
0.78 
0.82 
8.10 
0.82 S 
TABLE B.5 continued 
d. Sample 86-S 
Deployment 4, Upstream 010227-1- Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37Cl-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
1 3C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
1 3C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C- I ,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 3 
M ion area 
1832710 
113114000 
lO4822OOO 
104628000 
105835000 
136920000 
92476300 
103224000 
5 17773 
42920300 
47607700 
46828900 
3842 1700 
54320100 
90424200 
76450600 
20607800 
16085600 
4 lo99800 
27676900 
Deployed SPMD 
M+ ion area 
2413260 
l358O9OOO 
12 I972000 
125902000 
83935600 
58291100 
65511000 
362080 
88670900 
95558700 
95814900 
78746800 
41957700 
68838700 
5891 1900 
47693900 
36746600 
38622000 
30742200 
Concentration 
Cex (nglextract) 
1.96 
79.40 
99.17 
45.10 
94.10 
54.36 
72.19 
0.52 
110.23 
79.00 
98.90 
93.30 
116.67 
93.07 
66.40 
62.26 
72.97 
66.32 
% Surrogate 
Recovery 
79.40 
99.17 
90.21 
94.10 
54.36 
72.19 
[SPMD1 RR and RF (ng/kg) Peak Ratio Data Flags 
0.76 
0.83 
0.86 
0.83 
TABLE B.5 continued 
e. Sample 87-S 
Deployment 4, Upstream 0 10404 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 11 
M ion area 
38833600 
378972000 
306374000 
301579000 
283560000 
3848340 
5596510 
519567000 
445441 000 
253042000 
1863660 
586495 
3031190 
166524000 
99684700 
165385000 
120063000 
l88O95OOO 
205 148000 
213796000 
60393900 
69386300 
804780 
150375000 
1301950 
207270000 
443245 
Deployed SPMD 
M+ ion area 
49309900 
467990000 
381 536000 
386265000 
2321350 
3995500 
322969000 
277543000 
180980000 
1480420 
440371 
2150180 
312153000 
186469000 
310158000 
224964000 
151718000 
165601000 
172551000 
133416000 
155978000 
73321 1 
1430 18000 
1279480 
235756000 
451601 
Concentration 
Cex (nglextract) 
11.18 
84.16 
93.48 
38.55 
96.25 
91.92 
71.54 
0.59 
0.30 
0.97 
113.53 
68.56 
11 3.96 
99.59 
99.39 
99.99 
71.83 
100.26 
0.56 
112.02 
1.18 
189.83 
0.38 
% Surrogate 
Recovery 
84.16 
93.48 
77.10 
96.25 
91.92 
71.54 
[SPMD1 RR and RF (ng/kg) Peak Ratio Data Flags 
0.79 
0.81 
0.80 
0.78 
TABLE B.5 continued 
f. Sample 90-S 
Deployment 4, Upstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
3 7C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C- 1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
010228-1- Run 
Retention Time 
36.51 
36.50 
38.11 
ND 
39.00 
39.04 
ND 
ND 
51.48 
54.49 
ND 
*55.54&55.57 
60.52 
ND 
ND 
ND 
60.52 
60.58 
61.59 
62.52 
ND 
ND 
ND 
? 
62.19 
SAMPLE 3 
M ion area 
3187830 
184503000 
136522000 
148379000 
121013000 
2560 19000 
2 l4OO6OOO 
166702000 
743985 
69791500 
841 95600 
84061500 
69773 100 
76836600 
155384000 
1 I2674000 
39203700 
33195000 
74849200 
40659500 
Deployed SPMD 
M+ ion area 
4069440 
213533000 
161117000 
179848000 
154835000 
1351 19000 
120908000 
531712 
l3839OOOO 
164246000 
1655 17000 
137183000 
59083300 
1 I5575000 
86677600 
88593600 
77708300 
69536400 
45898300 
Concentration 
Cex (nglextract) 
2.02 
89.55 
107.99 
39.70 
117.85 
79.18 
81.18 
0.49 
115.07 
78.70 
109.46 
108.14 
111.40 
109.02 
85.68 
95.85 
101.63 
81.52 
% Surrogate 
Recovery 
89.55 
107.99 
79.40 
117.85 
79.18 
81.18 
[SPMD1 RR and RF 
(ng/kg) 
Peak Ratio Data Flags 
0.78 
0.86 
0.85 
0.83 
TABLE B.5 continued 
g. Sample 91-S 
Deployment 4, Upstream 01 0401 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-1 3C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8NxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
1 3C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 7 
M ion area 
25 158400 
261085000 
182714000 
209544000 
18 1642000 
1678470 
3451550 
343625000 
301957000 
226398000 
725181 
64140500 
56272800 
473 16800 
3058 1600 
53504300 
58225300 
51257100 
13457400 
47206300 
527157 
105539000 
1317280 
16973 1000 
Deployed SPh4D 
M+ ion area 
32221400 
323823000 
236263000 
273354000 
1101040 
2029080 
2 12600000 
185227000 
167433000 
595618 
120670000 
102381000 
87351400 
57344600 
44365000 
47234800 
4266 1400 
29244600 
106392000 
494074 
103580000 
1310430 
193063000 
Concentration 
Cex (nglextract) 
10.54 
99.88 
112.1 1 
42.25 
0.53 
1.12 
89.37 
80. I6 
82.69 
0.83 
96.81 
89.48 
88.61 
103.99 
87.35 
95.55 
110.34 
88.99 
0.53 
94.47 
1.50 
149.46 
% Surrogate 
Recovery 
99.88 
112.11 
84.51 
89.37 
80.16 
82.69 
96.81 
89.48 
88.61 
103.99 
87.35 
95.55 
110.34 
88.99 
94.47 
74.73 
RR and RF 
0.93 
1.40 
1 .O5 
1 .O3 
2.35 
0.94 
1 .oo 
1.49 
1.45 
0.93 
1.14 
1.27 
1.25 
1.18 
1.31 
2.03 
1.89 
1.62 
0.90 
1.13 
0.95 
1 .oo 
1.19 
1.18 
1.41 
1.38 
0.41 
1.84 
0.92 
2.36 
0.97 
2.58 
1.06 
Peak Ratio Data Flags 
0.78 
0.81 
0.77 
0.77 
1.52 
1.70 
1.62 
1.63 
1.35 

TABLE B.5 continued 
i. Sample 93-S 
Deployment 4, Upstream 0 1040 1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C- 1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C- 1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 9 
M ion area 
7879500 
80157900 
61 200700 
62724300 
57182600 
831315 
13233 10 
1 14847000 
105416000 
83 139600 
263299 
306573 
327839 
28840600 
23513700 
20484 100 
38486500 
3 10222 
54812500 
60394500 
64583000 
25112100 
2048 1800 
344420 
35914000 
1026640 
58254000 
210830 
Deployed SPMD 
M+ ion area 
lo299200 
100922000 
78852200 
83701400 
563428 
903679 
705 15800 
65029000 
56381200 
186486 
258372 
286219 
52338200 
45001900 
37650800 
71853400 
268915 
45033500 
49948200 
53035100 
54530400 
45642400 
305088 
34344600 
1222840 
67667600 
250500 
Concentration 
Cex (nglextract) 
10.79 
92.50 
101.70 
39.71 
0.80 
1.30 
89.10 
83.89 
87.63 
0.44 
0.83 
0.43 
33.96 
30.86 
30.54 
104.21 
0.55 
71.16 
79.83 
164.32 
30.59 
1 .oo 
25.34 
3.70 
41.42 
0.69 
% Surrogate 
Recovery 
92.50 
101.70 
79.43 
89.10 
83.89 
87.63 
RR and RF 
0.93 
1.40 
1 .O5 
1 .O3 
2.35 
0.94 
1.00 
1.49 
1.45 
0.93 
1.14 
1.27 
1.25 
1.18 
1.31 
2.03 
1.89 
1.62 
0.90 
1.13 
0.95 
1.00 
1.19 
1.18 
1.41 
1.38 
0.41 
1.84 
0.92 
2.36 
0.97 
2.58 
1 .O6 
Peak Ratio Data Flags 
TABLE B.5 continued 
j. Sample 94-S 
Deployment 4, Upstream 010401 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-13C-1,2,3,7,8,9-H~CDD 
1,2,3,4,6,7,8NpCDF 
1,2,3,4,7,8,9NpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 10 
M ion area 
13679900 
14071 1000 
99455300 
1 O839OOOO 
107482000 
1190380 
2099350 
194393000 
l8O229OOO 
14 l39OOOO 
326468 
1264690 
42754100 
34260600 
74702800 
62391500 
95887200 
ll237SOOO 
115338000 
38221700 
33854600 
392307 
683 11 100 
1458120 
98222700 
Deployed SPMD 
M+ ion area 
l74OO9OO 
174999000 
I28653000 
141325000 
8674 14 
1462490 
1 18444000 
1 lO787OOO 
97843700 
270773 
900133 
8062 1600 
64943400 
138521000 
1 15793000 
78720800 
9 10 12200 
93478100 
8422 1000 
73738900 
340333 
66546100 
1497360 
1 I2538000 
Concentration % Surrogate 
Cex (ndextract) Recovery RR and RF 
0.93 
1.40 
1.05 
1.03 
2.35 
0.94 
1.00 
1.49 
1.45 
0.93 
1.14 
1.27 
1.25 
1.18 
1.31 
2.03 
1.89 
1.62 
0.90 
1.13 
0.95 
1.00 
1.19 
1.18 
1.41 
1.38 
0.41 
1.84 
0.92 
2.36 
0.97 
2.58 
1.06 
Peak Ratio Data Flags 
0.79 
0.80 
0.77 
0.77 
1.37 
1.44 
1.64 
1.63 
1.45 C 
1.21 
1.41 
0.53 
0.53 
0.54 
0.54 
TABLE B.5 continued 
k. Sample 97-S 
Deployment 4, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C- 1,2,3,7,8PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1 ,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1 ,2,3,6,7,8-HxCDD 
IS-13C- 1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010327-1 Run 
Retention Time 
41.14 
41.12 
42.49 
ND 
43.40 
43.43 
ND 
ND 
55.47 
57.43 
ND 
58.28 
62.36 
ND 
63.35 
ND 
62.35 
62.42 
63.34 
64.26 
63.49 
ND 
ND 
63.47 
63.51 
64.14 
ND 
ND 
66.30 
68.01 
67.38 
67.38 
71.02 
71.01 
ND 
SAMPLE 6 
M ion area 
2634200 
160592000 
1370 17000 
102273000 
84098000 
l7O477OOO 
163 142000 
102 lO4OOO 
4 16498 
132380 
56266300 
40609900 
463 10600 
39963400 
266988 
71295600 
6342 1000 
77309300 
42238200 
35289900 
743850 
72807600 
929260 
84502400 
Deployed SPMD 
M+ ion area 
2948100 
194439000 
166343000 
136533000 
113851000 
103649000 
102092000 
361433 
92867 
107657000 
76359600 
87901 500 
73652000 
192069 
59649500 
50924900 
64340800 
92069600 
74566500 
673994 
69338800 
1216600 
97077600 
Concentration 
Cex (nglextract) 
1.52 
48.07 
36.06 
25.46 
28.76 
26.23 
23.59 
0.37 
0.14 
120.94 
67.74 
89.35 
85.13 
0.30 
129.71 
75.58 
102.65 
88.63 
1.01 
94.95 
2.22 
142.07 
% Surrogate 
Recovery 
48.07 
36.06 
50.93 
28.76 
26.23 
23.59 
[SP*l RR and RF 
(ng/kg) 
Peak Ratio Data Flags 
0.89 
0.83 
0.82 
0.75 
TABLE B.5 continued 
I. Sample 98-S 
Deployment 4, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-l,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1 ,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
010331 Run 
Retention Time 
42.03 
41.58 
43.5 1 
ND 
44.38 
44.40 
56.18 
58.06 
56.17 
58.04 
ND 
58.52 
62.57 
63.04 
63.53 
64.45 
62.55 
63.04 
63.53 
64.44 
ND 
ND 
ND 
64.07 
64.14 
64.34 
ND 
ND 
66.49 
68.20 
ND 
67.57 
71.27 
71.25 
ND 
SAMPLE 4 
M ion area 
11452800 
2783 1 1000 
256704000 
235 152000 
21 ll93OOO 
768693 
1801230 
348689000 
3 15837000 
29608 1000 
920558 
48022 1 
97462 1 
450290 
147172000 
92380600 
13 1543000 
104000000 
I99789000 
147950000 
195481000 
56745200 
59163200 
134226000 
2 176940 
195239000 
Deployed SPMD 
M+ ion area 
15045800 
351475000 
3273 16000 
303584000 
559873 
1201670 
2 1 l527OOO 
188968000 
225979000 
6622 12 
456163 
7008 I6 
391728 
274703000 
1697 13000 
243635000 
193161000 
160288000 
1 l78OOOOO 
l5863OOOO 
125459000 
135458000 
127419000 
2473 140 
223885000 
Concentration 
Cex (nglextract) 
4.37 
80.52 
90.84 
32.73 
0.25 
0.59 
51.58 
37.01 
40.25 
0.3 1 
0.31 
0.40 
0.23 
109.13 
65.36 
99.20 
93.43 
107.37 
79.09 
87.54 
114.37 
119.74 
1.87 
194.94 
% Surrogate 
Recovery 
80.52 
90.84 
65.46 
51.58 
37.01 
40.25 
[SPMD1 RR and RF 
(ng'w 
Peak Ratio Data Flags 
TABLE B.5 continued 
m. Sample 9 9 4  
Deployment 4, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1 ,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010331 Run 
Retention Time 
42.43 
42.40 
44.32 
ND 
45.21 
45.25 
ND 
ND 
56.42 
58.26 
59.12 
63.11 
ND 
64.05 
ND 
63.10 
63. I8 
64.06 
64.56 
ND 
ND 
ND 
64.20 
64.27 
64.47 
ND 
ND 
66.59 
68.3 1 
68.09 
68.08 
71.41 
71.40 
71.48 
SAMPLE 5 
M ion area 
13648300 
240307000 
263396000 
242381000 
240737000 
3497 1 1000 
289324000 
223270000 
324289 
922074 
99935 100 
4726 1000 
70586300 
91 I92500 
98533500 
68792700 
l5326OOOO 
492 17400 
5 1068400 
1 128460 
ll9942OOO 
1908700 
168835000 
311801 
Deployed SPMD 
M+ ion area 
17868400 
301610000 
325069000 
29291 1000 
210078000 
176652000 
184674000 
25868 1 
745286 
186963000 
87822200 
13 1239000 
168882000 
77095900 
54236000 
1245 17000 
1075 14000 
1 l426lOOO 
985055 
1 13676000 
1919250 
194213000 
349940 
Concentration % Surrogate 
Cex (nglextract) Recovery [SP*l RR and RF (ng/kg) Peak Ratio Data Flags 
0.76 
0.80 
0.81 
0.83 
DPE 
1.66 
1.64 
1.24 
DPE 
0.53 
0.54 
0.54 
0.54 
1.28 
1.27 
1.23 
DPE 
TABLE B.5 continued 
n. Sample 100-S 
Deployment 4, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010331 Run 
Retention Time 
42.29 
42.25 
44. I6 
ND 
45.04 
45.08 
56.33 
58.18 
56.32 
58.17 
59.04 
59.03 
63.04 
ND 
63.59 
64.5 1 
63.02 
63.10 
63.59 
64.50 
ND 
ND 
ND 
64.13 
64.20 
64.41 
ND 
ND 
66.5 1
68.22 
68.00 
67.59 
71.30 
71.30 
ND 
SAMPLE 6 
M ion area 
3 108580 
70582500 
5181 1700 
61426700 
48989200 
409256 
962758 
87691600 
78789000 
241177 
64458500 
380298 
912528 
248152 
18933000 
17396000 
14215000 
9758050 
17 129800 
18030300 
l6O7OOOO 
3919130 
12835300 
381150 
26103800 
1 179680 
41388800 
Deployed SPMD 
M+ ion area 
3646930 
86562200 
64959600 
78380800 
29 1282 
699333 
54500200 
48176300 
230816 
43933500 
271086 
705 192 
191621 
3474 1300 
32538900 
2542 1700 
18425400 
13937500 
14076800 
12640500 
9042560 
28467900 
385027 
24121400 
1325580 
48715800 
Concentration 
Cex (@extract) 
4.47 
100.48 
117.90 
37.62 
0.53 
1.30 
65.48 
46.55 
0.50 
41.79 
0.99 
3.64 
1.24 
171.25 
153.59 
129.26 
109.29 
114.25 
117.85 
76.80 
299.36 
1.58 
283.49 
4.69 
516.91 
% Surrogate 
Recovery 
100.48 
117.90 
75.23 
65.48 
46.55 
41.79 
[SP*l RR and RF (nglkg) Peak Ratio Data Flags 
TABLE B.5 continued 
o. Sample 101-S 
Deployment 4, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1 ,2,3,7,8,9-HxCDD 
1 3C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
0 1033 1 Run 
Retention Time 
42.11 
42.08 
43.59 
ND 
44.48 
44.52 
ND 
58.09 
56.21 
58.07 
ND 
58.55 
62.57 
ND 
63.53 
64.43 
62.56 
63.04 
63.52 
64.44 
ND 
ND 
ND 
64.07 
64.13 
64.34 
ND 
ND 
66.46 
68. I6 
ND 
67.54 
71.22 
71.22 
ND 
SAMPLE 7 
M ion area 
6318330 
130726000 
102562000 
ll2567OOO 
99708400 
1154380 
164647000 
140541000 
l2O894OOO 
170494 
459244 
137278 
4 1062200 
25346000 
27802800 
19143800 
38526800 
2797 1500 
3 1958500 
7782 160 
173441 00 
ll92l2OO 
2069 170 
71430700 
Deployed SPMD 
M+ ion area 
8262270 
163546000 
125856000 
143416000 
850253 
99389200 
87074400 
95269800 
151343 
332455 
114236 
72372800 
50518300 
52645300 
35775600 
30670900 
2 1599500 
25753 100 
16647700 
38907700 
10757000 
2301930 
81339100 
Concenkation 
Cex (ngtextract) 
5.15 
96.20 
110.35 
38.68 
0.88 
62.16 
42.67 
42.61 
0.23 
0.88 
0.37 
180.05 
116.09 
130.52 
105.95 
126.60 
90.52 
72.01 
202.82 
63.68 
4.83 
436.00 
% Surrogate 
Recovery 
96.20 
110.35 
77.36 
62. I6 
42.67 
42.61 
180.05 
1 16.09 
130.52 
105.95 
126.60 
90.52 
72.01 
202.82 
63.68 
218.00 
[SPMD1 RR and RF (W'W Peak Ratio Data Flags 
0.76 
0.80 
0.81 
0.78 
TABLE B.5 continued 
p. Sample 104-S 
Deployment 4, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
010331 Run 
Retention Time 
42.07 
42.02 
43.54 
ND 
44.42 
44.45 
ND 
58.07 
56.20 
58.06 
ND 
58.54 
ND 
ND 
63.53 
ND 
62.56 
63.04 
63.53 
64.44 
ND 
ND 
ND 
64.08 
64.14 
64.35 
ND 
ND 
66.49 
68.21 
ND 
67.58 
71.28 
71.27 
ND 
SAMPLE 8 
M ion area 
6832240 
136074000 
113237000 
122435000 
103965000 
1178910 
171 264000 
143287000 
130600000 
288017 
38005900 
244 14000 
26899700 
17904400 
3603 1500 
3 1009200 
29299800 
24133200 
23086000 
5 1264500 
1 124940 
69153600 
Deployed SPMD 
M+ ion area 
9212710 
169554000 
138966000 
15506 1000 
858026 
106 162000 
87040500 
95576000 
225064 
70327200 
44382000 
48575700 
32962300 
29274000 
24928400 
23632200 
53541800 
5248 1500 
47376700 
1128030 
7948 1900 
Concentration 
Cex (ngkxtract) 
5.46 
90.49 
108.35 
36.53 
0.88 
59.15 
39.10 
40.38 
0.61 
187.48 
114.77 
133.51 
106.99 
130.27 
111.37 
249.65 
297.07 
301.99 
2.56 
462.50 
% Surrogate 
Recovery 
90.49 
108.35 
73.05 
59.15 
39.10 
40.38 
[SPMD1 RR and RF 
(nelkg) 
Peak Ratio Data Flags 
0.74 
0.80 
0.81 
0.79 
1.37 
1.61 
1.65 
1.37 C 
DPE 
1.28 
0.54 S 
0.55 
0.55 
0.54 
TABLE B.5 continued 
q. Sample 105-S 
Deployment 4, Downstream 
Congener 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010331 Run 
Retention Time 
42.12 
42.06 
43.58 
ND 
44.46 
44.50 
56.24 
58.11 
56.22 
58.08 
ND 
58.56 
62.59 
63.08 
63.55 
64.48 
62.58 
63.06 
63.55 
64.47 
ND 
ND 
ND 
64.10 
64.16 
64.37 
ND 
ND 
66.50 
68.22 
68.00 
67.59 
71.30 
71.29 
ND 
SAMPLE 9 
M ion area 
8287950 
170956000 
144022000 
14774 1000 
133568000 
8898 15 
1411610 
2 12 194000 
l9O7O6OOO 
153733000 
459616 
279095 
581190 
360215 
44 1 16200 
36488100 
33798400 
22795500 
41 349600 
39440400 
37097200 
30578700 
26065200 
577813 
62075000 
1365330 
90600000 
Deployed SPMD 
M+ ion area 
lo68 1400 
207181000 
176644000 
185660000 
562758 
922607 
l277O5OOO 
116985000 
108679000 
362121 
228235 
502261 
3 19590 
82870600 
68173200 
62689500 
43066000 
33469400 
3 1382000 
2991 7600 
69045700 
57698400 
515012 
57020800 
1548160 
105 129000 
Concentration 
Cex (nglextract) 
5.22 
88.05 
102.38 
36.90 
0.46 
0.76 
57.00 
41.08 
36.84 
0.53 
0.42 
1.00 
0.82 
173.58 
137.92 
134.81 
109.42 
117.88 
1 1  1.37 
252.91 
260.09 
0.95 
287.99 
2.51 
481.05 
% Surrogate 
Recovery 
88.05 
102.38 
73.79 
57.00 
41.08 
36.84 
RR and RF 
0.96 
1.34 
1.08 
1.02 
2.51 
0.94 
1 .oo 
1.86 
2.34 
0.88 
2.22 
1.23 
1.14 
1.12 
1.25 
1.09 
1.13 
1 .O7 
0.90 
1.07 
0.91 
0.99 
0.95 
0.95 
1.38 
1.32 
0.59 
0.48 
0.97 
0.62 
1.19 
0.61 
1.16 
Peak Ratio Data Flags 
0.78 
0.83 
0.82 
0.80 
1.58 
1.53 
1.66 
1.63 
1.41 
1.27 
1.22 
1.16 
1.13 
0.53 
0.54 
0.54 
0.53 
1.24 
1.26 
1.24 
0.44 
0.45 
1.12 
1 .O9 
0.88 
0.86 
TABLE B.5 continued 
r. Sample 106-S 
Deployment 4, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
1s-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1 ,2,3,6,7,8-HxCDD 
IS-I 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010331 Run 
Retention Time 
42.10 
42.05 
43.57 
ND 
44.45 
44.49 
ND 
58.10 
56.22 
58.07 
ND 
58.55 
62.59 
ND 
63.54 
m 
62.58 
63.06 
63.54 
64.46 
m 
ND 
ND 
64.09 
64.15 
64.36 
ND 
ND 
66.49 
68.21 
67.59 
67.58 
71.29 
71.27 
71.35 
SAMPLE 10 
M ion area 
10305000 
190985000 
17661 2000 
168188000 
140 1 18000 
1547350 
239079000 
209274000 
171 192000 
412079 
701 720 
46742 100 
39253400 
3 785 1200 
25309800 
43967900 
42628400 
44804000 
33412900 
31998700 
730409 
63865300 
1893080 
91814000 
645094 
Deployed SPMD 
M+ ion area 
13250900 
239792000 
215386000 
209571 000 
1046930 
146928000 
126227000 
123597000 
3 18490 
553443 
88475300 
72203600 
69664500 
47110200 
37299400 
33394800 
35471400 
73969200 
6991 2000 
690750 
59829900 
2003740 
106843000 
773252 
Concentration 
Cex (nglextract) 
5.69 
82.05 
94.89 
3 1 .56 
0.77 
52.95 
36.65 
33.86 
0.44 
1.04 
154.30 
122.61 
125.40 
100.44 
106.89 
99.80 
227.57 
264.17 
1.19 
249.71 
3.31 
407.60 
1.23 
% Surrogate 
Recovery 
82.05 
94.89 
63.13 
52.95 
36.65 
33.86 
154.30 
122.61 
125.40 
100.44 
106.89 
99.80 
227.57 
264.17 
249.71 
203.80 
Peak Ratio Data Flag6 
0.78 
0.80 
0.82 
0.80 
TABLE B.5 continued 
s. Sample 107-S 
Deployment 4, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C- 1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1 ,2,3,6,7,8-HxCDD 
1 ,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-l3C-I,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
01033 1 Run 
Retention Time 
42.33 
42.29 
44.21 
ND 
45.10 
45.14 
56.39 
58.22 
56.37 
58.20 
ND 
59.08 
63.07 
63. I6 
64.00 
64.53 
63.05 
63.14 
64.01 
64.54 
ND 
ND 
ND 
64. I6 
64.23 
64.42 
ND 
ND 
66.55 
68.27 
68.06 
68.04 
71.35 
71.34 
71.43 
SAMPLE 1 1 
M ion area 
2670 1400 
472576000 
483224000 
424329000 
344032000 
1706940 
3006750 
509753000 
413127000 
308641000 
732047 
163610 
750819 
456848 
11 1533000 
70844300 
84890300 
52448 100 
102074000 
98321300 
I17234000 
62930100 
63285800 
744756 
128448000 
4044780 
199774000 
1415780 
Deployed SPMD 
M+ ion area 
33687700 
587777000 
60776 1000 
538684000 
1275560 
2059540 
3 lO596OOO 
25 1424000 
234878000 
608602 
154269 
693642 
373054 
207360000 
l3O452OOO 
15545 1000 
98744700 
80758200 
79536100 
96226500 
143 136000 
142992000 
744993 
120308000 
4082900 
227558000 
1548050 
Concentration 
Cex (nglextract) 
5.92 
72.57 
86.92 
28.32 
0.39 
0.76 
40.43 
26.08 
22.43 
0.34 
0.14 
0.54 
0.44 
136.85 
83.28 
105.42 
78.86 
90.44 
87.81 
164.23 
201.09 
0.62 
188.85 
3.21 
329.73 
1.19 
% Surrogate 
Recovery 
72.57 
86.92 
56.65 
40.43 
26.08 
22.43 
[SPMD1 RR and RF (Wk) 
6.19 0.96 
Peak Ratio Data Flags 
TABLE B.5 continued 
t. Sample 108-S 
Deployment 4, Downstream 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1 ,2,3,4,7,8-HxCDF 
1,2,3,6,7,8NxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010401 Run 
Retention Time 
42.26 
42.22 
44.14 
ND 
45.05 
45.07 
ND 
58.18 
56.33 
58.17 
ND 
59.04 
63.05 
63.13 
63.59 
64.53 
63.03 
63.12 
63.59 
64.52 
ND 
ND 
ND 
64.14 
64.22 
64.41 
ND 
ND 
66.55 
68.27 
68.05 
68.04 
71.36 
71.35 
ND 
SAMPLE 6 
M ion area 
20855400 
435961000 
338351000 
333646000 
2748 17000 
2753560 
509467000 
419531000 
306156000 
408783 
241999 
485929 
351250 
80796200 
63806200 
65364500 
42131300 
78562400 
78835100 
86163800 
62743700 
6 1989000 
543452 
130639000 
1633330 
205479000 
Deployed SPMD 
M+ ion area 
26033000 
546754000 
439805000 
440556000 
1892220 
3 18909000 
260887000 
220002000 
357903 
176297 
429738 
323204 
15081 8000 
1 l79lOOOO 
1 l95l7OOO 
8045 1000 
62455700 
65477900 
69867300 
138887000 
138665000 
606877 
124572000 
1678110 
233296000 
Concentration 
Cex (nglextract) 
5.13 
90.35 
96.78 
34.52 
0.68 
71.66 
60.28 
59.48 
0.26 
0.18 
0.42 
0.42 
73.03 
61.69 
73.22 
87.27 
75.76 
78.70 
313.59 
69.97 
0.49 
69.39 
1.56 
108.81 
% Surrogate 
Recovery 
90.35 
96.78 
69.05 
71.66 
60.28 
59.48 
Peak Ratio Data Flags 
0.80 
0.80 
0.77 
0.76 
Appendix C 
SPMD QUALITY CONTROL SAMPLE INFORMATION AND RAW DATA 
SPREADSHEETS FROM THE 2000 FIELD SEASON 
Table C. 1 SPMD Quality Control Sample Information Log, 2000 
Table C.2 SPMD Raw Data Calculation Spreadsheets for Method Detection Limit 
Study One Samples 
Table C.3 SPMD Raw Data Calculation Spreadsheets for Deployment One Quality 
Control Samples 
Table C.4 SPMD Raw Data Calculation Spreadsheets for Deployment Two Quality 
Control Samples 
Table C.5 SPMD Raw Data Calculation Spreadsheets for Deployment Three Quality 
Control Samples 
Table C.6 SPMD Raw Data Calculation Spreadsheets for Deployment Four Quality 
Control Samples 
Table C.7 SPMD Raw Data Calculation Spreadsheets for Method Detection Limit 
Study Two Samples 
ND Peak was not detected 
Data Flag Information Key: 
B Positive peak identification for a blank 
C Co-eluting peak present 
DPE Diphenyl ether interference with the dioxin peak 
S Percent surrogate recoveries were either above or below the established 
limits set by the EPA in method 161 3-B (Telliard 1994) 
APPENDIX C.1. SPMD Quality Control Sample Information Log, 2000 
Method Detection Limit (MDL) Study One 
Samvle ID# Descrivtor SPMDs per sample # revlicates 
I I-S Dialysis Blank 1 7 
12-S 1 
1 3 4  1 
14-S I 
15-S 1 
16-S 1 
1 7 4  1 
Deployment One: Androscoggin River at Dixfield, ME Site 10 
Retrieval I Samples: 6/2/00 lo 6/9/00 10-A Site 
S a m ~ l e  ID# Descrivtor SPMDs wr Samvle # revlicates 
18-S Field Blank 10-A 1 I 
2 4 4  Process Blank 0 1 
Retrieval 2 Samples: 6/2/00 to 6/16/00 10-B Site 
2 5 4  Field Blank 10-B 1 1 
2 6 4  Dialysis Blank 1 1 
3 2 4  Process Blank 0 I 
Retrieval 3 Samples: 6/2/00 to 6/23/00 10-A Sile 
33-S Field Blank 10-A I 1 
39-S Process Blank 0 1 
Retrieval 4 Samples: 6/2/00 to 6/30/00 10-B Sile 
40-S Field Blank 10-B I 1 
4 1 4  Matrix Spike 1 1 
4 7 4  Process Blank 0 1 
Deployment Two: Androscoggin River at Dixfield, ME Site 10 
Retrieval I Samples: 7/7/00 to 7/14/00 10-A Site 
Samvle ID# Descrivtor SPMDs ver Samde # revlicates 
48-S Field Blank 10-A 1 I 
50-S Process Blank 0 I 
Remmeval 2 Samples: 6/30/00 to 7/14/00 10-B Site 
5 1-S Field Blank 10-B I 1 
Retrieval 3 Samples: 7/7/00 to 7/28/00 10-A Site 
54-S Dialysis Blank I 1 
55-S Field Blank 10-A I 1 
57-S Process Blank 0 1 
Deployment Two Androscoggin River at Dixfield, ME Site 10 (eont.) 
Retrieval 4 Samples: 6/30B0 to 7/28/00 10-B Site 
Samvle ID# Descrivtor SPMDs per Samvle # revlicates 
5 8 4  Field Blank 10-B 1 I 
59-S Matrix Spike 1 I 
65-S Process Blank 0 I 
Deployment Three: Upstream-Downstream on the Kennebec River 
Upstream Site I I in Norridgewock, ME: 8/3/00 lo 9/26/00 
Samvle ID# Descrivtor SPMDs ver Samvle # revlicates 
6 6 4  Field Blank 1 I 
6 7 4  Dialysis Blank 1 1 
73-S Process Blank 0 I 
Downstream Site I2 in Fairjield, ME: 8/3/00 to 9/26/00 
74-S Field Blank 12 1 1 
75-S Matrix Spke 1 1 
81-S Process Blank 0 1 
Deployment Four: Upstream-Downstream on the Androscoggin River 
Upstream Site 13 in Rumford, ME: 9/19/00 to 1O/1 7/00 
Samvle ID# Descrivtor SPMDs ver Samvle # revlicates 
82-S Field Blank 13 2 1 
8 8 4  Process Blank 0 I 
89-S Dialysis Blank 2 I 
95-S Process Blank 0 1 
Downstream Site 10 in Dkfield, ME: 9/19/00 lo lO/l7/OO 
96-S Field Blank 10 2 1 
1024  Process Blank 0 1 
1034  Matrix Spke 2 1 
109-S Process Blank 0 1 
Method Detection Limit (MDL) Study Two 
Samvle ID# Descrivtor SPMDs Der Samvle # re~licates 
110-S MDL sample 2 7 
I 1 I-S spiked with PAR 2 
1124 2 
113-S 2 
1144  2 
1 15-S 2 
1 16-S 2 
TABLE C.2. SPMD Raw Data Calculation Spreadsheets for Method Detection Limit Study One Samples 
a. Sample 11-S 
MDL Experiment 000818 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS- 13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CLTCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1 ,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8NxCDF 
1,2,3,7,8,9-HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
13C- 1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8NxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-1 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 3 
M ion area 
18938.9 
1787020 
4745800 
20701.9 
1979550 
5173660 
2031 14 
187479 
4397000 
3874650 
18944 1 
3498 190 
300703 
305275 
281378 
230824 
2865890 
3121440 
2860950 
2399630 
164963 
179099 
2323 10 
3573530 
3638820 
641 1370 
430740 
275984 
3473 130 
2506350 
240096 
4631950 
28991 6 
5308620 
407247 
M+ ion area 
26746.2 
2530690 
6086530 
25165.3 
2426190 
164639 
128095 
2942210 
2524 180 
168046 
2982570 
24 1827 
259918 
232691 
194689 
5931710 
5861730 
5659290 
5033020 
129788 
156296 
166972 
2874270 
3000160 
5033710 
408506 
286196 
7965220 
5758450 
2067 17 
4486230 
3 12667 
5823760 
436352 
Concentration 
Cex (@extract) 
1.12 
28.69 
0.94 
42.32 
45.68 
5.46 
5.02 
40.96 
3 1 .O7 
5.23 
40.64 
5.02 
5.17 
5.33 
4.98 
56.43 
55.94 
61.35 
70.85 
4.19 
5.29 
6.18 
54.99 
55.23 
4.86 
4.71 
123.89 
1 19.02 
5.07 
102.84 
10.34 
180.55 
13.15 
% Surrogate 
Recovery 
28.69 
42.32 
91.36 
40.96 
31.07 
40.64 
56.43 
55.94 
61.35 
70.85 
54.99 
55.23 
123.89 
1 19.02 
102.84 
90.28 
RR and RF Peak Ratio Data Flags 
TABLE C.2 continued 
b. Sample 12-S 
MDL Experiment 0008 1 8 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1 ,2,3,6,7,8-HxCDD 
1s-1 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 4 
M ion area 
23399.8 
2258610 
6056470 
35967.3 
2571860 
7690950 
222843 
2 18040 
5458620 
4756860 
284482 
4995850 
486612 
4 10893 
440622 
375126 
4992970 
4309010 
4263290 
39 18040 
278430 
270168 
355418 
5022210 
5894480 
9365850 
443092 
341512 
3965150 
3000550 
381703 
80 17280 
103680 
1542330 
90968.5 
M+ ion area 
32304 
2988570 
7254640 
50983.8 
2932160 
138191 
139579 
34793 10 
3290320 
163589 
4140970 
400109 
324033 
325499 
301060 
9995320 
8402090 
8396850 
7741520 
211943 
2305 15 
263082 
4068 140 
4556510 
7505860 
47233 1 
355086 
9057200 
6716970 
3 17993 
7443810 
101518 
1740190 
91070.6 
Concentration 
Cex (ngtextract) 
1.12 
28.38 
1.43 
43.02 
53.21 
4.40 
4.53 
40.59 
3 1.80 
4.65 
46.63 
4.82 
4.75 
5.35 
5.05 
65.22 
53.69 
61.84 
75.39 
4.95 
5.02 
6.41 
52.59 
58.98 
4.66 
4.96 
95.68 
94.93 
4.68 
11 8.29 
1 1.94 
36.1 1 
9.62 
% Surrogate 
Recovery 
28.38 
43.02 
106.42 
40.59 
31.80 
46.63 
65.22 
53.69 
61.84 
75.39 
52.59 
58.98 
95.68 
94.93 
118.29 
18.06 
RR and RF 
0.95 
1.39 
1.10 
0.96 
2.39 
0.92 
0.98 
1.65 
1.90 
1.06 
1.47 
1.23 
1.22 
1.13 
1.15 
1.36 
1.40 
1.21 
0.92 
1 .O9 
0.95 
0.99 
1.02 
1 .O5 
1.51 
1.44 
0.81 
0.61 
0.97 
0.77 
1 .O5 
0.54 
1.15 
Peak Ratio Data Flags 
TABLE C.2 continued 
c. Sample 13-S 
MDL Experiment 000818 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1 ,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C- 1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 5 
M ion area 
8500.06 
1093660 
3397330 
9073.58 
1206610 
4567200 
102233 
124066 
3036730 
2546080 
141994 
2707090 
223984 
193727 
196125 
173202 
2150330 
2159130 
2379090 
1793330 
125685 
133934 
153560 
2202930 
285 1200 
4381740 
305479 
2 17698 
2475 140 
1938130 
164553 
3713160 
53025.5 
996784 
47623.6 
M+ ion area 
12710.5 
1536670 
4253510 
13387.7 
1673390 
77027.4 
76802.2 
1873500 
17221 10 
1 10004 
2 152490 
175064 
173697 
173506 
145464 
4072600 
4145180 
4499380 
3526520 
11 1964 
132799 
15602 1 
1818010 
2369060 
3591610 
301 194 
206220 
5525460 
4624590 
151112 
3339620 
71666.6 
1106470 
60 106.8 
Concentration 
Cex (nglextract) 
0.85 
24.75 
0.71 
39.17 
56.33 
3.98 
4.79 
38.80 
29.34 
4.91 
43.15 
5.22 
4.79 
4.75 
5.21 
57.30 
56.35 
71.09 
72.79 
5.42 
5.35 
6.78 
49.22 
62.34 
5.02 
4.47 
124.39 
135.66 
4.63 
114.18 
11.32 
48.96 
8.89 
% Surrogate 
Recovery 
24.75 
39.17 
1 12.66 
38.80 
29.34 
43.15 
57.30 
56.35 
71.09 
72.79 
49.22 
62.34 
124.39 
135.66 
114.18 
24.48 
RR and RF 
0.95 
1.39 
1.10 
0.96 
2.39 
0.92 
0.98 
1.65 
1.90 
1 .O6 
1.47 
1.23 
1.22 
1.13 
1.15 
1.36 
1.40 
1.21 
0.92 
1 .O9 
0.95 
0.99 
1.02 
1.05 
1.51 
1.44 
0.81 
0.61 
0.97 
0.77 
1.05 
0.54 
1.15 
Peak Ratio Data Flags 
TABLE C.2 continued 
d. Sample 14-S 
MDL Experiment 0008 18 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1 ,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
1 3C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8NxCDD 
IS-1 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 6 
M ion area 
19524.5 
2146330 
65 17790 
31530.8 
2381980 
7017970 
209964 
2078 18 
5335930 
5004390 
2477 18 
4771760 
536859 
493497 
538481 
331380 
5567640 
5282930 
63 10930 
3483680 
323472 
291230 
253421 
5837600 
6405970 
8744370 
538207 
42 1925 
4659 170 
3573480 
346920 
7475580 
131358 
20663 10 
77920.3 
M+ ion area 
26642.4 
2805200 
7975350 
49545.2 
3088720 
156364 
131109 
3640750 
3371560 
147027 
4083480 
427729 
381 199 
44503 1 
279362 
1 1339700 
1 0504700 
12716500 
7029670 
262501 
237240 
265040 
4672790 
4808980 
7149700 
55 1065 
364788 
10605600 
8498380 
323997 
7062760 
129985 
2379590 
111103 
Concentration 
Cex (ndextract) 
0.99 
24.59 
1.34 
39.28 
45.12 
4.45 
4.12 
37.44 
30.40 
4.22 
41.50 
4.65 
4.55 
4.57 
5.05 
78.09 
70.79 
98.65 
72.16 
5.11 
4.94 
4.83 
64.54 
67.19 
4.73 
4.51 
119.06 
125.18 
4.78 
118.07 
1 1.22 
51.92 
7.38 
% Surrogate 
Recovery 
24.59 
39.28 
90.23 
37.44 
30.40 
41.50 
78.09 
70.79 
98.65 
72.16 
64.54 
67.19 
1 19.06 
125.18 
1 18.07 
25.96 
RR and RF 
0.95 
1.39 
1.10 
0.96 
2.39 
0.92 
0.98 
1.65 
1.90 
1 .O6 
1.47 
1.23 
1.22 
1.13 
1.15 
1.36 
1.40 
1.21 
0.92 
1.09 
0.95 
0.99 
1.02 
1.05 
1.51 
1.44 
0.81 
0.61 
0.97 
0.77 
1.05 
0.54 
1.15 
Peak Ratio Data Flags 
TABLE C.2 continued 
e. Sample 15-S 
MDL Experiment 000818 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-I ,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 7 
M ion area 
32326.5 
3908330 
12487900 
42829 
46461 10 
1253 1200 
42805 1 
347720 
11550400 
9929290 
578837 
1 1494700 
1274000 
1236710 
1 192890 
863581 
14746400 
13538400 
14436800 
9674860 
737954 
605703 
8872 15 
15499800 
13606 100 
24630500 
7935 1 1 
5930 13 
7474150 
5045210 
801538 
18803900 
18306 1 
3526460 
161040 
M+ ion area 
46867.3 
5189140 
15674400 
50972.4 
5328850 
253446 
2505 12 
7 126090 
6399160 
46 1030 
9124170 
1028950 
974171 
99363 1 
668086 
303 1 1700 
26950200 
29430500 
I9479000 
567945 
555091 
7 12693 
12333200 
10863 100 
19838300 
823455 
553352 
178 18500 
12390300 
760372 
17958900 
203368 
3860960 
161791 
Concentration 
Cex (nglextract) 
0.92 
23.25 
0.85 
36.85 
42.05 
3.97 
3.73 
40.09 
30.49 
4.78 
49.73 
4. I6 
4.48 
4.41 
4.57 
74.38 
64.89 
81.29 
71.52 
4.30 
4.97 
6.19 
61.09 
52.39 
4.24 
4.55 
70.5 1 
64.62 
4.40 
106.72 
9.99 
30.84 
7.58 
% Surrogate 
Recovery 
23.25 
36.85 
84.09 
40.09 
30.49 
49.73 
74.38 
64.89 
81.29 
71.52 
61.09 
52.39 
70.5 1 
64.62 
106.72 
15.42 
RR and RF 
0.95 
1.39 
1.10 
0.96 
2.39 
0.92 
0.98 
1.65 
1.90 
1 .O6 
1.47 
1.23 
1.22 
1.13 
1.15 
1.36 
1.40 
1.21 
0.92 
1 .O9 
0.95 
0.99 
1.02 
1.05 
1.51 
1.44 
0.81 
0.61 
0.97 
0.77 
1.05 
0.54 
1.15 
Peak Ratio Data Flags 
TABLE C.2 continued 
f. Sample 16-S 
MDL Experiment 000818 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1 ,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1 ,2,3,7,8,9-HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
1 3C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1 ,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1 ,2,3,6,7,8-HxCDD 
IS-13C-I ,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 8 
M ion area 
32485.1 
2908 170 
8648300 
16706.9 
3063540 
99 12290 
255487 
241874 
7572370 
6856130 
384087 
8030290 
777497 
629532 
676 177 
683034 
8628 120 
778 1700 
8742640 
7498770 
4347 12 
37602 1 
6 I6628 
8926850 
10030700 
17 142700 
7 18896 
583414 
7146120 
5396230 
616881 
15766300 
141843 
2656680 
151 151 
M+ ion area 
38581.5 
3932400 
11434300 
26136.1 
3642380 
169540 
201998 
4870890 
4556520 
300494 
6446550 
600078 
495033 
561 199 
496647 
17708500 
15296500 
17238 100 
15 120300 
3 16396 
364943 
4 17688 
701 1100 
8101920 
14073200 
723008 
602036 
l684OOOO 
13654500 
559232 
15 134600 
143078 
3145350 
178435 
Concentration 
Cex (ngtextract) 
1.10 
24.52 
0.58 
34.74 
48.02 
3.72 
3.96 
37.46 
29.89 
4.48 
48.97 
4.26 
4.00 
4.21 
4.54 
61.94 
52.69 
68.59 
79.05 
4.32 
4.28 
6.14 
49.83 
55.31 
3.98 
4.31 
95.26 
100.59 
3.94 
127.78 
9.38 
34.50 
9.85 
% Surrogate 
Recovery 
24.52 
34.74 
96.05 
37.46 
29.89 
48.97 
61.94 
52.69 
68.59 
79.05 
49.83 
55.31 
95.26 
100.59 
127.78 
17.25 
RR and RF 
0.95 
1.39 
1.10 
0.96 
2.39 
0.92 
0.98 
1.65 
1.90 
1.06 
1.47 
1.23 
1.22 
1.13 
1.15 
1.36 
1.40 
1.21 
0.92 
1.09 
0.95 
0.99 
1.02 
1.05 
1.5 1 
1.44 
0.81 
0.61 
0.97 
0.77 
1 .O5 
0.54 
1.15 
Peak Ratio Data Flags 
TABLE C.2 continued 
g. Sample 17-S 
MDL Experiment 0008 18 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C- 1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 9 
M ion area 
13366.1 
3702420 
1 lOO63OO 
53167.9 
3962620 
ll726lOO 
322794 
360202 
9578610 
9096320 
483986 
9459520 
852275 
77794 1 
892 170 
737759 
9490970 
8915070 
10369200 
8020220 
484739 
577543 
748763 
9988770 
11310600 
20 128400 
860746 
646359 
8043990 
6081690 
786669 
17494700 
270768 
42 17420 
232152 
M+ ion area 
21030.3 
4750750 
13784400 
61070.2 
5048930 
235243 
237940 
6199710 
60 18980 
403297 
7672130 
723346 
625993 
745048 
62 1 508 
19434600 
17939200 
20656900 
15712500 
4 15978 
421053 
601596 
79895 10 
90008 10 
16094600 
842088 
616327 
19434300 
14388700 
757695 
16823100 
303358 
4851390 
220581 
Concentration % Surrogate 
Cex (nglextract) Recovery RR and RF 
0.95 
1.39 
1.10 
0.96 
2.39 
0.92 
0.98 
1.65 
1.90 
1.06 
1.47 
1.23 
1.22 
1.13 
1.15 
1.36 
1.40 
1.21 
0.92 
1.09 
0.95 
0.99 
1.02 
1.05 
1.51 
1.44 
0.81 
0.61 
0.97 
0.77 
1.05 
0.54 
1.15 
Peak Ratio Data Flags 
a. Sample 18-S 
Deployment 1, Retrieval 1 010404 Run 
Congener Retention Time 
TABLE C.3. SPMD Raw Data Calculation Spreadsheets for Deployment One Quality Control Samples 
SAMPLE 9 Field Blank 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
lS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
M ion area M+ ion area Concentration % Surrogate [SPMD] Cex (ngtextract) Recovery (Wk) RR and RF Peak Ratio Data Flags 
TABLE C.3 continued 
b. Sample 24-S 
Deployment I, Retrieval 1 0 10402 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8NxCDD 
1,2,3,6,7,8-HxCDD 
1 ,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 3 
M ion area 
1 I7626000 
l34O98OOO 
85282200 
145410000 
198265000 
201 864000 
l5O89OOOO 
126167 
3 10875 
207234 
103286000 
103987000 
102386000 
90569800 
113970 
140061 000 
154052000 
239854000 
69050700 
58803700 
191756 
126278000 
598868 
1 59O7OOOO 
179380 
Process Blank 
M+ ion area 
146830000 
17601 2000 
1 I4695000 
123761000 
1255 12000 
95650500 
104987 
224071 
162156 
191793000 
205879000 
I95224000 
175024000 
103541 
1105 15000 
l2349OOOO 
194 158000 
1 55608000 
129396000 
173924 
123262000 
62 I488 
184571000 
198002 
Concentration 
Cex (nglextract) 
54.81 
62.21 
44.72 
58.53 
53.81 
48.07 
0.06 
0.16 
0.11 
93.44 
97.85 
122.40 
65.60 
0.08 
127.54 
168.44 
66.62 
68.30 
0.15 
74.99 
0.68 
136.57 
0.20 
% Surrogate 
Recovery 
54.81 
62.21 
89.44 
58.53 
53.81 
48.07 
93.44 
97.85 
122.40 
65.60 
127.54 
168.44 
66.62 
68.30 
74.99 
68.28 
RR and RF 
0.93 
1.56 
1 .O7 
1 .O4 
2.42 
0.94 
1.01 
1.77 
1.96 
0.94 
1.65 
1.20 
1.25 
1.12 
1.24 
0.73 
0.73 
0.56 
0.93 
1.08 
0.95 
1.01 
0.45 
0.38 
1.42 
1.39 
0.78 
0.63 
0.95 
0.77 
1 .O4 
0.58 
1.11 
Peak Ratio Data Flags 
TABLE C.3 continued 
c. Sample 25-S 
Deployment 1, Retrieval 2 000821 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C- 1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8NxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8HpCDD 
OCDD 
13C-OCDD 
OCDF 
Sample 5 
M ion area 
1384000 
5393850 
1419570 
4623480 
3433920 
3123910 
3 177870 
Field Blank 
M+ ion area Concentration % Surrogate Cex (nglextract) Recovery Peak Ratio 
0.76 
0.82 
0.84 
1.61 
1.56 
1.49 
0.5 1 
0.52 
0.5 1 
0.52 
1.27 
1.21 
1.23 
0.45 
0.42 
1.07 
0.83 
Data Flags 
S 
S 
S 
TABLE C.3 continued 
d. Sample 26-S 
Deployment 1, Retrieval 2 000821 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
Sample 3 
M ion area 
2720070 
19725 100 
3045230 
21 946700 
11417100 
6704180 
34491.7 
8066140 
26271.2 
28230.6 
5691670 
6893480 
8479220 
6084400 
6998860 
10181400 
13526400 
2951150 
298051 
12995400 
Dialysis Blank 
M+ ion area 
3837090 
24849600 
3720780 
73 14700 
4243470 
21116.1 
5 186030 
18348.4 
21099.5 
10108000 
14699700 
16738100 
1 1824300 
5922670 
8 165660 
10730900 
6608020 
196684 
14818400 
Concentration 
Cex (nglextract) 
10.21 
14.83 
47.06 
24.90 
12.00 
0.41 
18.14 
0.23 
0.19 
55.67 
73.91 
92.20 
79.03 
61.78 
74.48 
50.75 
2.36 
154.25 
% Surrogate 
Recovery 
10.21 
14.83 
94.13 
24.90 
12.00 
18.14 
55.67 
73.91 
92.20 
79.03 
61.78 
74.48 
50.75 
2.36 
77.13 
[SPMD1 RR and RF 
(ngk) 
Peak Ratio 
0.71 
0.79 
0.82 
1.56 
1.58 
1.63 
1.56 
1.43 
1.34 
0.56 
0.47 
0.51 
0.5 1 
1.18 
1 .25 
1 .26 
0.45 
1.52 
0.88 
Data Flags 
S 
S 
S 
S 
B 
S 
B 
B 
S 
TABLE C.3 continued 
e. Sample 32-S 
Deployment 1, Retrieval 2 00082 1 run 
Congener Retention Time 
Sample 4 
M ion area 
27 18940 
2799970 
2128370 
3406820 
4402590 
4442260 
3716070 
Process Blank 
Concentration % Surrogate M+ ion area Cex (nglextract) Recovery RR and RF (ng/kg) 
Peak Ratio Data Flags 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
TABLE C.3 continued 
f. Sample 33-S 
Deployment I, Retrieval 3 00082 1 run 
Congener Retention Time 
Sample 7 
M ion area 
7793 13 
3948220 
809000 
22 10670 
24 15970 
2332470 
2373300 
Field Blank 
Concentration % Surrogate M+ ion area Cex (ngtextract) Recovery [SPMD1 RR and RF (ng/kg) Peak Ratio 
0.85 
0.81 
0.86 
1.59 
1.66 
1.49 
0.54 
0.49 
0.53 
0.51 
1.35 
1.36 
1 .25 
1.07 
0.45 
0.44 
1 .O7 
0.85 
Data Flags 
5 
5 
5 
B 
5 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37Cl-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
1 3C-I,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1 ,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
TABLE C.3 continued 
g. Sample 39-S 
Deployment 1, Retrieval 3 00082 1 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8HxCDD 
1 ,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
Sample 9 
M ion area 
2191760 
28891 10 
1604 100 
1811260 
3797810 
3768730 
3325860 
Process blank 
Concentration % Surrogate M+ ion area Cex (ngfextract) Recovery [SPMD1 RR and RF (ng/kg) 
Peak Ratio Data Flags 
TABLE C.3 continued 
h. Sample 40-S 
Deployment 1, Retrieval 4 0008 1 1 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C- 1,2,3,7,8-PeCDD 
1 ,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 7 
M ion area 
46 1020 
1689680 
393539 
1287220 
948648 
81 1952 
959400 
22275.1 
1602620 
2039240 
1880720 
1874000 
1428850 
2362770 
7200660 
2392620 
3647780 
4 104020 
Field Blank 
M+ ion area 
576885 
2056250 
507750 
553099 
525778 
995045 
17096 
3222760 
4 190200 
3894110 
3877160 
1010760 
1742650 
5536760 
5393730 
3423430 
4732390 
Concentration 
Cex (ngtextract) 
19.18 
24.22 
31.15 
28.73 
19.60 
35.59 
0.55 
3 1.90 
39.39 
39.41 
46.60 
22.76 
3 1.46 
67.02 
58.24 
81.57 
% Surrogate 
Recovery 
19.18 
24.22 
62.30 
28.73 
19.60 
35.59 
[SPMD1 RR and RF 
~~g/kg) 
Peak Ratio Data Flags 
TABLE C.3 continued 
i. Sample 41-S 
Deployment 1, Retrieval 4 000808 run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-1 3C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-l,2,3,7,8,9-H~CDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
Matrix Spike 
M ion area 
2 13095 
1001330 
3801440 
252447 
1082760 
2934350 
2607350 
2562970 
261 7240 
2505640 
2964360 
2589080 
4978500 
5851470 
6270760 
7399090 
2 104480 
2719260 
2814760 
3276590 
3834530 
4360560 
7567130 
3 173590 
391 1040 
10218200 
6586150 
439 1 130 
2202400 
1434700 
43 16970 
4262370 
7663870 
6682190 
7 174600 
M+ ion area 
238316 
1344960 
4658810 
327597 
1376050 
1725190 
1762110 
1741910 
1627010 
2560610 
1894050 
4084270 
4785160 
5241500 
6036350 
4 167030 
5366360 
5575290 
6425770 
3061 130 
3596960 
6290880 
2492340 
3101300 
7992840 
6390400 
4255000 
4946250 
3331250 
4108870 
4039370 
8742890 
7380610 
7872060 
SAMPLE 9 
Concentration 
Cex (nglextract) 
20.95 
19.25 
21.90 
28.39 
32.65 
107.12 
107.93 
30.54 
23.86 
120.13 
32.34 
1 18.45 
110.30 
123.20 
11 2.33 
29.43 
36.87 
40.86 
57.03 
112.75 
121.77 
215.92 
36.08 
37.92 
120.44 
123.55 
50.55 
38.78 
112.05 
52.85 
235.03 
103.88 
183.38 
% Surrogate 
Recovery 
52.37 
48.11 
54.75 
28.39 
65.30 
53.56 
53.96 
30.54 
23.86 
60.06 
32.34 
59.23 
55.15 
61.60 
56.17 
29.43 
36.87 
40.86 
57.03 
56.38 
60.88 
107.96 
36.08 
37.92 
60.22 
61.78 
50.55 
38.78 
56.02 
52.85 
58.76 
5 1.94 
45.84 
RR and RF 
0.92 
1.44 
1.08 
1.02 
2.36 
0.93 
0.97 
1.69 
2.05 
1 .O3 
1.64 
1.22 
1.19 
1.1 1 
1.23 
1.17 
1.20 
1.13 
0.93 
1.08 
0.93 
1.01 
0.86 
1.02 
1.51 
1.47 
0.78 
0.67 
0.91 
0.86 
0.99 
0.74 
1.17 
Peak Ratio Data Flags 
TABLE C.3 continued 
j. Sample 47-S 
Deployment 1, Retrieval 4 000808 run 
Congener Retention Time 
SAMPLE 10 Process Blank 
M ion area M+ ion area Concentration % Surrogate Cex (@extract) Recovery [SP*l RR and RF (ng'w Peak Ratio Data Flags 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
lS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
1s-13C-1 ,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
TABLE C.4. SPMD Raw Data Calculation Spreadsheets for Deployment Two Quality Control Samples 
a. Sample 48-S 
Deployment 2, Retrieval 1 010402-1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-1 3C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8PeCDF 
2,3,4,7,8PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-1 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C- 1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 2 
M ion area 
3205440 
5 13392000 
320199000 
387237000 
37041 5000 
1981340 
635242000 
604649000 
499826000 
204493 
1847840 
145883000 
129888000 
1 l7O63OOO 
220338000 
72409.5 
140242000 
131471000 
334428000 
Field Blank 
M+ ion area 
4329640 
655723000 
41 4972000 
510595000 
1348590 
4028 14000 
385634000 
300702000 
147995 
1527900 
276582000 
244050000 
2 l9O69OOO 
420433000 
67039.3 
11 1753000 
105612000 
270197000 
Concentration % Surrogate [SPMD] RR and RF Peak Ratio 
Cex (nglextract) Recovery (%k3) Data Flags 
DPE, B 
DPE, B 
C 
DPE, B 
DPE 
DPE, B 
DPE 
B 
DPE, C 
DPE, C 
B 
DPE, B 
TABLE C.4 continued 
b. Sample 50-S 
Deployment 2, Retrieval 1 010401 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-13C-l,2,3,7,8,9-H~CDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 3 
M ion area 
1841230000 
1244040000 
1357070000 
1 196620000 
3073790 
7518190 
2299300000 
2274230000 
1851380000 
1987020 
1893970 
9705920 
2362010 
847652000 
769062000 
763 188000 
727978000 
1524740 
1100560000 
1 I79230000 
966246000 
101 1500 
400300000 
347619000 
756968000 
2633250 
1206180000 
1686190 
Process Blank 
M+ ion area 
23 14 120000 
1616690000 
1784180000 
1846150 
4698880 
1434490000 
1424690000 
13171 10000 
1647610 
1483610 
7568240 
I889 140 
1522440000 
1493340000 
1428290000 
1358170000 
1 1  12180 
908078000 
958657000 
802057000 
886914 
882873000 
767434000 
73 l53OOOO 
2719190 
1371320000 
1883130 
Concentration 
Cex (nglextract) 
103.92 
106.81 
40.88 
0.14 
0.33 
87.87 
89.13 
97.43 
0.12 
0.12 
0.67 
0.16 
65.94 
67.77 
76.58 
131.05 
0.12 
95.21 
102.87 
0.12 
176.10 
34.3 1 
35.71 
0.43 
56.40 
0.26 
% Surrogate 
Recovery 
103.92 
106.81 
81.77 
87.87 
89.13 
97.43 
[SPMD1 RR and RF 
(ng/kg) 
Peak Ratio 
0.80 
0.77 
0.76 
1.66 
1.60 
1.60 
1.60 
1.41 
1.21 
1.28 
1.28 
1.25 
0.56 
0.5 1
0.53 
0.54 
1.37 
1.21 
1.23 
1.20 
1.14 
0.45 
0.45 
1 .O3 
0.97 
0.88 
0.90 
Data Flags 
DPE, B 
DPE, B 
C 
DPE,B 
DPE, B 
DPE, B 
DPE, B 
B 
DPE, B 
S 
B 
DPE, B 
TABLE C.4 continued 
c. Sample 51-S 
Deployment 2, Retrieval 2 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1 ,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
0 10402- 1 Run 
Retention Time 
42.58 
42.58 
44.46 
ND 
45.39 
45.42 
ND 
58.27 
56.46 
58.29 
ND 
59.15 
ND 
ND 
64.06 
ND 
63.13 
63.21 
64.08 
65.01 
ND 
ND 
ND 
64.24 
64.30 
SAMPLE 3 
M ion area 
4109110 
1242540000 
955625000 
882454000 
1063530000 
8709490 
1285740000 
1029210000 
678469000 
1548 1900 
336559000 
2 17888000 
3675 14000 
236799000 
358725000 
585953000 
Field Blank 
M+ ion area 
5 178090 
1566690000 
1229410000 
1 140420000 
5871990 
8 1 l72OOOO 
6564 16000 
471 l9OOOO 
11957500 
638762000 
410570000 
694 164000 
451393000 
289675000 
466965000 
Concentration 
Cex (ndextract) 
0.35 
82.64 
% Surrogate 
Recovery 
82.64 
89.30 
91.80 
54.11 
39.32 
31.81 
151.75 
97.5 1 
214.55 
83.53 
162.16 
313.99 
[SPMD1 RR and RF (ngW Peak Ratio 
0.79 
0.79 
0.78 
0.77 
1.48 
1.58 
1.57 
1.44 
1.29 
0.53 
0.53 
0.53 
0.52 
1.24 
1.25 
Data Flags 
DPE, B 
DPE, B 
C 
DPE, B 
S 
S 
S 
S 
TABLE C.4 continued 
d. Sample 54-S 
Deployment 2, Retrieval 3 010402-1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
13C-1 ,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 5 
M ion area 
803808000 
480352000 
608854000 
522 132000 
425460 
987520000 
866056000 
622264000 
l87O38OOO 
156946000 
135645000 
96225500 
168741000 
169646000 
147477000 
42394500 
152260000 
2 10006 
313 185000 
942283 
44634 1000 
394603 
Dialysis Blank 
M+ ion area 
1020580000 
612564000 
781590000 
2428 13 
6 l737OOOO 
545890000 
48847 1000 
357439000 
293720000 
258814000 
182683000 
133185000 
134624000 
ll9856OOO 
95 173800 
341836000 
226307 
298236000 
1151640 
505980000 
455956 
Concentration 
Cex (ngtextract) 
107.29 
122.72 
44.83 
0.04 
82.77 
65.85 
61.45 
279.90 
231.03 
263.38 
11 1.85 
249.49 
299.80 
66.23 
291.13 
0.08 
298.3 1 
0.42 
614.43 
0.16 
% Surrogate 
Recovery 
107.29 
122.72 
89.66 
82.77 
65.85 
61.45 
279.90 
231.03 
263.38 
1 1  1.85 
249.49 
299.80 
66.23 
291.13 
298.31 
307.21 
[SPMD1 RR and RF 
(ngW 
Peak Ratio 
0.79 
0.78 
0.78 
1.75 
1.60 
1.59 
1.27 
0.52 
0.53 
0.52 
0.53 
1.27 
1.26 
1.23 
0.45 
0.45 
0.93 
1.05 
0.82 
0.88 
0.87 
Data Flags 
DPE, C 
DPE, B 
C 
S 
S 
S 
S 
S 
S 
B 
S 
B 
S 
DPE, B 
TABLE C.4 continued 
e. Sample 55-S 
Deployment 2, Retrieval 3 010402-1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37Cl-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 4 
M ion area 
1361480 
572225000 
387173000 
424661000 
383347000 
642233 
689733000 
555586000 
413175000 
156184 
502804 
13271 1000 
I22935000 
94682600 
672 12600 
lO4664OOO 
121739000 
109460000 
127060000 
104973000 
203425000 
589704 
305542000 
Field Blank 
M+ ion area 
1726020 
722042000 
4887 14000 
554900000 
484994 
437752000 
351511000 
303471000 
112344 
363728 
252206000 
233297000 
181352000 
128637000 
83229300 
96131300 
88275900 
282150000 
235329000 
192844000 
661443 
345765000 
Concentration 
Cex (nglextract) 
0.26 
94.98 
107.88 
40.84 
0.12 
72.56 
52.78 
49.47 
0.06 
0.28 
267.52 
246.90 
249.18 
106.18 
209.91 
290.23 
266.33 
271.09 
261.39 
0.37 
568.12 
% Surrogate 
Recovery 
94.98 
107.88 
81.67 
72.56 
52.78 
49.47 
267.52 
246.90 
249.18 
106.18 
209.91 
290.23 
266.33 
271.09 
261.39 
284.06 
[SPMD1 RR and RF (ng/kg) 
0.54 0.93 
Peak Ratio 
0.79 
0.79 
0.79 
0.77 
1.32 
1.58 
1.58 
1.36 
1.39 
1.38 
0.53 
0.53 
0.52 
0.52 
1.26 
1.27 
1.24 
0.45 
0.45 
1.05 
0.89 
0.88 
Data Flags 
DPE, B 
DPE, B 
C 
DPE, B 
DPE, B 
S 
S 
S 
S 
S 
S 
S 
S 
B 
S 
TABLE C.4 continued 
f. Sample 57-S 
Deployment 2, Retrieval 3 01 040 1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C- 1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 4 
M ion area 
6 12400 
55 l85OOOO 
367691000 
405660000 
358409000 
537105 
795161000 
775480000 
639520000 
36705 1000 
359852000 
345742000 
3 16345000 
472906000 
499998000 
460942000 
200056000 
155407000 
327656000 
528819000 
Process Blank 
M+ ion area 
74454 1 
688969000 
477681000 
534425000 
302495 
498856000 
487236000 
395363000 
658203000 
692867000 
640629000 
588867000 
386840000 
404889000 
381051000 
442399000 
344733000 
3 19503000 
600322000 
Concentration 
Cex (ndexfract) 
0.12 
105.01 
108.17 
41.43 
0.07 
103.05 
102.97 
107.69 
59.91 
66.23 
72.39 
1 19.42 
85.59 
91.44 
185.16 
32.32 
32.61 
51.89 
% Surrogate 
Recovery 
105.01 
108.17 
82.86 
103.05 
102.97 
107.69 
[SPMD1 RR and RF 
(ngPlcg) 
Peak Ratio Data Flags 
0.82 DPE, B 
0.80 
0.77 
0.76 
1.78 DPE, B 
1.59 
1.59 
TABLE C.4 continued 
g. Sample 58-S 
Deployment 2, Retrieval 4 020101 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-I 3C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-1 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 9 
M ion area 
13936300 
25701000 
16042700 
12047100 
16926700 
15629400 
17276400 
76767.7 
55144.6 
6025000 
8459 180 
7471970 
6484 180 
13073400 
16910500 
24706400 
3760560 
3955980 
9652490 
481409 
16595300 
Field Blank 
M+ ion area 
18031800 
34451600 
22143700 
11 264400 
10272100 
15454600 
57534.2 
45014.5 
13392900 
16390700 
14228900 
12690600 
1 lO49lOO 
14060300 
20569300 
87 1 I860 
9343380 
10272500 
577543 
20141700 
Concentration 
Cex (@extract) 
38.91 
59.79 
20.76 
39.70 
36.36 
56.67 
0.53 
0.5 1
46.87 
43.72 
46.39 
45.91 
72.35 
62.64 
35.39 
44.35 
47.88 
5.70 
105.82 
% Surrogate 
Recovery 
38.91 
59.79 
41.52 
39.70 
36.36 
56.67 
Peak Ratio Data Flags 
1.33 DPE, B 
1.23 ' DPE, B 
0.45 
0.52 
0.53 
0.51 
TABLE C.4 continued 
h. Sample 59-S 
Deployment 2, Retrieval 4 020101 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7.8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
1 3C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-1 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 10 
M ion area 
5897170 
55362300 
59146900 
7154490 
61368300 
3 1726700 
3874 1200 
39868300 
7 1305 100 
66877800 
45134200 
74692300 
4009 1800 
45745300 
41245700 
38921500 
32518800 
35940800 
32937800 
3069 1200 
38823800 
42088000 
42565800 
55 197900 
78025700 
68844400 
3 1682600 
289242.00 
191 10600 
16903300 
30165600 
50889800 
66655100 
93679000 
61 062400 
Matrix Spike 
M+ ion area 
7584670 
71553800 
78373700 
9433940 
83808900 
24238000 
25090000 
45563600 
43459100 
25982900 
61 370400 
3 1740500 
36171600 
32821000 
30234800 
61273300 
73659400 
65082 100 
6045 1400 
29034600 
38035000 
35622200 
46152000 
64173900 
58065900 
30695600 
27613100 
45463300 
4092 1200 
3 11 79500 
5 1789500 
78930100 
1 lO758OOO 
68792600 
Concentration 
Cex (nglextract) 
1 1.43 
67.56 
11.51 
99.43 
23.76 
56.44 
57.81 
71.99 
67.75 
51.40 
103.04 
58.55 
61.99 
64.23 
73.88 
80.76 
68.79 
74.76 
77.85 
58.62 
55.61 
60.13 
108.45 
102.61 
68.89 
70.60 
65.37 
68.79 
63.22 
88.02 
140.92 
210.09 
114.86 
% Surrogate 
Recovery 
28.56 
168.91 
28.77 
99.43 
47.52 
28.22 
28.91 
71.99 
67.75 
25.70 
103.04 
29.28 
3 1 .OO 
32.12 
36.94 
80.76 
68.79 
74.76 
77.85 
29.3 1 
27.80 
30.06 
108.45 
102.61 
34.44 
35.30 
65.37 
68.79 
31.61 
88.02 
35.23 
105.04 
28.72 
RR and RF 
0.93 
1.37 
0.99 
1.06 
2.26 
0.95 
1.02 
1.18 
1.18 
1.02 
0.96 
1.31 
1.21 
1.18 
1 .O3 
0.92 
1.26 
1.03 
0.92 
1.14 
1.01 
1.07 
0.74 
1 .O9 
1.40 
1.38 
0.78 
0.66 
0.95 
0.92 
1.01 
0.77 
1.11 
Peak Ratio Data Flags 
TABLE C.4 continued 
i. Sample 65-S 
Deployment 2, Retrieval 4 020101 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37Cl-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-I ,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 3 
M ion area 
57507000 
74942 100 
52268200 
41091900 
64830000 
6787 1900 
60358300 
322207 
25 1733 
33641400 
44503400 
373 1 6900 
362 14400 
493 18900 
76002400 
99248700 
182012 
23940500 
2 1682000 
247527 
56185300 
2241600 
88647700 
567046 
Process Blank 
M+ ion area 
70708000 
96065800 
66563900 
4061 1300 
41 799700 
3474 1200 
263997 
202060 
65789800 
86422 100 
72648500 
70520700 
39371000 
59621 100 
78737300 
174119 
53956800 
5 1239800 
215154 
54540000 
2661860 
101643000 
614177 
Concentration 
Cex (nglextract) 
54.89 
65.45 
24.29 
52.23 
54.16 
57.92 
0.45 
0.41 
61.05 
58.60 
59.80 
65.01 
67.67 
69.78 
0.33 
56.23 
61.85 
0.44 
67.68 
5.10 
139.44 
1.12 
% Surrogate 
Recovery 
54.89 
65.45 
49.58 
52.23 
54.16 
57.92 
61.05 
58.60 
59.80 
65.01 
67.67 
69.78 
56.23 
61.85 
67.68 
69.72 
RR and RF 
0.93 
1.37 
0.99 
1.06 
2.26 
0.95 
1.02 
1.18 
1.18 
1.02 
0.96 
1.31 
1.21 
1.18 
1 .O3 
0.92 
1.26 
1 .O3 
0.92 
1.14 
1.01 
1.07 
0.74 
1 .O9 
1.40 
1.38 
0.78 
0.66 
0.95 
0.92 
1.01 
0.77 
1.11 
Peak Ratio Data Flags 
1.22 DPE, B 
1.25 - DPE, B 
0.5 1 
0.5 1 
0.51 
0.51 
1.25 
1.27 
1.26 
1.05 DPE, B 
0.44 
0.42 
1.15 B 
1.03 
0.84 B 
0.87 
0.92 DPE, B 

TABLE C.5 continued 
b. Sample 67-S 
Deployment 3 010210 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
lS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 12 
M ion area 
19490000 
2 1289900 
I4929500 
13620800 
18225900 
20666 100 
16401300 
265 18.6 
46446.4 
8987700 
99 18220 
8905980 
8035130 
11035700 
14065500 
18886200 
5135350 
4202930 
8453440 
4916870 
Dialysis Blank 
M+ ion area 
25009400 
27448500 
19934000 
1 1636000 
12548600 
10159000 
21705.4 
38539.3 
17492100 
19452600 
16983600 
15 168500 
8740060 
1 l67lOOO 
15042900 
1 1831500 
9352120 
79254 10 
5593280 
Concentration 
Cex (nglextract) 
69.01 
66.39 
27.97 
54.02 
59.21 
56.68 
0.15 
0.31 
71.47 
73.26 
69.49 
69.86 
65.50 
75.94 
59.59 
49.75 
51.34 
44.99 
% Surrogate 
Recovery 
69.01 
66.39 
55.93 
54.02 
59.21 
56.68 
[SPMD1 RR and RF 
(ng/kg) 
Peak Ratio Data Flags 
1.61 
1.22 DPE, B 
DPE 
DPE 
1.21 - -  DPE, B 
0.51 
0.51 
0.52 
0.53 
TABLE C.5 continued 
c. Sample 73-S 
Deployment 3 010210 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C- 1 ,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C- 1.2,3,7,8,9-HxCDF 
1 ,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7&HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 5 
M ion area 
9 1927700 
102955000 
69389500 
58885000 
9023 1200 
102572000 
75628 100 
126797 
114504 
1801 19 
89936.8 
43210700 
49927500 
42 1 16900 
36222 100 
49079000 
70873200 
8644 1400 
103128 
28366700 
2369 1600 
151255 
52387000 
739138 
8075 1700 
Process Blank 
M+ ion area 
1 IS867000 
1 34OO2OOO 
90758300 
56 1 19000 
62 167300 
43762700 
97722.1 
105664 
137978 
81 123.5 
83 122900 
9443 1900 
80225800 
69734200 
400 16200 
57121400 
70583800 
9644 1 
64882400 
54 196200 
150880 
49223400 
860663 
90382700 
Concentration 
Cex (@extract) 
66.28 
62.72 
25.00 
54.46 
60.40 
52.40 
0.14 
0.13 
0.23 
0.14 
73.68 
77.8 1 
70.96 
68.93 
63.76 
81.60 
0.18 
70.76 
61.77 
0.32 
68.81 
1.90 
158.28 
% Surrogate 
Recovery 
66.28 
62.72 
50.00 
54.46 
60.40 
52.40 
RR and RF 
0.86 
1.32 
0.97 
1 .08 
2.29 
0.91 
0.99 
1.13 
1.15 
0.93 
0.96 
1.25 
1.19 
1.13 
1.19 
1 .O9 
1.18 
1.10 
0.98 
1.12 
0.99 
1.05 
0.89 
1 .oo 
1.40 
1.40 
0.84 
0.80 
0.92 
0.94 
0.98 
0.69 
1.30 
Peak Ratio Data Flags 
DPE 
0.79 
0.77 
0.76 
1.73 
1.30 DPE, B 
1 .08 DPE, B 
1.31 DPE, B 
1.11 - - DPE,B 
0.52 
0.53 
0.52 
0.52 
1.07 DPE, B 
0.44 
0.44 
1 .oo B 
1 .O6 
0.86 B 
0.89 
TABLE C.5 continued 
d. Sample 74-S 
Deployment 3 01021 1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3.7,8-PeCDD 
13C- 1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-H~CDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C- 1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 6 
M ion area 
149069 
15 1376000 
138616000 
I12687000 
84946800 
157641 000 
15 1254000 
1 l47OlOOO 
157810 
122343 
230299 
163288 
70285200 
73306800 
71 686300 
70675800 
127057 
99584600 
110307000 
l5O357OOO 
551 12800 
49471300 
110180000 
376458 
124987000 
1 14428 
Field Blank 
M+ ion area 
179058 
189847000 
I75649000 
l464O3OOO 
90185200 
86972500 
77553600 
136735 
109580 
186743 
131258 
136485000 
139575000 
138622000 
134920000 
11  1925 
78 196900 
8403 1 100 
1 15766000 
122950000 
113215000 
106 lO6OOO 
393190 
140584000 
150596 
Site 12: Fairfield. ME 
Concentration 
Cex (ndextract) 
0.11 
75.44 
76.73 
26.46 
66.11 
55.11 
55.18 
0.11 
0.09 
0.17 
0.11 
70.40 
67.88 
72.22 
81.01 
0.13 
74.21 
69.62 
77.57 
83. I8 
90.02 
0.57 
152.53 
0.15 
% Surrogate 
Recovery 
75.44 
76.73 
52.92 
66.11 
55.11 
55.18 
RR and RF 
0.89 
1.44 
0.98 
1.07 
2.32 
0.97 
1 .O4 
1.19 
1.38 
0.95 
1.11 
1.27 
1.27 
1.16 
1.28 
1.10 
1.18 
1 .O9 
0.95 
1.08 
0.96 
1.01 
0.90 
1 .O5 
1.48 
1.44 
0.86 
0.73 
0.94 
0.90 
1.01 
0.65 
1.35 
Peak Ratio Data Flags 
0.83 DPE, B 
0.80 
0.79 
0.77 
1.48 
1.15 DPE, B 
1.12 DPE, B 
1.23 DPE, B 
1.24 ' DPE, B 
0.5 1 
0.53 
0.52 
0.52 
0.45 
0.44 
1.04 
0.96 B 
0.89 
0.76 DPE, B 
TABLE C.5 continued 
e. Sample 7 5 4  
Deployment 3 010211 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS- 13C- 1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 12 
M ion area 
12138100 
54442100 
4 1 146900 
9367290 
37929700 
26929500 
66565200 
69498400 
57944800 
5653 1800 
49755 100 
40424200 
71326500 
77187300 
72493400 
7 1022700 
28340 100 
29459400 
28678700 
27787600 
48090200 
495 17600 
54 178600 
37988700 
42545600 
5 lO2O8OO 
67577400 
598 15200 
22622700 
2047 1800 
50889400 
45393 100 
75522100 
63742700 
84339600 
Matrix Spike 
M+ ion area 
14888700 
65632800 
5 1893600 
12096700 
47965700 
40203900 
41555700 
32482300 
32664200 
29323800 
24265300 
550 18200 
59503600 
567 17200 
53782400 
55989200 
57515200 
56546 100 
54480000 
3770 1 100 
39034500 
43089500 
2820 1700 
32642600 
38220500 
62515900 
55796000 
50687300 
46844400 
494 14000 
42222200 
87366200 
70684400 
92233900 
Concentration 
Cex (nglextract) 
25.37 
89.67 
25.60 
85.92 
28.26 
122.02 
120.18 
8 1.48 
69.70 
129.15 
62.71 
118.06 
123.31 
130.28 
118.59 
85.62 
82.71 
87.28 
96.67 
120.00 
122.72 
135.81 
82.39 
80.33 
120.17 
1 19.40 
95.23 
102.63 
121.73 
108.75 
238.96 
230.24 
194.79 
% Surrogate 
Recovery 
63.43 
89.67 
64.01 
85.92 
56.51 
61.01 
60.09 
81.48 
69.70 
64.58 
62.71 
59.03 
61.66 
65.14 
59.30 
85.62 
82.71 
87.28 
96.67 
60.00 
61.36 
67.90 
82.39 
80.33 
60.08 
59.70 
95.23 
102.63 
60.87 
108.75 
59.74 
115.12 
48.70 
RR and RF 
0.89 
1.44 
0.98 
1.07 
2.32 
0.97 
1 .O4 
1.19 
1.38 
0.95 
1.11 
1.27 
1.27 
1.16 
1.28 
1.10 
1.18 
1.09 
0.95 
1 .O8 
0.96 
1.01 
0.90 
1 .O5 
1.48 
1.44 
0.86 
0.73 
0.94 
0.90 
1.01 
0.65 
1.35 
Peak Ratio Data Flags 
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TABLE C.6. SPMD Raw Data Calculation 
a. Sample 82-S 
Deployment 4 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C- 1 ,2,3,4,7,8-HxCDF 
13C-1 ,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C- 1 ,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010222 Run 
Retention Time 
ND 
36.47 
38.11 
ND 
38.56 
38.58 
ND 
ND 
51.26 
54.36 
ND 
*55.41&55.56 
ND 
ND 
ND 
ND 
60.42 
60.50 
61.49 
62.44 
ND 
ND 
ND 
62.05 
SAMPLE 3 
M ion area 
l38O98OOO 
98395800 
1 O8947OOO 
97886900 
200420000 
159820000 
136085000 
72136100 
59292900 
58779000 
53427100 
91363900 
91599300 
89622000 
29326600 
22348500 
60590000 
80 140200 
Spreadsheets for Deployment Four Quality Control Samples 
Field Blank 
M+ ion area 
174459000 
125065000 
142945000 
124758000 
99335 100 
89945500 
132275000 
125859000 
1 17 164000 
105424000 
64055700 
80285000 
71412500 
67432400 
5 1577500 
57623700 
9008 1800 
Concentration 
Cex (ngtextract) 
97.77 
110.36 
41.25 
125.89 
97.88 
124.47 
123.72 
90.36 
98.68 
101.46 
141.23 
89.57 
76.02 
8 1.46 
106.86 
178.47 
% Surrogate ISPMD1 RR and RF Peak Ratio Data Flags Recovery (ngflcg) 
TABLE C.6 continued 
b. Sample 88-S 
Deployment 4 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37Cl-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9NxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010228-1- Run 
Retention Time 
ND 
36.33 
37.54 
ND 
38.42 
38.44 
ND 
ND 
51.22 
54.33 
ND 
*55.39&55.45 
ND 
ND 
ND 
ND 
60.43 
60.52 
61.51 
62.46 
ND 
ND 
ND 
? 
62.12 
SAMPLE 2 
M ion area 
238442000 
166285000 
I78O94OOO 
157899000 
291 976000 
3 14687000 
233472000 
907 12800 
168388000 
108459000 
1 l38lOOOO 
139499000 
208650000 
171427000 
691 04400 
52245700 
11 lO7lOOO 
779391 
57598200 
Process Blank 
M+ ion area 
300252000 
206479000 
224182000 
l775O5OOO 
194137000 
161747000 
178549000 
322362000 
212119000 
21 9846000 
105760000 
162634000 
132647000 
154934000 
120862000 
105462000 
896209 
62487200 
Concentration 
Cex (@extract) 
96.77 
105.68 
42.53 
107.53 
92.14 
89.07 
97.57 
101.92 
92.18 
114.30 
131.79 
97.94 
98.47 
98.09 
99.93 
2.53 
74.15 
% Surrogate 
Recovery 
96.77 
105.68 
85.06 
107.53 
92.14 
89.07 
RR and RF 
(nwkg) 
Peak Ratio 
0.79 
0.81 
0.79 
1.64 
1.62 
1.44 
0.5 1 
0.52 
0.51 
0.52 
1.32 
1.28 
1 .29 
0.45 
0.43 
1.05 
0.87 
0.92 
Data Flags 
C 
B 

TABLE C.6 continued 
d. Sample 95-S 
Deployment 4 010327-1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-1 3C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1 ,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1 ,2,3,7,8,9-HxCDF 
1 ,2,3,4,7,8-HxCDD 
1 ,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 3 
M ion area 
I33794000 
102871000 
100086000 
95833900 
188679000 
194239000 
154580000 
89563500 
1 lO617OOO 
969 10200 
86769000 
98496300 
l6O327OOO 
133080000 
67381500 
58099200 
115621000 
182430000 
Process Blank 
M+ ion area 
168197000 
130192000 
1261 10000 
123714000 
124675000 
157468000 
171341000 
205806000 
18489 1000 
161731000 
79173800 
127034000 
lO7284OOO 
1464 18000 
13 lO98OOO 
1 1 0546000 
205418000 
Concentration 
Cex (nglextract) 
53.22 
44.46 
38.65 
41.13 
40.81 
46.92 
113.43 
107.99 
110.56 
109.72 
103.72 
1 1  1.94 
96.30 
89.95 
89.03 
178.83 
% Surrogate 
Recovery 
53.22 
44.46 
77.30 
41.13 
40.8 1 
46.92 
113.43 
107.99 
110.56 
109.72 
103.72 
11 1.94 
96.30 
89.95 
89.03 
89.42 
[SPMD1 RR and RF 
(nglkg) 
Peak Ratio Data Flags 
TABLE C.6 continued 
e. Sample 96-S 
Deployment 4 010327-1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8HxCDD 
1,2,3,6,7,8NxCDD 
1,2,3,7,8,9HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-l,2,3,7,8,9-H~CDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8NpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 5 
M ion area 
99999400 
69467900 
67808300 
66373400 
1 15222000 
106549000 
70096600 
35569900 
3082 1900 
55734800 
44300400 
68435500 
76886700 
60650600 
28387700 
23544700 
56380800 
61285900 
Field Blank 
M+ ion area 
123355000 
88077500 
88152800 
74582200 
69064500 
71438000 
67313500 
57668300 
1 O43OOOOO 
82682200 
56862200 
6 1947400 
498 1 1400 
60952700 
5 1224700 
53137700 
68380200 
Concentration % Surrogate 
Cex (nglextract) Recovery [SPMD1 RR and RF (W/%) 
Peak Ratio Data Flags 
TABLE C.6 continued 
f. Sample 102-S 
Deployment 4 010327-1 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-1 3C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1 ,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
13C-1 ,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1 ,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8HxCDD 
IS-1 3C-1 ,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 4 
M ion area 
15 I728000 
126 152000 
1 l317lOOO 
97385000 
230476000 
243371000 
187116000 
1 l7OO3OOO 
1 l9l33OOO 
1 I8252000 
103428000 
l3834OOOO 
li'O648OOO 
I47429000 
81 11 1700 
67667900 
142398000 
541371 
1 18953000 
Process Blank 
M+ ion area 
192375000 
156262000 
149898000 
l5O482OOO 
I59734000 
193653000 
2286 19000 
222716000 
223774000 
195797000 
1 lO9l6OOO 
136131000 
1 18373000 
179462000 
150357000 
l3845OOOO 
649088 
1345 10000 
Concentration 
Cex (nglextract) 
50.04 
42.67 
32.03 
41.39 
42.57 
47.25 
135.89 
105.50 
121.35 
119.48 
131.58 
108.06 
106.14 
93.74 
99.98 
0.88 
105.68 
% Surrogate 
Recovery 
50.04 
42.67 
64.05 
41.39 
42.57 
47.25 
135.89 
105.50 
121.35 
1 19.48 
131.58 
108.06 
106.14 
93.74 
99.98 
52.84 
rSP*l RR and RF (WW Peak Ratio 
0.79 
0.81 
0.75 
1.53 
1.52 
0.97 
0.5 1
0.53 
0.53 
0.53 
1 .25 
1.25 
1.25 
0.45 
0.45 
1 .O3 
0.83 
0.88 
Data Flags 
C 
B 
TABLE C.6 continued 
g. Sample 103-S 
Deployment 4 010401 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1 ,2,3,7,8,9-HxCDF 
13C-1 ,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
1 3C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1 ,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1 ,2,3,4,7,8-HxCDD 
13C-1 ,2,3,6,7,8-HxCDD 
IS-I 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
I3C-OCDD 
OCDF 
SAMPLE 5 
M ion area 
137916000 
664543000 
528692000 
1 19946000 
504923000 
488747000 
7842 16000 
6 l5797OOO 
753 105000 
553453000 
380701000 
377577000 
283539000 
17885 1000 
21 3207000 
145624000 
129703000 
81831600 
101 245000 
66437600 
15 I569000 
127984000 
144855000 
129474000 
125 166000 
139759000 
73927200 
237076000 
25707300 
9 1747000 
185422000 
177101000 
322996000 
299155000 
409755000 
Matrix Spike 
M+ ion area 
177351000 
826287000 
684345000 
150140000 
665493000 
494479000 
389891000 
466247000 
342729000 
2794 17000 
285264000 
221552000 
137963000 
l6795OOOO 
1 12694000 
244260000 
151443000 
188994000 
I23442000 
I22475000 
102940000 
115974000 
104991 000 
100324000 
1 l6O23OOO 
71416000 
224123000 
60444400 
201380000 
181735000 
171583000 
374750000 
349443000 
45 l595OOO 
2 SPMDs 
Concentration 
Cex (nglextract) 
22.72 
87.93 
22.03 
93.85 
39.29 
111.60 
111.73 
67.67 
50.93 
106.60 
48.07 
106.23 
109.05 
111.76 
104.00 
71.93 
48.3 1 
70.12 
82.46 
103.61 
108.19 
1 13.59 
76.84 
75.01 
1 19.72 
113.81 
81.74 
62.35 
114.13 
57.84 
222.92 
98.11 
250.71 
% Surrogate 
Recovery 
56.80 
87.93 
55.09 
93.85 
78.58 
55.80 
55.87 
67.67 
50.93 
53.30 
48.07 
53.12 
54.52 
55.88 
52.00 
71.93 
48.31 
70.12 
82.46 
51.80 
54.09 
56.79 
76.84 
75.01 
59.86 
56.91 
81.74 
62.35 
57.07 
57.84 
55.73 
49.06 
62.68 
RR and RF 
0.93 
1.40 
1.05 
1 .O3 
2.35 
0.94 
1.00 
1.49 
1.45 
0.93 
1.14 
1.27 
1.25 
1.18 
1.31 
2.03 
1.89 
1.62 
0.90 
1.13 
0.95 
1 .oo 
1.19 
1.18 
1.41 
1.38 
0.41 
1.84 
0.92 
2.36 
0.97 
2.58 
1.06 
Peak Ratio Data Flags 
TABLE C.6 continued 
h. Sample 109-S 
Deployment 4 
Congener 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
1 3C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1.2.3.6.7.8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
010331 Run 
Retention Time 
ND 
41.14 
43.07 
ND 
43.51 
43.54 
ND 
ND 
55.46 
57.37 
ND 
58.28--cope& 
ND 
62.46 
ND 
ND 
62.36 
62.45 
63.34 
64.28 
ND 
ND 
ND 
63.49 
63.57 
SAMPLE 3 
M ion area 
6486 1800 
54140800 
5 1022900 
40352200 
100346000 
107675000 
98756400 
93296.1 
73 164500 
75839200 
73 128900 
66061900 
97680800 
107834000 
1 O69%OOO 
39887100 
34098500 
78023300 
531501 
1 I9536000 
Process Blank 
M+ ion area 
80460000 
67444500 
65367000 
61272700 
65743900 
671 59700 
76880 
138382000 
I42298000 
137359000 
I25625000 
78897100 
86227200 
871 59700 
891 17400 
78053300 
72623400 
629460 
138533000 
Concentration % Surrogate 
Cex (nglextract) Recovery Peak Ratio Data Flags 
1.47 
DPE 
1.21 DPE, B 
DPE 
- . DPE 
0.53 
0.53 
0.53 
0.53 
TABLE C.7. SPMD Raw Data Calculation Spreadsheets for Method Detection Limit Study Two Samples 
a. Sample 110-S 
MDL Study Sample 010328 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8PeCDD 
1,2,3,4,7,8HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8NpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 3 
M ion area 
135921 
188 17400 
16052400 
24890 1 
171 74600 
13634300 
1428470 
1509160 
22758600 
14599200 
1527480 
18857000 
761795 
1661970 
1317650 
1 162620 
7725070 
12044500 
9248350 
8395720 
1032530 
1220810 
1467630 
7779030 
18621500 
16852700 
1202530 
1 120630 
6811340 
5972490 
1551 110 
12719900 
1630710 
2 1529800 
1680280 
M+ ion area 
193573 
23020300 
19694000 
292391 
20146100 
1009800 
1032580 
21758100 
143 13700 
1343190 
20784600 
651189 
1282160 
948758 
907244 
12973500 
25 177400 
17449500 
15638100 
716328 
1069550 
1240 170 
670 1540 
15 179000 
14506300 
860355 
942281 
14874400 
13 140600 
1672720 
1349 1200 
1263700 
24 163700 
1694220 
Concentration 
Cex (nglextract) 
0.85 
83.48 
1.70 
92.47 
37.04 
5.83 
8.95 
89.98 
59.09 
7.61 
96.45 
5.42 
6.60 
7.58 
9.83 
108.12 
87.68 
88.30 
89.13 
12.55 
6.50 
10.94 
78.10 
94.71 
6.57 
7.74 
83.71 
82.21 
13.37 
84.27 
1 1.67 
160.43 
14.72 
% Surrogate 
Recovery 
83.48 
92.47 
74.09 
89.98 
59.09 
96.45 
108.12 
87.68 
88.30 
89.13 
78.10 
94.71 
83.71 
82.21 
84.27 
80.22 
RR and RF 
0.93 
1.40 
0.86 
1.13 
2.29 
0.94 
0.98 
1.38 
1.37 
0.95 
1.15 
1.26 
1.20 
1.12 
0.88 
0.61 
1.35 
0.96 
0.86 
0.96 
1.04 
1 .O3 
0.59 
1.14 
1.45 
1.39 
0.83 
0.74 
0.92 
0.99 
1 .O9 
0.91 
1 .oo 
Peak Ratio Data Flags 
TABLE C.7 continued 
b. Sample 111-S 
MDL Study Sample 010328 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-l3C-l,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1 ,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
lS-l3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8NpCDF 
1,2,3,4,7,8,9-HpCDF 
13C- I ,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C- 1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 4 
M ion area 
77192.8 
4938870 
4526080 
33591.9 
4129170 
2835250 
283922 
291651 
5437530 
4872400 
102788 
2740040 
132268 
348217 
22 1002 
140780 
1108750 
3326410 
2008250 
1550750 
302769 
283346 
172167 
1783250 
3310450 
3748310 
186432 
207852 
1283540 
1136140 
545 198 
2396320 
723594 
3253260 
311068 
M+ ion area 
99342.6 
6010430 
5447380 
36290.6 
4808610 
207790 
214351 
3622900 
3048200 
78524.5 
1995620 
101 155 
266181 
174700 
1 12220 
2378440 
5706160 
3783460 
3102370 
245546 
255063 
159519 
1509910 
3216860 
2914250 
16793 1 
181064 
2703690 
23 17690 
467167 
2124470 
841620 
3309220 
328622 
Concentration 
Cex (nglextract) 
1.73 
78.31 
0.91 
79.37 
27.32 
5.77 
6.5 1 
65.64 
58.02 
4.02 
41.30 
5.32 
5.68 
6.10 
6.21 
85.73 
100.14 
90.16 
81.22 
17.30 
7.91 
6.59 
83.60 
86.08 
6.14 
8.08 
72.44 
69.92 
24.34 
68.41 
43.94 
108.45 
19.43 
% Surrogate 
Recovery 
78.3 1 
79.37 
54.64 
65.64 
58.02 
41.30 
RR and RF 
0.93 
1.40 
0.86 
1.13 
2.29 
0.94 
0.98 
1.38 
1.37 
0.95 
1.15 
1.26 
1.20 
1.12 
0.88 
0.61 
1.35 
0.96 
0.86 
0.96 
1.04 
1.03 
0.59 
1.14 
1.45 
1.39 
0.83 
0.74 
0.92 
0.99 
1.09 
0.91 
1.00 
Peak Ratio Data Flags 
TABLE C.7 continued 
c. Sample 1124 
MDL Study Sample 010328 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-I ,2,3,7,8,9-HxCDD 
1,2,3,4,6.7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 5 
M ion area 
896026 
61087800 
47037400 
752470 
52324400 
42070200 
4627 120 
4233090 
78085500 
761 13500 
3084840 
67829500 
2927040 
6022480 
4221550 
3908390 
23385400 
55724900 
36962400 
33 175200 
2445380 
4376780 
4520560 
33767100 
75494200 
65288700 
4481120 
3732130 
27137800 
23371200 
3345820 
56953900 
60 16600 
83760500 
5362290 
M+ ion area 
ll5O5lO 
78862200 
61636700 
848588 
69710800 
28853 10 
3094070 
50084000 
48748500 
2367770 
48 18 1400 
22407 10 
52632 10 
331 1770 
2985700 
38994200 
1 13468000 
69895800 
64155400 
1637060 
3558870 
3580610 
25983700 
61 8 17700 
54270000 
3985550 
3270630 
6 1264400 
49773600 
3308750 
54734900 
6299090 
94259200 
5743770 
Concentration 
Cex (nglextract) 
1.57 
91.86 
1.53 
99.46 
39.01 
6.24 
5.98 
85.22 
83.94 
4.94 
92.85 
6.58 
5.57 
6.29 
8.09 
85.46 
104.53 
92.70 
94.67 
7.10 
5.54 
8.02 
84.52 
100.92 
6.62 
6.87 
89.50 
82.52 
6.48 
94.19 
12.75 
163.94 
12.44 
% Surrogate 
Recovery 
91.86 
99.46 
78.02 
85.22 
83.94 
92.85 
85.46 
104.53 
92.70 
94.67 
84.52 
100.92 
89.50 
82.52 
94.19 
8 1.97 
RR and RF 
0.93 
1.40 
0.86 
1.13 
2.29 
0.94 
0.98 
1.38 
1.37 
0.95 
1.15 
1.26 
1.20 
1.12 
0.88 
0.61 
1.35 
0.96 
0.86 
0.96 
1.04 
1.03 
0.59 
1.14 
1.45 
1.39 
0.83 
0.74 
0.92 
0.99 
1.09 
0.91 
1 .oo 
Peak Ratio Data Flags 
TABLE C.7 continued 
d. Sample 113-S 
MDL Study Sample 010328 Run 
Congener Retention Time 
2,3,7,8-TCDF 40.09 
13C-2,3,7,8-TCDF 40.14 
IS-13C-1,2,3,4-TCDD 4 1.40 
2,3,7,8-TCDD 42.43 
13C-2,3,7,8-TCDD 42.40 
37C1-TCDD 42.41 
1,2,3,7,8-PeCDF 55.09 
2,3,4,7,8-PeCDF 57.10 
13C-1,2,3,7,8-PeCDF 55.05 
13C-2,3,4,7,8-PeCDF 57.08 
1,2,3,7,8-PeCDD 58.02 
13C-1,2,3,7,8PeCDD 58.02 
1 ,2,3,4,7,8-HxCDF 62.17 
1,2,3,6,7,8-HxCDF 62.23 
2,3,4,6,7,8-HxCDF 63.11 
1,2,3,7,8,9-HxCDF 64.10 
13C-1 ,2,3,4,7,8-HxCDF 62.18 
13C-1 ,2,3,6,7,8-HxCDF 62.23 
13C-2,3,4,6,7,8-HxCDF 63.14 
13C-1,2,3,7,8,9-HxCDF 64.09 
1,2,3,4,7,8-HxCDD 63.29 
1,2,3,6,7,8-HxCDD 63.35 
1,2,3,7,8,9-HxCDD 63.59 
13C-1 ,2,3,4,7,8-HxCDD ? 
13C-1 ,2,3,6,7,8-HxCDD 63.33 
IS-13C-1,2,3,7,8,9-HxCDD 63.58 
1,2,3,4,6,7,8-HpCDF 66.16 
1,2,3,4,7,8,9-HpCDF 67.46 
13C-1,2,3,4,6,7,8-HpCDF 66.14 
13C-1,2,3,4,7,8,9-HpCDF 67.48 
1,2,3,4,6,7,8-HpCDD 67.23 
13C-1,2,3,4,6,7,8-HpCDD 67.25 
OCDD 70.46 
13C-OCDD 70.48 
OCDF 70.52 
SAMPLE 6 
M ion area 
19451.7 
543573 
839537 
35458.3 
800732 
906049 
60896.9 
4973 1.5 
568914 
548076 
85419.7 
266736 
46526.1 
6083 1.7 
72235.8 
78102.8 
345800 
424595 
293988 
331417 
132897 
12406 1 
229846 
171406 
843277 
561020 
77097.4 
95291.5 
24343 1 
264756 
2883 15 
474407 
24 1 034 
68545 1 
189643 
M+ ion area 
27945.1 
666 182 
1007780 
39868.9 
954039 
45489.1 
30595.4 
404099 
331815 
61853.7 
195747 
34806.8 
46865.4 
61458.5 
63014 
597225 
845823 
639023 
581256 
90219.7 
90825 
167089 
156693 
690770 
492676 
67596.6 
84858.7 
526696 
434307 
257281 
477063 
240538 
604500 
189777 
Concentration 
Cex (nglextract) 
4.21 
46.71 
% Surrogate 
Recovery 
46.71 
84.13 
94.14 
38.06 
34.80 
21.77 
146.60 
89.06 
91.84 
100.73 
52.66 
127.93 
88.47 
89.48 
91.04 
67.39 
RR and RF 
0.93 
1.40 
0.86 
1.13 
2.29 
0.94 
0.98 
1.38 
1.37 
0.95 
1.15 
1.26 
1.20 
1.12 
0.88 
0.61 
1.35 
0.96 
0.86 
0.96 
1.04 
1 .O3 
0.59 
1.14 
1.45 
1.39 
0.83 
0.74 
0.92 
0.99 
1 .O9 
0.91 
1 .oo 
Peak Ratio 
0.70 
0.82 
0.83 
0.89 
0.84 
1.34 
1.63 
1.41 
1.65 
1.38 
1.36 
1.34 
1.30 
1.18 
1.24 " 
0.58 
0.50 
0.46 
0.57 
1.47 
1.37 
1.38 
1.09 
1.22 
1.14 
1.14 
1.12 
0.46 
0.61 
1.12 
0.99 
1 .oo 
1.13 
1.00 
Data Flags 
C 
C 
C 
s ,  c 
S 
TABLE C.7 continued 
e. Sample 114-S 
MDL Study Sample 0 10328 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37CI-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 7 
M ion area 
41025.7 
3415520 
3344180 
60853.1 
2380890 
2151050 
157887 
225361 
2728330 
27 18250 
297961 
1557750 
121737 
348819 
249956 
169714 
55 1727 
1681520 
9 14656 
783914 
165567 
26 1394 
181701 
661 120 
1846810 
1678290 
137935 
84804.9 
304039 
399 124 
280042 
936273 
212232 
1304820 
173604 
M+ ion area 
50833.1 
4075500 
3960700 
66536.5 
2863080 
95575.1 
169068 
1856520 
1658620 
228734 
1295390 
99124.7 
258056 
187088 
148124 
966586 
3033600 
1760690 
1449250 
107179 
223125 
159844 
50844 1 
1614800 
1316020 
113522 
74062.5 
708502 
779869 
246 102 
943426 
21 1741 
1518240 
168535 
Concentration 
Cex (nglextract) 
1.32 
73.14 
2.84 
63.58 
28.05 
5.88 
9. I8 
45.35 
43.78 
19.39 
33.97 
11.56 
10.74 
14.58 
16.25 
83.06 
116.32 
92.67 
86.73 
24.23 
13.42 
14.39 
66.06 
101.58 
17.15 
9.67 
40.93 
53.11 
30.43 
63.29 
27.67 
103.81 
24.16 
% Surrogate 
Recovery 
73.14 
63.58 
56.11 
45.35 
43.78 
33.97 
83.06 
116.32 
92.67 
86.73 
66.06 
101.58 
40.93 
53.11 
63.29 
51.90 
RR and RF 
0.93 
1.40 
0.86 
1.13 
2.29 
0.94 
0.98 
1.38 
1.37 
0.95 
1.15 
1.26 
1.20 
1.12 
0.88 
0.61 
1.35 
0.96 
0.86 
0.96 
1 .O4 
1 .O3 
0.59 
1.14 
1.45 
1.39 
0.83 
0.74 
0.92 
0.99 
1.09 
0.91 
1 .oo 
Peak Ratio Data Flags 
TABLE C.7 continued 
f. Sample 115-S 
MDL Study Sample 010328 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C- 1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1 ,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8-HxCDD 
1,2,3,6,7,8-HxCDD 
1 ,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-13C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 8 
M ion area 
1985000 
1 13247000 
72502000 
1485100 
74959300 
41 080200 
14486600 
18434700 
143542000 
160825000 
15092400 
134161000 
13520800 
33086300 
22135400 
22036500 
59694300 
140591 000 
96385500 
89410100 
88541 50 
25569000 
19626900 
77293200 
197734000 
176922000 
20819100 
18718300 
7020 1400 
6 1982400 
I5200400 
141685000 
28795500 
249009000 
32203700 
M+ ion area 
2706670 
143095000 
91381300 
1813000 
9875 1200 
9249380 
12239100 
92345900 
101591000 
14868700 
1724 12000 
10786500 
26641600 
17579900 
17582300 
1 I7564000 
270342000 
I842 19000 
171 508000 
6359050 
20994500 
16013200 
61111200 
157208000 
I44873000 
19455300 
174 14400 
156466000 
l3487SOOO 
15075500 
135337000 
33762000 
280921 000 
36437700 
Concentration 
Cex (nglextract) 
1.96 
1 1  1.57 
2.22 
93.88 
24.71 
10.70 
11.90 
104.00 
116.99 
10.27 
162.70 
10.89 
12.13 
12.64 
17.33 
90.23 
94.33 
90.44 
94.29 
1 1.42 
12.58 
14.09 
72.74 
96.92 
12.27 
13.17 
85.26 
82.51 
11.88 
86.79 
21.75 
181.32 
25.82 
% Surrogate 
Recovery 
111.57 
93.88 
49.42 
104.00 
116.99 
162.70 
90.23 
94.33 
90.44 
94.29 
72.74 
96.92 
85.26 
82.51 
86.79 
90.66 
RR and RF 
0.93 
1.40 
0.86 
1.13 
2.29 
0.94 
0.98 
1.38 
1.37 
0.95 
1.15 
1.26 
1.20 
1.12 
0.88 
0.61 
1.35 
0.96 
0.86 
0.96 
1.04 
1 .O3 
0.59 
1.14 
1.45 
1.39 
0.83 
0.74 
0.92 
0.99 
1 .O9 
0.91 
1 .oo 
Peak Ratio Data Flags 
TABLE C.7 continued 
g. Sample 116-S 
MDL Study Sample 010328 Run 
Congener Retention Time 
2,3,7,8-TCDF 
13C-2,3,7,8-TCDF 
IS-13C-1,2,3,4-TCDD 
2,3,7,8-TCDD 
13C-2,3,7,8-TCDD 
37C1-TCDD 
1,2,3,7,8-PeCDF 
2,3,4,7,8-PeCDF 
13C-1,2,3,7,8-PeCDF 
13C-2,3,4,7,8-PeCDF 
1,2,3,7,8-PeCDD 
13C-1,2,3,7,8-PeCDD 
1,2,3,4,7,8-HxCDF 
1,2,3,6,7,8-HxCDF 
2,3,4,6,7,8-HxCDF 
1,2,3,7,8,9-HxCDF 
13C-1,2,3,4,7,8-HxCDF 
13C-1,2,3,6,7,8-HxCDF 
13C-2,3,4,6,7,8-HxCDF 
13C-1,2,3,7,8,9-HxCDF 
1,2,3,4,7,8HxCDD 
1,2,3,6,7,8HxCDD 
1,2,3,7,8,9-HxCDD 
13C-1,2,3,4,7,8-HxCDD 
13C-1,2,3,6,7,8-HxCDD 
IS-1 3C-1,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDF 
1,2,3,4,7,8,9-HpCDF 
13C-1,2,3,4,6,7,8-HpCDF 
13C-1,2,3,4,7,8,9-HpCDF 
1,2,3,4,6,7,8-HpCDD 
13C-1,2,3,4,6,7,8-HpCDD 
OCDD 
13C-OCDD 
OCDF 
SAMPLE 9 
M ion area 
55915.8 
10473400 
8837760 
19684.4 
8995600 
7380260 
713667 
699689 
11217500 
lo398900 
290947 
5282310 
368139 
811393 
561948 
488285 
2580710 
6620790 
4406830 
3639780 
383191 
517591 
445336 
3285240 
8841320 
7074990 
498548 
339739 
2727180 
2052220 
451672 
5430710 
846457 
7139880 
506970 
M+ ion area 
67226.5 
12981300 
10241400 
22948.8 
1 1605400 
427494 
490753 
7565800 
6423410 
272007 
4025780 
249322 
697350 
406642 
415829 
4413190 
12973800 
825 1920 
6779750 
297822 
387222 
354093 
2596650 
7 I90490 
5571830 
438440 
283425 
5742410 
4610690 
417724 
4984290 
95 1299 
7935 190 
520239 
Concentration 
Cex (nglextract) 
0.56 
87.69 
0.24 
95.63 
36.42 
6.46 
7.21 
71.13 
64.42 
6.35 
42.43 
7.01 
6.43 
6.83 
9.90 
90.59 
114.45 
103.81 
95.81 
12.03 
5.41 
7.12 
78.66 
11  1.39 
7.64 
6.71 
81.07 
71.06 
9.07 
83.03 
21.97 
131.24 
13.58 
% Surrogate 
Recovery 
87.69 
95.63 
72.84 
71.13 
64.42 
42.43 
90.59 
114.45 
103.81 
95.81 
78.66 
11 1.39 
81.07 
71.06 
83.03 
65.62 
RR and RF 
0.93 
1.40 
0.86 
1.13 
2.29 
0.94 
0.98 
1.38 
1.37 
0.95 
1.15 
1.26 
1.20 
1.12 
0.88 
0.61 
1.35 
0.96 
0.86 
0.96 
1.04 
1.03 
0.59 
1.14 
1.45 
1.39 
0.83 
0.74 
0.92 
0.99 
1.09 
0.91 
1 .oo 
Peak Ratio Data Flags 
Appendix D 
SPMD QUALITY CONTROL SAMPLE CONCENTRATIONS 
FOR THE 2000 FIELD SEASON 
Table D. 1 SPMD Quality Control Sample Concentrations for the 2000 Field 
Season 
Quality Control Identification Key: 
DB Dialysis Blank 
FB Field Blank 
MS Matrix Spike 
PB Process Blank 
Data Flag Information Key: 
B Positive peak identification for a blank 
C Co-eluting peak present 
DPE Diphenyl ether interference with the dioxin peak 
0 Carryover from HRGC 1 HRMS calibration standard 
S Percent surrogate recoveries were either above or below the established 
limits set by the EPA in method 161 3-B (Telliard 1994) 
Y Syringe contamination in the laboratory during extraction or cleanup 
TABLE D.1. SPMD Quality Control Sample Concentrations for the 2000 Field Season 
a. Dedovment One: Androscomin River at Dixfield 6/2/00 to 6/30/00 
PMD Concentrations 
1 ,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDD 
OCDD 
TEQ (<DL = 0) 
TEQTp (<DL = 0) 
NOTE: DL = Detection Limit 
2.84 
2.3 1 
6.70 
<DL 
<DL 
<DL 
0.00 
0.00 
0.03 
0.06 
0.28 
0.02 
0.00 
<DL 
<DL 
<DL 
0.00 
0.00 
<DL 
<DL 
<DL 
0.94 
0.86 
<DL 
<DL 
<DL 
0.00 
0.00 
<DL 
<DL 
<DL 
0.00 
0.00 
<DL 
<DL 
<DL 
0.00 
0.00 
<DL 
<DL 
<DL 
0.1 1 
0.00 
451.81 
234.45 
491.79 
624.65 
425.70 
<DL 
<DL 
<DL 
0.00 
0.00 
0, B 
0, B 
0, B 

TABLE D.l continued 
c. Deployment Three: Kennebec River at Norridgewock and Fairfield 8/3/00 to 9/26/00 
NOTE: DL = Detection Limit 
TABLE D.l continued 
NOTE: DL = Detection Limit 
d. Deployment Four: Androscoggin River at Rumford and Dixfield 9/19/00 to 10/17/00 
1 ,2,3,7,8,9-HxCDD 
1,2,3,4,6,7,8-HpCDD 
OCDD 
TEQ (<DL = 0) 
TEQm (<DL = 0) 
2.84 
2.3 1 
6.70 
<DL 
<DL 
<DL 
0.00 
0.00 
<DL 
<DL 
2.65 
0.00 
0.00 
<DL 
0.56 
3.60 
0.46 
0.26 
<DL 
<DL 
<DL 
0.00 
0.00 
<DL 
<DL 
<DL 
0.00 
0.00 
<DL 
<DL 
0.92 
0.00 
0.00 
1 18.84 
119.41 
233.23 
284.07 
20 1.25 
<DL 
<DL 
0.79 
0.01 
0.00 
B 
B 
Appendix E 
SPMD SAMPLE PERCENT SURROGATE RECOVERIES 
FOR THE 2000 FIELD SEASON 
Table E. 1 Percent Surrogate Recoveries for the 2000 Field Season Deployed 
SPMD Samples 
Table E.2 Percent Surrogate Recoveries for the 2000 Field Season Quality 
Control SPMD Samples 
Data Flag Information Key: 
C Co-eluting peak present 
M Shifted peak unable to be quantified 
S Percent surrogate recoveries were either above or below the established 
limits set by the EPA in method 161 3-B (Telliard 1994) 
Quality Control Identification Key: 
DB Dialysis Blank 
FB Field Blank 
MS Matrix Spike 
PB Process Blank 
Cleanu~ Standard Recoverv 

TABLE E.l continued 
Cleanup Standard Recovery 
$37C1-TCDD 1 53.50 1 56.05 1 57.39 1 55.38 1 57.73 1 51.01 1 52.35 1 58.82 1 50.16 1 54.96 1 54.73 1 


l ~ l e a n u o  Standard Recoverv 

TABLE E.2 continued 
Cleanun Standard Recoverv 1 
TABLE E.2 continued 
Cleanu~ Standard Recoverv 
Cleanup Standard Recovery 
37C1-TCDD 1 82.49 1 85.06 1 86.41 1 77.30 1 79.28 1 64.05 1 78.58 1 59.30 1 76.56 I 
TABLE E.2 continued 
Cleanup Standard Recovery 
37C1-TCDD 1 74.09 1 54.64 1 78.02 1 94.14 1 56.11 1 49.42 1 72.84 1 68.47 1 
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